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Preface 
 
 
The outstanding advances of disciplines related to life sciences during the last decades led to 
the definition of a new type of scientist, quite different from the traditional figures of the last 
century. Today, the borderline between chemistry, biology, material science and other 
disciplines has become less defined. A modern scientist is no longer a person with a high 
experience in a very well delimited area, but he should rather have the ability to combine his 
defined background with a wide knowledge in many different fields, being able to deal at the 
same time with chemistry, biology, physics, medicine, and so on, in order to get a more 
complete understanding of the processes studied. 
In the work reported in this Ph.D. Thesis we tackled several aspects generally related to life 
sciences starting from a hard core of organic chemistry and trying to combine it with different 
disciplines, in order to have a deeper understanding concerning the properties of the 
synthesized molecules. The leading actors in this work are Peptide Nucleic Acids (PNAs), a 
class of oligonucleotide analogues able to recognize complementary nucleic acid sequences 
with improved selectivity and sensitivity, if compared to standard DNA oligonucleotides. 
This property has already made them very attractive tools for applications in many fields. In 
biology, they are extremely useful for genetic studies; in medicine, they are studied as tool in 
antisense and antigene therapy, and for the realization of diagnostic devices for genetic 
diseases; in food science, they can be used for specifically recognizing the ingredients in a 
food product; in material science, their assembly on surface can be manipulated in order to 
obtain desired patterns; in chemistry, synthetic approaches and chemical modifications are 
often investigated as well as their supramolecular binding properties. 
In this thesis, studies on modified PNAs will be reported. In particular, new chemical 
modifications will be introduced in the PNA backbone in order to ad hoc tune their properties 
for different applications. In particular, these new probes will be exploited for the 
development of new diagnostic methods and in nuclear uptake experiments. 
In Chapter 1 PNAs will be introduced, starting from the origins, reporting the various 
synthetic approaches used to synthesize these molecules, and showing the potential 
modifications which can be introduced in backbone and nucleobase, together with a summary 
of their main applications, both in biomedicine and diagnostics. 
Preface 
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In Chapter 2 a particular type of modified PNA probe will be presented, PNA molecular 
beacons. This type of molecule can recognize DNA without the need to label it in a pre-assay 
step, because of their ability to selectively recognize complementary sequences and to emit a 
fluorescence signal when hybridization takes place. PNA beacons will be applied in AE-
HPLC to develop a system able to detect with good selectivity a single nucleotide 
polymorphism diagnostic of an olive cultivar.  
In Chapter 3 the synthesis of chiral PNAs based on the structure of arginine will be described. 
These PNAs are designed in analogy to those based on lysine, which already demonstrated 
enhanced recognition performances compared to standard PNAs, especially in point mutation 
recognition. The replacement of lysine with arginine is necessary to develop chiral PNAs to 
be used on surfaces, for example for the fabrication of PNA-microarrays. In the chapter, the 
synthesis of the modified monomers will be reported and different designs will be tested. 
Finally the recognition properties of these probes will be compared with those of lysine-
PNAs. 
Chapter 4 will show their application for the fabrication of microarrays to be used for the 
recognition of two SNPs into the ApoE gene, which are involved in Alzheimer disease early 
onset. The design and synthesis of these PNA probes will be described together with the 
optimization of the method for the realization of the microarray system. Finally, the use of the 
device for the recognition of the different genotypes which can be given by the combination 
of possible SNPs will be reported. 
The possibility to upgrade the fabrication of the devices presented in Chapter 4 will be 
discussed in Chapter 5. Here, the use of microcontact printing for the derivatization of 
surfaces with chiral PNAs will be demonstrated. In the first part the optimization of the 
method will be described, since this is the first reported study on the use of microcontact 
printing involving PNAs. The potential applications of these simple devices will be 
demonstrated, studying the probe performances when linked to the surface, and testing the 
selectivity of the devices. The fabrication of microarrays performed by coupling a commercial 
array spotter with microcontact printing will be demonstrated, showing the improvements in 
terms of time required, reproducibility and cost of the device. 
Chapter 6 will explore a new potentiality of chiral PNAs, i.e. the ability to behave as a protein 
analogue, rather than as an oligonucleotide analogue. The design and synthesis of a model 
chiral PNA mimicking a Nuclear Localization Signal, a peptide able to be actively 
internalized in the nucleus by a receptor-mediated system, will be shown. The potential 
interaction between the modified PNA and the receptor will be shown through nuclear uptake 
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experiments. The modified PNA labeled with a fluorophore will be demonstrated to behave 
exactly like the NLS peptide, entering the nucleus, whereas a standard achiral PNA did not 
show this ability.  
The results presented in this Ph.D. Thesis are an important contribution to the field of Peptide 
Nucleic Acids and the advancements here presented pave the way for new applications. 
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Chapter 1 
 
PNAs: From birth to adulthood 
 
This chapter presents a general overview about Peptide Nucleic Acid synthesis, development 
and applications. The section includes the various synthetic approaches to this class of 
molecules, including standard and modified synthetic strategies. The insertion of many 
interesting features within the backbone or into the nucleobases are described, together with 
their influence on the hybridization properties, with particular focus on chiral PNAs, a class 
of molecules characterized by the insertion of amino acid side chains as substituents in the 
backbone. Finally, some of the most promising applications in medicine and analytical 
biochemistry are reported, showing some results obtained in the recognition of nucleic acids 
so far. 
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1.1 Introduction 
One of the most challenging target for the scientists in the last years is to understand what 
takes place in the cells and the ability to specifically control cell behavior, directing it towards  
desired functions. In particular, one of the most important and studied process is the storage, 
replication and use of all the information encoded in DNA because of its involvement, 
together with other factors, in the processes that regulate the whole cell life. How the genetic 
information is stored in this molecule, how it is transferred to RNA and how it is used in all 
aspects of cell life have been the subject of extensive studies. Nowadays many of these 
processes have been understood, but still some are unknown. What is clear is that the ability 
to control and manipulate nucleic acids in a cell might open the possibility to control the cell 
itself. Targeting a particular gene directly in the nucleus or the messenger RNA produced in 
the cytoplasm can selectively suppress or enhance the presence of a certain protein in a cell, 
changing its fate in terms of development, replicative ability, toxicity, or killing it. This ability 
could be exploited in many fields, but one of the most important is undoubtedly medicine, 
where selective killing or selective growth of particular cells can make the difference between 
health or illness. Anyway, gene regulation is only part of the goals that can be achieved by 
techniques aimed at specific gene targeting, since also diagnostic applications are of 
paramount importance. A specific and selective detection of particular sequences may be 
useful in order to better understand cellular processes in which those sequences are involved. 
Alternatively, when it is already known that a particular sequence is involved in the onset of a 
disease, its fast recognition can be extremely useful in the early diagnosis. Finally, the 
recognition of DNA sequences typical of bacteria or contaminant organisms, or RNA 
sequences typical of viruses, can give very important information about their presence or 
absence in air, water or food.  
1.2 Synthetic DNA Analogues 
It is clear that nucleic acid recognition  is a very hot topic. In order to achieve this task, highly 
performing molecular tools, able to form stable complexes only with the desired sequences 
are needed. As a matter of fact, given a particular DNA sequence in a given genome, there 
always is a huge number of other sequences, only differing for few bases or even for only 
PNAs: from birth to adulthood 
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one, that can also be recognized by the same probe due to the similarity with the target 
sequence. For this reason, the molecular probe used to target a given sequence has to be very 
selective and, at the same time, it has to form very stable complexes, given the low amount of 
DNA to be recognized usually present in the biological matrices. 
 Synthetic DNA oligonucleotides complementary to the target sequence are among the most 
common probes used for this purpose.  Nowadays, DNA oligonucleotides are commercially 
available and quite cheap, but several drawbacks are associated with them. Synthetic 
nucleotides identical to natural ones can obviously be recognized and cleaved by DNAse 
enzymes, a limitation for in vivo applications, and a potential problem also for in vitro 
applications, when contaminations occur. Moreover, in order to obtain stable complexes, long 
oligonucleotides are often required (20 nuclobases or more), and this can lead to a decreased 
selectivity that may disturb target recognition in diagnostic applications or affect 
unselectively many different cells during in vivo applications.1  
A further problem is given by the high ionic strength required for overcoming the electrostatic 
repulsion between the two negatively charged strands (the target DNA and the 
oligonucleotide probe), limiting diagnostic applications in a low ionic strength environment. 
Finally, in vivo applications of DNA oligonucleotides are usually limited by the low cellular 
uptake, since simple oligonucleotides are not able to enter the cells2. The answers to these 
problems might come from the synthesis of new molecules obtained by suitable modifications 
of the DNA structure3.  
Many modifications have been introduced, and among those which gave good results, some 
presented only minor changes (for example the bonds between each DNA monomer), others 
showed major structural changes within the backbone (Figure 1-1). 
Phosphorothioate oligonucleotides (PS-DNA) can be obtained by substitution of one non 
linking oxygen atom from the phosphate group with a sulfur4. These molecules are more 
chemically and enzimatically resistant, and they have been used as antisense drugs, and are 
usually classified as first generation antisense oligonucleotides. However, they still presented 
some problems, such as a lower binding efficiency towards RNA, aspecific interactions with 
some proteins, and some toxicity when used in living organisms. N3’-P5’ phosphoroamidates 
(NPs)5, are another structure obtained by the substitution of an oxygen atom from the 
phosphodiester group with a nitrogen atom. These analogues were synthesized and tested in 
binding assays, showing increased binding towards complementary sequences if compared to 
DNA oligonucleotides as well as enhanced enzyme resistance. Evolution towards better 
modifications led to 2’-O-methyl (OMe) and 2’-O-methoxy-ethyl RNA (MOE), usually 
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classified as second generation antisense oligonucleotides. In these classes of molecules, 
substituents have been introduced in position 2’ of the ribose ring, improving performances in 
terms of RNA affinity and lowering the in vivo toxicity. These oligonucleotides have been 
applied as antisense agents thanks to their ability to bind and block m-RNA.  
 
Figure 1-1: Chemical structure of the main oligonucleotide analogues of first, second and third 
generation 
These features have been further improved with the so-called third generation 
oligonucleotides, where more substantial modifications have been inserted. Locked Nucleic 
Acids (LNAs) are among the most popular and are obtained by inserting a methylene bridge 
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between the 2’oxygen and the 4’ carbon of the ribose ring6. Pure LNA oligonucleotides can 
be used, as well as mixed oligonucleotides with standard DNA monomers and LNA 
monomers, obtaining an increased affinity for DNA and RNA, and resistance to enzymes. The 
good cellular uptake also allowed applications in gene therapy with good results7. In 
morpholino oligonucleotides (MF), the ribose ring is replaced by a morpholino moiety and 
phosphoroamidate linkages are used instead of phosphodiester bonds8. The affinity for 
complementary sequences is similar to that of DNA oligonucleotides, the enzymatic stability 
is high and unspecific interactions with proteins are not observed, allowing for their use for 
in-vivo applications. Cyclohexene nucleic acids (CeNA)9, tricyclo-DNA (tcDNA)10, 2’-
deoxy-2’-fluoro-β-D-arabino nucleic acid (FANA)11 are other types of DNA analogues which 
show an increased affinity towards DNA and RNA, if compared to standard oligonucleotides. 
The affinity usually increases because of the absence of negative charges in the backbone, 
avoiding electrostatic repulsions with the target DNA strand, or for the introduction of more 
rigid groups, able to maintain the correct nucleobase orientation to form Watson-Crick 
interactions. The increase of in vivo stability usually observed is due to the inability of 
degrading  enzymes to recognize the modified structures12. 
1.3 PNA 
The quest for the development of a high performance DNA analogue led in 1991 to the 
synthesis of another type of modified nucleic acids, called Peptide Nucleic Acids (PNAs)13.  
 
Figure 1-2: Comparison of PNA and DNA chemical structures (P. E. Nielsen et al., Science, 1991, 
254, 1497) 
This class of nucleic acid analogues has been obtained by completely changing the DNA 
backbone chemistry. The classical sugar-phosphate backbone, in fact, has been replaced with 
PNA DNA
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a psudopeptide one based on the repetition of achiral N-(2-aminoethyl)glycine monomer units 
linked by amide bonds (Figure 1-2). Nucleobases are derivatised with a carboxymethyl unit 
that is linked to the nitrogen in position 3 of the backbone by another amide bond. Although 
this class of molecules appears very different from standard DNA molecules, it preserves the 
correct features to form Watson-Crick bonds, since the distances between the nucleobases, 
and their distances from the backbone, are the same as in standard DNA. Although they 
preserve the ability to form the same interactions as the DNA oligonucleotides, the different 
chemical structure of PNAs causes some modifications of their chemical and physical 
properties. The most evident difference is the lack of charge in the PNA backbone, due to the 
replacement of the phosphate bond with an amide one. This feature avoids charge repulsion 
when the molecule forms duplexes with DNA or RNA, increasing duplex stability. 
Unfortunately, the very same feature introduces some problems in the use of the PNAs, since 
the lack of charges actually reduces probe solubility in water, making solubility highly 
sequence-dependent14. For the same reason, self aggregation in solution often occurs, as well 
as aspecific adsorption on polystyrene vials, which may be a problem since it reduces the 
concentration of active molecules in solution. 
An important feature for a probe that has to recognize biomolecules is its chemical stability as 
well as the resistance towards enzymes. From this point of view, PNAs can be considered 
optimal, because their unnatural structure prevents recognition both by DNAses (because the 
backbone has a peptide-like structure) and by proteases (because of the pseudopeptide 
backbone). Moreover, the typical stability of the amide bonds allows for a long storage of the 
molecules and of the devices built with them15. The pseudopeptide structure, finally, allows to 
obtain these molecules by using solid phase peptide synthesis, rather than oligonucleotide 
one, making their production easier and less sensitive to synthetic impurities such as moisture. 
1.4 Hybridization properties of PNAs 
The study of PNA hybridization properties is crucial in order to understand their ability to 
bind complementary sequences; for this reason, it is important to evaluate the energy 
necessary to denaturate a PNA-DNA or a PNA-RNA duplex. Melting temperature 
measurement is one of the simplest method to evaluate the affinity of PNAs for 
complementary sequences; it consists in warming up a solution containing the duplex and 
measuring the temperature where the complex is half denaturated. This value can be obtained 
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that may compete with the formation of the duplex. PNAs can also form stable PNA-PNA 
duplexes, still based on standard Watson-Crick hydrogen bonds. Recognition experiments 
demonstrated that PNA-PNA duplexes are more stable than PNA-RNA and PNA-DNA 
complexes. 
Although natural nucleic acids form duplexes only in the antiparallel form, PNAs have the 
peculiar property to bind complementary sequences either in antiparallel and parallel 
orientation, albeit antiparallel binding is usually strongly preferred, giving more stable 
duplexes. The antiparallel is conventionally defined as the one in which the amino terminus of 
the PNA faces the 3’ end of the DNA19 (and obviously parallel complexation is defined in the 
other way round) (Figure 1-3) 
One of the most important features of PNAs is their ability to selectively recognize a 
complementary sequence and to discriminate it from other sequences only differing for one 
nucleobase20. Recognition experiments done on PNA-DNA duplexes showed a selectivity, 
expressed as difference in Tm between fullmatch and mismatch duplexes, which is more than 
5°C higher than that measured for the corresponding DNA-DNA duplexes. This binding 
specificity makes PNAs suitable for all the diagnostic and therapeutic applications where 
mismatch recognition is required. 
Another interesting feature of PNAs is their ability to form complexes other than duplexes. 
Homo-pyrimidine PNAs bind to complementary DNA sequences to form (PNA)2-DNA 
triplexes exploiting Watson-Crick interaction for one PNA strand and Hoogstein for the 
binding of the second strand. Since a protonated cytosine is involved in the base triplet 
formation, this is most stable in the pH range of 5.0 –5.521 (Figure 1-4). These complexes are 
characterized by a very high stability: a poly-T PNA decamer hybridized with a poly-A DNA 
decamer showed a melting temperature of 72°C, while only 23°C was observed for the DNA-
DNA complex. The formation of analogous (PNA)2-RNA complexes has been investigated as 
Figure 1-4: Watson-Crick and Hoogstein interaction in triplex formation. 
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well, and their stability has been found to be similar to that of the triplexes formed with DNA. 
Modified nucleobases, such as isocytosine, which is permanently protonated in one 
Hoogsteen hydrogen bond donor site, independently from the pH, make the triplex formation 
easier22. The PNA ability to form very stable triplexes can be exploited when the probes are 
targeted to double stranded DNA: when the target sequence is homopurinic, homopyrimidinic 
PNAs show the ability to open and invade the double helix, performing strand invasion, to 
form (PNA)2-DNA triplex (triplex invasion)23. Moreover, purine-rich PNAs, are also able to 
invade DNA-DNA helices by forming PNA-DNA duplexes (duplex invasion)24, while C rich 
PNAs triplex forming ability can be exploited in double stranded DNA to form PNA-(DNA)2 
triplex complexes22 (Figure 1-5). 
 
Figure 1-5: Scheme of the complexes formed by PNA and double-stranded DNA. PNA oligomers are 
drawn in bold. (1) Standard duplex invasion complex formed with some homopurine PNAs. (2) 
Double-duplex invasion complex, possible with PNAs containing modified nucleobases. (3) 
Conventional triplex formed with cytosine-rich homopyrimidine PNAs (4) Triplex invasion complex, 
leading to the displacement of the second DNA strand into a ‘D-loop’. (F. Pellestor, P. Paulasova, 
European Journal of Human Genetics, 2004, 12, 694) 
This ability can be exploited in vivo, because it allows to easily target the desired nucleic acid 
sequence. Unfortunately, the necessity to have homo-pyrimidine or homo-purine sequences 
for efficient DNA invasion is a strong limitation, because it limits the choice of the target 
sequence.  
In order to overcome this problem, new methods have been developed to perform strand 
invasion. One of the most efficient strategy is the so-called double duplex strand invasion, 
which is possible to achieve by using two PNA sequences targeted to complementary 
sequences of the double strand DNA; in order to avoid the formation of a PNA-PNA duplexes 
(the two PNAs are obviously complementary to each other), PNAs should contain 
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pseudocomplementary nucleobases, such as diaminopurine (as an adenine substitute) and 
thiouracil (as a thymine substitute), that bind complementary nucleobases (thymine and 
adenine respectively), but do not bind to each other25. Another strategy is PNA tail-clamp, 
which takes place by coupling the probe complementary to the target sequence with a 
homopurine sequence (the “tail”). This tail opens the DNA and binds to the double helix, 
allowing the insertion of the second real targeting sequence26. 
Recently the use of chiral γ-PNA containing an alanine residue with a precise stereochemistry 
allowed the formation of PNA-DNA Watson-Crick complexes with double stranded DNA. 
The preorganization given to the probe by the insertion of these substituents increased the 
stability of the complexes obtaining probes able to perform strand invasion quite easily, 
simplifying the design of the probe27. Chiral PNAs have been also tested in strand invasion 
tests, in particular PNAs bearing 2D-Lysine monomers have been used in double strand 
invasion experiments. It was found that when a lysine chain is introduced in the monomers 
bearing the pseudo complementary nucleobases, double strand invasion efficiency is highly 
incremented also in difficult sequences where it was never performed quantitatively with 
other methods28.  
The possibility to avoid the use of pseudo complementary nucleobases is offered by the use of 
single stranded DNA binding proteins which, trapping the single-stranded portion formed by 
the invasion, promote the whole process29. If this strategy is coupled with the use of 2D-
Lysine modified PNAs it can be further improved since shorter and more stable probes can be 
used30. 
1.5 PNA synthesis 
PNAs can be synthesized on account of their pseudopeptide structure by using Solid Phase 
Peptide Synthesis procedures, by manual synthesis or automatic synthesizers, which also 
allow parallel syntheses when the screening of multiple sequences is necessary. The generic 
synthetic procedure can be summarized as in figure 1-6. 
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Figure 1-6 Schematic representation of the synthesis of PNAs by Solid Phase Peptide Synthesis 
(SPSS) 
Different strategies can be used, depending on the group used to temporarily protect the 
amino terminal moiety. In a perfect analogy with standard peptides, the first strategy used for 
PNA synthesis was the Boc strategy31, but later also the Fmoc approach has been extensively 
used32; nowadays, these two are the most used strategies for PNA synthesis and also the most 
affordable, since Boc and Fmoc protected PNA monomers (Figure 1-7) are today 
commercially available. The synthesis of PNAs always starts with the loading of the resin 
used with the first monomer of the sequence. The loading of the resin is important, because it 
sets the amount of molecules growing for each solid support: the high resin loading usually 
adopted in standard peptide synthesis (0.5-1 mmol/g in active sites) may cause problems 
during the synthesis, due to the steric hindrance among the growing PNA chains; thus usually 
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a loading of 0.2 mmol/g is used, and sometimes even lower loadings are required for long or 
hindered sequences. Unreacted amino groups after the downloading are usually blocked with 
a mixture of acetic anhydride and pyridine in N-Methylpyrrolidone (NMP). The synthesis 
continues with the deprotection of the primary amino group of the monomer loaded on the 
resin. The conditions of this reaction depends on the strategy adopted: Fmoc groups, in fact, 
are removable by treating the molecule with a solution of a nucleophilic base, such as 
piperidine, while Boc groups are removed under acidic conditions, usually with neat 
trifluoroacetic acid. Obviously the reactivity difference between the two strategies implies a 
difference in the group used for protecting the exociclic amino groups of the nucleobases, 
which should be stable during all the step of the synthesis. For this reason Bhoc groups are 
commonly used for Fmoc chemistry, and Z groups for Boc strategy. In the subsequent step, 
the deprotected amino groups are then linked to the carboxyl group of the next monomer. The 
coupling reaction is usually carried out with standard techniques derived from peptide 
synthesis: the carboxylic group is transformed in an active ester that can react with the amines 
of the growing chains. Many activators can be used, among which uronium reagents such as 
2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) and 2-
(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU) are 
the most used, albeit other activators have been employed, like 2-(3,4-dihydro-4-oxo-1,2,3-
benzotriazin-3-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TDBTU) and 3-
(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-on (DEPBT), especially when chiral 
centres are introduced in the molecule and their optical purity has to be preserved33.  
When the synthesis is complete, the molecule has to be removed from the resin and fully-
deprotected at the same time. The cleavage of the molecule from the resin is done by 
exploiting the active linkage of the molecule to the solid support. Depending on the strategy 
used, different polystyrene based supports can be used: Fmoc chemistry is usually done on 4-
Methylbenzhydrylamine (MBHA) Rink-Amide or Wang resin, that can be cleaved in TFA:m-
cresol mixture, while Boc chemistry is usually done on MBHA resin, that is cleaved in 
stronger acidic conditions (TFA:TFMSA mixtures). The presence of scavengers during the 
cleavage, such as m-cresol and thioanisol, is often necessary in order to block the reactive 
cations produced during the deprotection of all groups. The final product is the fully-
deprotected PNA having a free carboxylic group or a carboxamide at the C-terminus, 
depending on the linker used: MBHA-based resins produce PNA amides, while Wang resins 
may allow, when necessary, the production of the PNAs as free carboxylic acids. Due to the 
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repetitive and easy protocols used, the synthesis can be implemented on an automated 
synthesizer for peptide chemistry, making these molecules more affordable34. 
Many efforts have been done for finding alternatives to the standard synthetic strategies, in 
order to make PNA synthesis cheaper, or to use milder conditions for the linking of acid-
sensitive groups. This led to the development of other protecting groups: dithiasuccinoyl (Dts) 
(Figure 1-7) has been used because this group can be removed under mild deprotecting 
conditions by treatment with a thiol in slightly acidic conditions. The deprotection of Dts can 
be carried out by using dithiothreitol (DTT) in acetic acid-CH2Cl2, followed by neutralization 
with diisopropylethylamine (DIEA)-CH2Cl2 and subsequent coupling of Dts-PNA-monomer 
by using HBTU/DIEA in NMP35. The monomethoxytrityl (Mmt) protecting group (Figure 1-
7) strategy has been developed for the same reason, in order to use milder conditions during 
the synthesis36, since the Mmt group can be removed by treatment with 3% trichloroacetic 
acid in CH2Cl2. In order to ensure mild synthetic conditions, a new solid phase linker based 
on an aminohexyl spacer and a base cleavable succinyl linker have also been developed, 
which allow to perform the cleavage by treatment with an ammonia solution, with the 
simultaneous deprotection of the acyl-protected nucleobases. The four monomers have been 
synthesized and a PNA probe was produced by using this technique, obtaining a molecule of 
purity comparable with those produced by standard technique procedures.  
Other examples of different synthetic approaches can be found in the literature, such as the 
use of the azide groups (Figure 1-7) in order to mask primary amines; these groups protect the 
amine during the synthesis and can be reduced by phosphine after the coupling37. The 
synthesis of PNAs using 1-(4,4-dimethyl-2,6-dioxacyclohexylidene)ethyl (Dde) protected 
monomers has been demonstrated as well38 (Figure 1-7). This group represents an alternative 
to Fmoc group, since it can be removed under mild slightly basic conditions, using a 
hydrazine solution, that removes also the Fmoc group; lately a deprotection step has been 
optimized, using hydroxylamine (mixture of NH2OH·HCl and imidazole) under slightly 
acidic conditions which is fully orthogonal to the Fmoc group. 
Another strategy is the so called “fully protected backbone approach”, in which a backbone 
containing protecting groups in place of the nucleobase is synthesized. The selective 
deprotection of the protecting groups and coupling with the correspondent nucleobase gives 
the complete PNA39. PNAs were synthesized by using this technique, in order to verify the 
quality of the technique, only containing cytosine and thymine; more complex sequences still 
have to be synthesized. A challenging but charming approach is the template synthesis40, 
which implies the synthesis of a PNA backbone without nucleobases, and the use of a 
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complementary PNA sequence to address the nucleobases in the desired position, by 
exploiting the Watson-Crick complementarity. The nucleobases are linked to the amino group 
of the backbone by an N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) mediated 
coupling or deoxyPNA can be obtained when the reaction is a reductive amination. Recently 
another strategy has been developed in order to make the synthesis faster and cheaper41. The 
key step of this new strategy is the protection of the primary amino group by benzothiazole-2-
sulfonyl (Bts), which acts not only as a protecting group for the primary amino group, but also 
as activating group for the carboxyl moiety of the incoming monomer. The monomers are 
actually synthesisized as cyclic piperazinones (Figure 1-7), which can be stored for a long 
time in DMF and are reactive with an amino group. Nowadays this technique is exploited to 
synthesize commercially available PNAs. 
 
Figure 1-7: Structure of common protecting groups used in PNA synthesis 
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1.6 Modified PNAs 
The advantages of using PNAs in DNA recognition have been extensively discussed in the 
previous sections but, albeit their interesting properties, continuous improvements are being 
extensively pursued. These attempts led in the last years to the synthesis of several modified 
PNAs. PNAs can be modified by covalently linking to them other structures, such as 
oligonucleotides (PNA-DNA chimeras), peptides or other molecules, or modifying the PNA 
backbone or the nucleobases. One of the first modifications introduced in a PNA probe, 
adopted for its simplicity since the very first PNAs synthesized, was obtained by linking a 
positively charged amino acid (a lysine) at the C-terminus, in order to improve the molecule 
solubility. The conjugation with more complex peptides has also been subsequently exploited 
in order to tune the PNA properties, such as cell penetration, DNA affinity and solubility42. 
The linking of amino acids or peptide sequences to PNA is actually very straightforward, 
since the synthetic approach used for PNA can be readily extended to peptides, making the 
synthesis of PNA-peptide conjugates a simple task. A more complex chemistry has to be 
developed for the synthesis of PNA-DNA chimeras, due to the different synthetic strategies 
and conditions used for the peptide and for the oligonucleotide solid phase synthesis. PNA-
DNA chimeras are characterized by an improved solubility, due to the introduction of 
negative charges, and the possibility to be recognized by enzymes that usually do not 
recognize standard PNAs, such as DNA polymerases, although the non-standard structure 
also gives resistance towards nucleases43. 
The evolution of PNAs led to the development of probes containing one or more modified 
monomers. Most of the modifications have been inserted in order to increase the affinity and 
the specificity towards the complementary DNA sequences. The modifications can be applied 
to the nucleobases, in order to extend the hydrogen bond network with the complementary 
base, or to the backbone, in order to tune the rigidity and induce a preorganization more suited 
for the hybridization with the complementary DNA sequence44. The insertion of such 
modifications within the backbone can be done by changing the length of the backbone, by 
introducing substituents on  the backbone itself, usually in position 2 or 5, by cyclizing the 
backbone, by modifying the linker with the nucleobase, or by changing the chemistry of the 
bonds between the monomers. 
The effects of the backbone length on PNA hybridization properties have been studied by 
synthesizing PNA monomers containing one more methylene group in the glycine or the 
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aminoehtyl moieties, or in the linker unit to the base. PNAs containing such monomers have 
been synthesized either as completely modified oligomers, either as partially modified. The 
results showed that the standard monomer length is the optimal for DNA recognition in terms 
of duplex stability and selectivity45. The distance of the nucleobase from the backbone or 
between the nucleobases is the most influent factor, while not much difference was found 
when the backbone was lengthened on either sides.  
 
Figure 1-8: PNA backbone modifications based on acyclic structures 
Ornithine PNAs, instead are based on the structure of ornithine, having the carboxymethyl 
nucleobase linked to the nitrogen in α, and the ornithine side chain linked by its amino group 
to the following monomer46 (Figure 1-8). It was demonstrated that an omithine PNA analogue 
is a structural DNA mimic for recognizing RNA albeit not as effective as the original 
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aminoethyl glycine PNA. Using a poly-T ornithine-PNA, a triplex was formed with 
complementary RNA, while DNA was not bound47.  
Substituents inserted in the backbone are usually based on amino acid synthons, which are 
usually employed in order to have side chains either in position 2 or 5 (Figure 1-8). 
Monomers based on neutral, positively and negatively charged amino acids in position 2 have 
been synthesized and incorporated in PNAs48,49, then tested in binding assays. The results 
clearly indicated the roles played by different parameters for tuning the DNA affinity of 
PNAs: charge, steric hindrance, stereochemistry. By analyzing the PNA-DNA stability, in 
fact, it is possible to observe that the steric hindrance introduced by bulky side chains (typical 
examples are leucine, tryptophan or phenylalanine)50, as well as the electrostatic repulsion 
existing between negatively charged PNAs and DNA (for example when incorporating 
glutamic or aspartic acid)48 led to less performing PNA probes. On the other hand, side chains 
bearing a positive charge (based on lysine or arginine)48,49,51 inserted in the backbone 
positively contribute to the PNA-DNA duplex stability, due to the positive electrostatic 
interactions.  
As far as stereochemistry was concerned, the analysis of the binding abilities of PNAs 
incorporating in position 2 enantiomeric monomers either based on D- or L-amino acids led to 
the conclusion that stereochemistry plays a very important role in DNA recognition. It was 
found that D-amino acid containing monomers increase the PNA-DNA duplex stability as 
compared to the enantiomeric counterparts, independently from the nature of the side chain. 
In order to further improve the PNA abilities, the combined use of positive electrostatic 
interactions and chiral properties led to the development of monomers containing a D-lysine 
side chain in position 2. Incorporation of such monomers in PNAs showed a great 
improvement in complementary DNA and RNA  sequence  recognition, both in terms of 
affinity and single mismatch discrimination.52 When the lysine side chain is substituted with 
arginine, the binding properties are conserved, but in vivo experiments demonstrated better 
cellular uptake, allowing the application of these probes as antisense drugs53. The introduction 
of analogous side chains in position 5 has been used both to improve hybridization properties 
and to introduce fluorophore groups without affecting sequence recognition, obtaining the so 
called γPNAs54.  
Backbone modifications can be introduced not only on the carbon atoms, but also on the 
nitrogen ones. For example, peptoid and aminopeptoid PNAs (Figure 1-8) can be obtained if 
the aminoacidic side chains are introduced on the nitrogen in position 655. Such PNAs have 
been synthesized with side chains bearing an amino group at the end, but different carbon 
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spacers between this group and the backbone. The results showed that, although short chain 
resulted in PNA-DNA duplex destabilization, four or longer carbon spacers did not 
destabilize the complex, which conserved the same selectivity of unmodified PNAs. The 
observation that also biotin-labeled side chains did not disturb the binding demonstrated that 
this method can be exploited in order to add another position for labeling the PNA probe. 
Another type of backbone modification inspired by the peptide structures is that of the so-
called alanyl-PNAs56 (Figure 1-8), in which the backbone is a standard peptide structure 
including alternated alanyl units. The nucleobases are linked to the methyl side chain, in the 
β-position, the linker length can be changed obtaining homoalanyl and norvalyl PNA 
monomers. Preliminary studies carried out by hybridizing these molecules with similar 
structures demonstrated their ability to interact specifically via Watson-Crick and Hoogstein 
bonds, (even if non conventional pairing mode were observed in some cases) to form double 
strand structures; the system has been used to understand to role of side chains in the 
recognition processes. The results showed that a three atom linker (norvalyl-PNAs) has a 
reduced ability to form specific interactions due to its flexibility, while shorter carbon linkers 
show better performances. 
The attempt to induce preorganization in PNAs, in order to obtain more stable duplex and 
more rigid and selective probes, is one of the crucial points in PNA modification. As said 
before, the introduction of cyclic structures within the PNA backbone is one of the 
conceptually (albeit not synthetically) simplest ways to obtain this effect. Several cyclic 
PNAs have been developed, starting from five or six member rings. Modifications based on 
five membered rings originated from the structure of proline or pyrrolidine57. Libraries of 
cyclic backbone modifications were also developed, but very few of them showed 
improvement in DNA or RNA recognition, as compared to unmodified PNAs: among these, 
aminoethylpyrrolidinone PNA (aepone-PNA)58, pyrrolidine PNA and aminoethylprolyl PNA 
(aepPNA) showed significant hybridization properties59 (Figure 1-9). Cyclopentane PNAs of 
various stereochemistry were also tested and among these, (S,S)-trans-cyclopentane PNA 
contains the correct stereochemistry for DNA binding60.  
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Figure 1-9: Strucures of the main PNAs bearing cyclic modifications in the backbones 
Among PNAs containing six-membered rings, piperidine PNAs61 (Figure 1-9) showed good 
improvements in DNA recognition forming more stable triplexes when hybridized to polyA 
complementary DNA, the effect being particularly evident when the modified monomer was 
placed at the C-terminus. Aminocyclohexylglycyl PNA (Figure 1-9)57 showed good 
performance when the isomer SR or RS were used. In particular, the choice of the 
stereocenter configuration allowed to obtain PNAs more performing when the complementary 
DNA sequence had to be recognized, or when RNA had to be discriminated over DNA. While 
the insertion of one or two 1R-2S monomers increased the discrimination of a point mutation, 
the use of 1S-2R monomers increased the selectivity in poly-A RNA binding (compared to 
DNA). When using three modified monomers in the same sequence (one in the middle and 
Cyclic PNA Backbone Modification
Chapter 1 
24 
two and the opposite ends) PNAs showed an excellent discrimination of RNA mixed 
sequences over DNA, reaching 50°C of discrimination in the best case62. 
Aromatic PNAs (APNA) and the second generation N-(2-aminobenzyl)glycine or N-(2-
aminobenzyl)-β-alanine (APNA-PNA Chimera) are another example of cyclic PNAs in which 
the aminoethyl part of the monomer is replaced by aromatic rings (Figure 1-9). Several 
preliminary experiments with different structures demonstrated that, although the substituents 
are very bulky and the PNA conformation is strongly influenced by the aromatic ring, when 
modifying the distances between the nucleobases, the PNA-DNA complexes are only slightly 
destabilized, maintaining the same selectivity,63. 
The effects of modifications introduced in the linkers between PNAs and nucleobases have 
also been studied, in order to understand the role of the tertiary amide in complementary 
sequence recognition. For this reason, the carboxylic linker has been replaced by a double 
bond-based linker, obtaining Olefin PNA (OPAs)64. The molecules were synthesized by 
controlling the double bond stereochemistry, in order obtain (E)-OPAs or (Z)-OPAs and to 
check the different influence of the nucleobase orientation on the DNA affinity. The 
observation that OPAs conserved the PNA recognition properties, but showed a highly 
decreased DNA affinity, demonstrated the importance of the amide unit in the duplex 
formation. The same study was further extended by modifying the linker, such as in 
Fluorinated Olefinic PNAs (F-OPNAs), in which the OPA were further modified by linking a 
fluorine atom  to an olefinic carbon (Figure 1-8). Fluorine was used because it gives a dipole 
moment similar to that of carbonyl group, but it is not able to make hydrogen bonds. Strong 
dependence of the hybridization properties depending on the position of the modification was 
observed65, excluding that the linker dipole had an effect in the hybridization process. 
Another part that can be ad hoc modified to introduce new features in PNA is the chemical 
bond between two PNA monomers. Phosphono-PNA (pPNA, Figure 1-8) is a class of 
molecules characterized by the insertion of a phosphate ester or phosphonamide bond 
replacing the amide bond between monomers, mainly for solubility reasons. The insertion of 
negative charges, which could be a problem for DNA binding because of the electrostatic 
repulsion, was actually demonstrated to be almost ininfluent on the affinity of some mixed 
PNA-pPNA probes for the complementary DNA sequence, which did not change as 
compared to the unmodified probe66. Another type of modification introduced is that of Oxy-
PNA, another class of modified PNA molecules obtained using the monomer -NH-CH(CH2-
CH2-Base)-CH2-O-CH2-CO-. PNAs containing these modified structures have been 
synthesized and studied by UV spectrophotometry, demonstrating that they can hybridize 
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DNA and RNA complementary sequences showing a melting curve sharper than standard 
DNA-PNA duplexes and a comparable stability67. Finally, also deoxyribose or riboseamide 
PNA have been obtained, in which the phophodiester bond from DNA was substituted by an 
amide bond. Some PNA probes containing one or more of these modified monomers were 
synthesized and tested, although the performances were not particularly noteworthy68. The 
development of hydrazino-PNAs, probes having the primary terminal amino group replaced 
by a hydrazine moiety, took place projecting a monomer having two orthogonal protecting 
groups on the two nitrogen atoms of the hydrazine unit, being able to tune the reactivity of the 
molecule during the oligomerization69. 
As mentioned before, synthetic efforts have been devoted not only to the modifications of the 
backbone, but also to the introduction of new groups in the structures of the nucleobases, 
mainly with the aim of increasing the affinity for the complementary sequences. This was 
usually done in two ways: by increasing the aromatic part, in order to increase stacking 
interactions, or by increasing the possibility to form hydrogen bonds70. The synthesis of 
bicyclic or tricyclic analogues has been one of the most used ways to improve hydrophobic 
interactions. Many thymine analogues bearing an extra cycle have been developed: 7-chloro-
1,8-napthyridin-2(1H)one (7-Cl-bT, Figure 1-10) turned out to increase the PNA affinity 
towards complementary DNA71, and an also tryciclic cytosine based on benzothiazine-
pyrimidine (Figure 1-10) structure showed good performance as well, since it increased the 
stability of the duplex and was highly fluorescent72. The same structure was used in order to 
add an alkyl chain with a tertiary amine, able to form an extra hydrogen bond when guanine 
has to be bound, obtaining the so-called G-clamp (Figure 1-10); this modification increased 
the duplex stability as well as increased sequence selectivity73. Another field in which the 
modifications introduced into the nucleobases can have a big impact is the formation of PNA-
DNA2 triple helices. Since standard cytosine only forms Hoogsteen interaction when 
protonated, thus making its performances strongly pH-dependent, the use of 
pseudoisocytosine (J base), permanently protonated at the Hogsteen donor site,74 in place of 
cytosine, eliminates the necessity of having an acidic pH during triple helix formations; 1,8-
napthyridin-2,7-(1,8H)-dione (K base) was a further improvement in this field: due to its 
increased stacking contribution, formation of triplex at neutral pH was favoured75(Figure 1-
10). 
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Figure 1-10: Chemical structures of some of the most successful modified nucleobases developed to 
increase Watson-Crick (upper row) or Hoogsteen (lower row) interactions 
In general, the development of new modifications led to the synthesis of a large number of 
different bases, characterized by different properties. The introduction of alkyl chains ending 
with reactive groups has also been fully exploited in order to introduce fluorophores after the 
synthesis of PNAs or by directly synthesizing PNAs with bases bearing pre-linked 
fluorophores.  
Development of non-discriminating nucleobases (nucleobases which may recognize with the 
same stability A, G, T or C) is another field of studies that led to the synthesis of derivatives 
able to recognize all the nucleobases by stacking interactions, rather than by hydrogen bonds, 
obtaining PNA probes which may be used when sequences only differing for a point mutation 
have to be targeted with the same affinity70. 
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1.7 Chiral PNAs 
Among all these classes of modified PNAs, the introduction of stereogenic centers into the 
backbone is undoubtedly the best way to tune the PNA properties towards the desired 
functions. Suitably designed chiral PNAs are always those giving the best  results in terms of 
DNA affinity, mismatch recognition, RNA/DNA selectivity, ability to perform strand 
invasion, cellular uptake, solubility and so on. As described before, chirality can be 
introduced into the PNA backbone in many different ways. In this paragraph we will discuss 
more thoroughly the properties of chiral PNAs  having a backbone based on aminoacidic side 
chains inserted in position 2 or 5 or both. The earliest work was done on chiral PNAs 
modified in position 2. As outlined above, side chains based on different amino acids were 
tested, and the best results were obtained by using PNAs including monomers synthesized 
starting from D-lysine76, which showed an increased affinity towards the complementary 
sequences as well as a better selectivity in their recognition. Indeed, a PNA that allowed to 
obtain outstanding results in terms of selectivity was obtained by inserting three chiral 2D-
Lys monomers in adjacent positions, obtaining the so-called “chiral-box” PNA77. This probe 
was able to perfectly discriminate antiparallel DNA vs. parallel DNA in duplex formation, a 
recognition not affordable with standard PNAs. Moreover selectivity experiments showed that 
this probe also had a perfect selectivity in point mutation discrimination. A crystal structure 
obtained by hybridizing a “Chiral Box” PNA with the complementary DNA, allowed to 
investigate the contribution of the chiral modifications to the duplex structure.78  
The introduction of positively charged side chains was also exploited for opening DNA 
double helices in order to perform double strand invasion. Gel-shift experiments demonstrated 
that when the pseudocomplementary nucleobases are coupled with chiral monomers bearing 
D-lysine side chains in position 2, double strand invasion ability was improved and applicable 
also to difficult sequences79.  
Further modifications were subsequently introduced not only in position 2, but also in 
position 5. These molecules are called γPNAs, in order to distinguish them from the previous 
ones, called α-PNAs. It was demonstrated that when L-lysine side chains are introduced in 
this position, the recognition performances improve80. The lysine side chain can also be 
exploited for introducing fluorescent groups or peptides, since the increased affinity towards 
the complementary sequences are preserved also when the amino end is acetylated or 
derivatised; the stability decreases only when bulky fluorescent dyes are introduced81.  
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PNAs including monomers containing D- or L-Lysine side chains in position 2 and 5 were 
also synthesized and studied during the hybridization of complementary sequences. As 
predictable, the best configurations turned out to be 2D-5L, and the affinity and the selectivity 
where the highest for these probes.  
The reasons for the high performances showed by chiral PNAs were investigated by studying 
chiral PNA-PNA duplexes by circular dichroism, also by using  cyanine dyes such as Disc2(5) 
dye82, which is able to form aggregates into the minor groove of a duplex PNA-PNA or PNA-
DNA. The formation of such complexes can be detected by UV-Vis spectrophotometry, due 
to an ipsochromic effect, or by circular dichroism, due to the exciton coupling effect of the 
aggregate, indicative of its handedness, which is dictated by that of the double helix. These 
data clearly indicated that, while achiral PNA-PNA duplexes are an equimolar mixture of 
right-handed and left-handed helices, 2D-PNA and 5L-PNA preferentially formed right-
handed helices when hybridized to complementary achiral PNAs. Thus, 2-D and 5L-PNAs 
prefer the same handedness as DNA. This preference makes the formation of the duplex with 
complementary DNA easier and more stable83. 
Since chirality is of crucial importance in these probes, the eventual racemization has to be 
checked during the synthesis of such probes. Since the chiral center in position 2 can undergo  
racemization during standard peptide synthesis, as it is known for amino acids, a new 
strategy, called submonomeric strategy, was developed in order to preserve the enantiomeric 
purity. This synthetic approach allowed to reduce the racemization in this position from 30-
50% to 2-6%. This strategy consists in the synthesis of a submonomer that bears a Fmoc 
protecting group on the nitrogen in position 3 instead of the nucleobase. The carbammate 
formed with the Fmoc group is less electron withdrawing than the amide formed with the 
nucleobase, and this allows to reduce the acidity of the hydrogen in position 2 and thus the 
racemization during the carboxylic group activation. The Fmoc group can be removed after 
the coupling and the nucleobase is introduced by a standard coupling directly on the resin 
(Figure 1-11)84.  
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Figure 1-11: Submonomeric strategy used to avoid racemization during the coupling of a chiral PNA 
monomer 
1.8 PNA Applications 
Since their invention, it has been clear that the outstanding properties of PNAs could turn 
these molecules into powerful tools for life scientists, in all the fields where the selective 
recognition of complementary sequence is required, like biomedical or  diagnostic 
applications. 
When used as drugs, PNAs can be exploited to target DNA or RNA. Pharmaceutical 
applications that require DNA targeting have usually the purpose to block the replication of a 
gene related with the onset of certain illness such as cancer; this approach is the so-called 
antigene therapy. Alternatively, RNA can be targeted in the cytoplasm, in order to block the 
expression of selected proteins; in this case, the approach is called antisense. PNAs are also 
used in analytical applications, when specific sequences have to be identified, in order to 
predict a risk of illness onset, or to recognize the presence of biological contamination in 
complex matrices. Usually, the detection of  sequences having some biological meaning is to 
be performed in a fast and selective way.  
Coupling with
the submonomer
PNA completed by
standard SPPS Boc synthesis
Submonomeric strategy
Fmoc deprotection
Coupling with
the carboxymethil base
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1.8.1 Analytical Applications 
The recognition of a DNA sequence in a biological sample usually takes place in three steps: 
the extraction and purification of the DNA from the sample, the amplification by PCR of the 
genomic region containing the sequence to be detected, and the recognition of the sequence.  
Although DNA sequencing is often possible, the necessity to develop new assays based on 
probes that rapidly recognize a specific sequence is also necessary, because the sequencing is 
time-consuming, expensive and often made impossible by the low amounts of DNA. The use 
of specific probes can make the recognition more robust, faster and cheaper. PNAs are 
particularly suitable for these applications, because of their chemical stability, the affinity for 
DNA which enhances the sensitivity, the possibility of forming duplexes at low ionic strength 
that allows the hybridization in conditions where the DNA does not form secondary 
structures, and the selectivity, especially in the recognition of point mutations. 
DNA detection can be performed in solution or on surface. In solution assays, the PNA 
probes and the DNA to be analyzed are in homogeneous solution; a great number of different 
assays have been developed, being based on different readout signals. The easiest signal that 
can be exploited is the change of color of the sample, in colorimetric assays, when the this 
happens upon the nucleic acid hybridization. Molecules such as cyanine DiSC2(5) dye, able to 
interact with PNA-DNA double helix but not with PNA or DNA single strands, giving an 
ipsochromic effect due to aggregation which result in an instantaneous color change, have 
been exploited for these kinds of essays85. A colorimetric test using Disc2(5) dye, PNA and 
Succ-β-CyD was successfully applied for the detection of SNPs correlated to the 
apolipoprotein E gene, which have been linked to the Alzheimer disease86. Another effect 
causing changes in the color of a solution is the aggregation state of nanoparticles; the use of 
PNAs with gold nanoparticles was demonstrated to cause their collapse, that is reversible 
when complementary DNA is added, causing a different absorption band87.  
The possibility to link the PNA to a superparamagnetic iron oxide nanoparticles (MNP) 
obtaining MNP-conjugated PNAs (MPNA). These nanoparticles have been used for the 
detection of complementary DNA sequences, exploiting their capability of MPNA to enhance 
the relaxation time T2 in aqueous solutions when specific hybridization takes place88. 
More sensitive assays are those based on fluorescence, by exploiting the appearance of a 
signal upon PNA-DNA duplex formation. These particular PNAs are designed to be non 
fluorescent when non hybridized, and to have a conformational change when the 
hybridization takes place, leading to the lighting up of a fluorescent signal. PNA molecular 
PNAs: from birth to adulthood 
31 
beacons belong to a class of molecules used for this purpose: when they are not hybridized, 
their hairpin-like structure keeps the fluorophore (linked to one end of the probe) next to his 
quencher (linked to the opposite end), whereas when hybridization takes place the molecule 
has to stretch, moving the fluorophore away from the quencher, thus inducing fluorescence 
switch on89.  
Another kind of probes are the PNAs derivatised with thiazol orange, which are not usually 
fluorescent in solution, but when the duplex is formed, the dye can interact with the helix 
increasing its rigidity and modifying its electronic environment, so that the fluorescence is 
turned on90.  
The lack of charge of PNA probes has been exploited in applications like Southern Blot (for 
DNA detection) or Northern Blot (for RNA detection), where the use of labeled PNA can 
simplify the methods and speed them up. PNAs are hybridized with DNA before the gel 
separation: since PNA-DNA duplexes are characterized by having a different charge-mass 
ratios, they can be separated from free DNA, and be visualized through fluorescent, immuno-
enzymatic or radioactive signals, obtaining information about sequence and strand size at the 
same time91,92.  
A similar property has been exploited also in capillary electrophoresis (CE) in order to 
recognize complementary sequences and discriminate point mutations with a good selectivity. 
If a DNA strand is recognized and hybridized by the probe, a shift in its migration time is 
observed, allowing to obtain good performances in a short time, especially when highly 
specific chiral-box modified PNAs are used93; this allowed to recognize the presence of the 
R553X point mutation of the cystic fibrosis, using fluorescently labeled DNA oligonucleotide 
or amplified DNA93.  
The same effect can be exploited with the IE-HPLC technique, obtaining a robust and easy 
identification of DNA. When this method is performed by using fluorescently labeled DNA, 
the technique becomes more sensitive, since a fluorescence-based chromatogram is 
observed94. Recently a PNA Molecular-Beacon designed to recognize a sequence diagnostic 
of Roundup Ready soybean has been used in IE-HPLC95 using non labeled DNA, obtaining 
the same detection limits affordable with standard PNA and fluorescent DNA94.  
The strength of complexes formed between PNA and DNA is very useful for applications 
where the PNA molecule has to compete with other ligands for the hybridization with the 
complementary DNA strand; this happens, for example, when PNAs are coupled with PCR 
technique, such as in PCR-clamping96: in this technique the binding of the PNA probe to the 
complementary strand inhibits the amplification process, because it competes with the binding 
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of the primers, or of the polymerase, also at high temperature. Such a system allowed the 
detection of genetically modified organism in food samples97. 
PNAs can also be used in real time PCR, where the amplification process can be followed 
online by monitoring a fluorescence signal that increases during the amplification process: 
PNA probes can be designed for giving a fluorescence signal when the amplification takes 
place, in particular PNA-molecular beacons have recently been applied since they hybridize 
the amplified sequences creating a fluorescence signal during the process98. 
Diagnostic techniques on solid phase are heterogeneous systems in which the PNA probe is 
linked to a solid support, while the DNA to be analyzed is in solution, and is captured on the 
surface when recognized by the probe. PNAs can be linked to a wide range of materials such 
as gold, glass, plastic etc., exploiting many kind of interactions, such as covalent bonds, host-
guest or gold-thiol interactions etc. Microarray technology is a technique exploited in 
combination with PNAs. It is based on the deposition of the probe on flat surfaces in precise 
and well controlled positions using robotic systems based on contact printing or ink-jet 
deposition, obtaining probe spots in the range of some hundred micrometer. Chips fabricated 
in this way are hybridized at controlled temperature with pre-amplified DNA that can be 
labeled or label-free, non-hybridized sequences are washed away afterwards, and the sample 
can be analyzed using different effects. Signal are observed only where PNAs hybridize 
complementary sequences, and this allows to understand which sequence is in the sample. 
The size of the spots obtained by this technique allows to link to the surface a large number of 
different PNA probes in a very small area, giving the possibility to perform many assays at 
the same time using the same chip. A recent work demonstrated the realization of PNA 
microarrays to simultaneously detect the presence of hazelnut and peanut, by recognizing 
specific sequences, in raw materials and commercial products99. Another work shows the 
fabrication of Arg-PNA microarrays for a selective discrimination of SNPs on solid surface. 
The system thus fabricated allowed the selective and simultaneous recognition of two SNPs 
related to the apolipoprotein E gene, and so the discrimination of six different genotypes100. 
Other techniques that are based on bigger, more robust, devices, exploit the use of multi-well 
plates derivatized with PNAs in connection with the use of fluorescence detector: thus it is 
possible to read many wells in which different samples are analyzed at the same time, and to 
detect where hybridization is taking place. In order to analyze non labeled DNA samples this 
technique has been coupled with enzymatic systems, more typical of protein detection. When 
a DNA sequence is recognized by the probe on the surface, it forms a duplex. The duplex is, 
afterwards, recognized (by a non hybridized part of the target DNA sequence) by another 
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DNA strand labeled with a group  that can be recognized by an enzyme. The enzyme 
recognition starts a series of reactions that eventually produce a fluorescence signal101. 
PCR-free techniques are the very ultimate goal and a very difficult challenge for scientists 
that work in the field of DNA recognition, so that many efforts have been put in the 
realization of systems able to perform such assays. One of these systems is based on Surface 
Plasmon Resonance (SPR), a phenomenon which induces a change in the refractive index due 
to the increase of mass on the surface. If a PNA probe is linked to the surface, hybridization 
with the DNA/RNA complementary sequences will increase the mass laying on the surface 
giving rise to an SPR signal. If the target DNA is labeled with bulky groups (such as gold 
nanoparticles), or a sandwich assay is performed, using a further probe linked to gold 
nanoparticles, this method can become very sensitive, thus allowing the detection of DNA 
without the necessity of pre-amplification102. This technique has been applied using a 15-mer 
PNA sequence specifically designed to identify Roundup Ready (RR) genetically modified 
soybean, obtaining a selective sequence discrimination with a femtomolar sensitivity102. 
Sandwich assays like the ones described above have been used for label-free DNA detection, 
exploiting the hybridization of the target sequences with the PNA probe on one side and with 
a revealing labeled PNA probe on the other side.  
Also other interactions have been exploited in order to form such sandwiches for introducing 
different types of labeling groups. The interaction between a DNA strand hybridized to the 
PNA and a Zr4+ ion was used for introducing a rhodamine label that interact with the ion that 
is coordinated by DNA phosphates103. This fluorophore can be detected by Surface Enhanced 
Raman Scattering techniques on gold and silver derivatised silicon surfaces.  
Finally, QCM microbalance is another technique that can be exploited to detect non labeled 
nucleic acids, since the signal is given by the increase of mass linked to the sensor, which 
increases when a DNA strand hybridizes with the PNA probe104,105. 
Another critical point in the analysis of nucleic acid sequences is the matrix interferences 
found in the biological samples. DNA extraction and purification from a real sample is not 
always an easy step, and for this reason PNAs linked to surfaces have been applied in DNA 
purification by hybridization. PNAs, in fact, can be used to complex DNA molecules in 
complex matrices, separating them from other interferents. In this way, a concentration effect 
can be achieved, and DNA can be purified in a suitable way for subsequent PCR 
amplification and detection106.  
DNA extraction is not always necessary for diagnostic applications in vivo, since sometimes 
hybridization can be performed directly in the cells. Fluorescent PNA oligomers labeled with 
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different fluorophores, were used to hybridize complementary DNA or RNA in the cell and 
revealed by fluorescence microscopy. Fluorescence microscopy allows to recognize which 
fluorescent probe stays in the cell after the washings, obtaining information about the 
sequence hybridized. This analysis is called Fluorescence In Situ Hybridization (FISH) and 
has been largely exploited in biology for recognizing specific type of cells by their DNA; this 
approach can be used to identify different bacteria in the same cell culture, performing also 
multiple recognition at the same time thanks to the combination of many fluorophores107. The 
use of PNA probes increases the quality of the technique, since PNAs enter the cells more 
easily than oligonucleotides, are more resistant in vivo, and hybridize better to the 
complementary sequences108. 
1.8.2 Biomedical Applications 
When a therapy has DNA or RNA sequences as targets, selectivity is the main goal to 
achieve. Since in most cases the therapy requires a large number of cells to be killed, the 
possibility to act only against the target cells may allow to cure the illness without affecting 
the host body. Moreover, the possibility to specifically interact with the genetic code of a cell 
is a strong tool that can be used in order to control its life, since it allows to block some 
genetic mechanisms or to stimulate others. Many efforts have been done in the development 
of this approach, called genetic therapy, designing oligonucleotides able to target DNA or 
RNA within the cell; however, great limitations have been found when using standard 
oligonucleotides1. The introduction of DNA analogues improved the potential of these 
applications. In particular, as far as PNAs are concerned, the enzymatic stability of these 
molecules, together with their affinity and specifity in the recognition of the complementary 
sequences, makes them highly suitable tools for biomedical applications. In any case, when 
DNA is targeted, a series of problems are to be solved for making the strategy effective. Since 
DNA is present in the cell as a double strand helix, the hybridization can be performed only if 
the helix can be opened. The necessity to hybridize a sequence in double strand form, makes 
PNAs suitable for this application, because of their ability to perform strand invasion under 
certain circumstances; however the choice of the sequence is not always straightforward and 
chemical modifications may be necessary to perform invasion109. The fact that the DNA is 
located in the nucleus and protected by the nuclear membrane, which is permeable only by 
molecules specifically recognized by defined receptors, is another problem to be solved when 
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this approach is chosen. The solution has often been found by conjugating PNAs with carrier 
molecules which behave as keys able to recognize the lock and open the door to the inner part 
of the nucleus. One of the most common solution is the coupling with positively charged 
peptides, usually rich in lysine or arginine residues, such as NLS or Tat sequence, which also 
promote strand invasion because of the positive charges110.  
Recently, a new type of DNA target has been considered, the G-Quadruplex, a particular 
DNA structure formed in GC rich zones. Many studies have demonstrated the importance of 
this areas because many transcription factors recognize and bind to these kind of sequences. 
PNAs have been used to target  and block GC-rich zones, thanks to their ability to perform 
strand invasion111. 
The application of PNA in antisense therapy can increase the performance of the method, 
since the PNA molecules are not hydrolyzed in the cell, as it happens for standard 
oligonucleotides112. Compared to antigene applications, the antisense approach does not have 
to deal with the nuclear uptake of the molecule, because RNA targeting takes place in the 
cytoplasm and not in the nucleus. Although the hybridization process may appear easier 
because RNA is in single strand form, secondary structures may occur in RNA, making its 
targeting difficult PNAs facilitates the recognition, since the stability of PNA-RNA duplexes 
is usually enough to open the secondary structures. Unlike DNA, that exists as a single copy, 
RNA is produced in more than one copy, and its production continues during the treatment, 
making the time necessary for blocking it effectively longer.  
Another approach linked to the antisense therapy is the targeting of micro-RNAs, short RNA 
sequences 20-30 nucleotides long. MiRNAs are implicated in post-transcriptional gene 
regulation, which plays a vital role in cellular processes such as developmental control, 
metabolism and apoptosis. PNAs showed excellent performances in these applications, also 
when compared to other DNA analogues such as LNA or PS-DNA113,114. 
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Chapter 2 
 
 
Label-free detection of Single Nucleotide Polymorphisms 
(SNPs): PNA Molecular Beacons 
 
In this chapter the application of modified PNAs for SNP detection is shown. PNA beacons 
allow to detect complementary DNA sequences without the necessity to label it before or after 
PCR amplification. Upon hybridization, in fact, these molecules emit a fluorescence signal 
which is highly enhanced if compared to that of the free unhybridized beacon. The probes 
here presented were designed in order to recognize a SNP which is diagnostic for the olive 
cultivar “Ogliarola Leccese”. Three beacons of different length were synthesized, in order to 
test the recognition performances in relation to the PNA length. The application in AE-HPLC, 
together with solution assays, allowed to identify  the ideal length for specific and efficient 
DNA hybridization and to verify the PNA probes performances. After optimization of the 
method, the probe was applied to recognize the SNP in a sample of DNA extracted from olive 
leaves and amplified by PCR. It has been shown that this methodology can be applied  to real 
samples. 
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2.1 Introduction 
In the last years we have assisted to a fast development of selective and sensitive bioassays 
aimed at recognizing genetically significant DNA sequences with methods at the same time 
robust and simple1. Most of the research on DNA markers is related to genetic diseases, with 
the aim of providing efficient tools to assess the risk of an illness, also when symptoms are 
not yet present2,3. Actually, most polymorphisms are silent and do not have any pathological 
implication, but their identification can be exploited for identifying an organism or an 
individual (such as in forensic science)4. In food analysis, the recognition of DNA extracted 
from a defined ingredient can be extremely useful for tracing the origin of a food product or 
for evidencing ingredients undeclared, even if present in very small amounts5,6. Among the 
different DNA polymorphisms that can be usually exploited for these purposes, most studies 
concern the Single Nucleotide Polymorphisms (SNPs)7, which consists in a single nucleobase 
change, and microsatellite sequences, small repeating non-coding sequences differing in the 
number of repeats. Single Nucleotide Polymorphisms are the major source of variability 
within genomic DNA and may have a biological meaning or not, according to the position in 
which they are located in a given genome7,8. 
Although SNP recognition is of extreme importance, classical methods for their detection are 
time consuming and expensive. These methods usually imply DNA extraction and 
purification, amplification by polymerase chain reaction (PCR) and sequencing of the 
amplicons. Although sequencing has been improved by the use of automated techniques, 
these methods are still expensive and cumbersome, especially when more than one 
polymorphism in different genomic locations has to be detected, since the PCR-sequencing 
cycle has to be repeated for each single mutation. For this reason, new methods based on 
many different techniques have been developed in order to perform faster and cheaper 
analyses. The new methods are usually based on the synthesis of probes complementary to the 
sequence to be recognized, hybridization of the probes with amplified DNA and detection of a 
reading out signal when selective hybridization occurs. Although these assays look promising, 
many improvements are still possible in this field: the necessity to perform high throughput 
analysis, the possibility to develop PCR-free and label-free methods and the possibility to 
perform such assays with robust, reproducible and cheap techniques still represents a 
challenge. 
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DNA is added, the hybridization causes a change in conformation that switches on the 
fluorescence since the quencher moves away from the fluorescent unit19,20. Depending on the 
type of beacon, different strategies are used to keep the probe in the closed form when not 
hybridized: DNA beacons are usually kept closed thanks to a stem obtained using two short 
complementary sequences at the ends of the probe. PNA molecular beacons may be 
maintained closed by an electrostatic interaction exerted by two amino acids bearing opposite 
charges at both ends of the probe.  
PNA molecular beacons have been used together with many techniques for the recognition of 
complementary sequences obtaining a good signal-to-noise ratio, since the flexibility of the 
backbone allows a ready closure when no complementary sequence is hybridized. By 
coupling these molecules with PNA openers, i.e. PNAs able to strand invade duplex DNA, it 
was possible to hybridize not only single stranded DNA, but also double helices making the 
target sequence accessible to the PNA. The modified probes display a high selectivity in 
sequence recognition, being able to recognize single nucleotide polymorphisms19. In order to 
increase PNA selectivity, which is necessary in some applications, chiral centers within the 
PNA backbone were introduced21. A monomer bearing a L-lysine side chain in position 5 has 
been introduced in the middle of 
the sequence, as previous works 
demonstrated that enhanced 
binding performances are due to 
this modification22. Moreover, 
the side chain could be used for 
linking the PNA probe to 
functional active groups on 
surfaces or to nanoparticles23. 
The features offered by these 
probes allowed their application 
as useful tools in many 
analytical techniques. The 
fluorescent signal produced by 
the probe after hybridization is very useful in real time PCR, since it allows to monitor the 
amplification process in real time24. Good performances were obtained also by IE-HPLC21, 25, 
by combining the discriminative power offered by the chromatographic technique. 
Figure 2-4: Chemical structure of a PNA Molecular Beacon (F.
Totsingan, et al., Org. Biomol. Chem., 2008, 6, 1232) 
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2.2 Results and Discussion 
In this chapter, PNA molecular beacons are designed in order to be used in the field of food 
science, in particular in connection with the authenticity of monocultivar extra virgin olive 
oil. In fact, the recognition of SNPs characteristic of a specific cultivar of olive can allow to 
certify a monocultivar product. The probes used here had been developed in a previous 
work26 in order to recognize a specific cultivar of olive among twelve different cultivars. In 
particular, the cultivar taken in consideration was “Ogliarola Leccese”. For this cultivar, in 
fact, a thymine substitutes an adenine in the position 60 of the gene Actin. The PNA probes 
were synthesized in order to be complementary to the sequence containing the thymine, thus 
able to recognize this particular SNP. 
 
Three stemless PNA beacons, as previously described21 (Figure 2-4), were designed only 
differing for the  length of the sequence: 11, 13 and 15mer; with the mismatch position in the 
middle. The scope was to study the effect of the length on the efficiency of the probe. The 
melting temperature values of the three PNAs with the complementary and mismatched DNA 
oligonucleotides are reported in Table 2-1 and compared with a 13-mer standard PNA with 
the same sequence. As expected, the selectivity decreased with the increase of the length. It is 
to be noted that, whereas the 11-mer and 13-mer PNA probes showed a certain similarity in 
Table 2-1. PNA sequences and melting temperatures of the PNA:DNA antiparallel 
fullmatch/mismatch duplexes in phospate buffer (pH=7) at a 5µm concentration for each strand 
PNA  Sequence Tm (°C) 
PNA/DNA 
fullmatch 
Tm (°C) 
PNA/DNA 
mismatch 
ΔTm 
(°C) 
Beacon 
11 mer 
Fluo-Glu-ACTCATTCACC-Lys-Lys-(Dabcyl)-NH2 53 36 17 
Beacon 
13 mer 
Fluo-Glu-TTACTCATTCACC-Lys-Lys-(Dabcyl)-NH2 54 37 17 
Beacon 
15 mer 
Fluo-Glu-GGTTACTCATTCACC-Lys-Lys-(Dabcyl)-NH2 65 51 14 
PNA  
13 mer 
H-TTACTCATTCACC-NH2 54 35 19 
The monomer in bold corresponds to the SNP identifying the cultivar “Ogliarola Leccese” 
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fluorescence contribution due to the non hybridized beacon from the specific signal given by 
the hybrid formation, is to use the beacon in HPLC, where the two species may be 
chromatographically separated. Moreover, under the conditions in which HPLC analyses are 
performed, a partial denaturation of duplexes occurs, which has been demonstrated to be 
optimal for maximizing the selectivity. In particular, anion exchange HPLC has been 
demonstrated to be the optimal technique to separate PNA-DNA duplexes from free DNA and 
PNA. The eluents used in this method are at a slightly basic pH, which maximizes the 
fluorescence intensity of fluorescein. Moreover, the ionic strength stabilize the closed 
conformation of the unbound PNA-beacon, minimizing the aspecific fluorescence signal. The 
only species that could interfere with the detection is the free probe, but if this molecule is 
well separated from the peak corresponding to the duplex, there is no risk of interference from 
other molecules, since free DNA or residues from the PCR mixture are not fluorescent. This 
behavior allows to develop fast gradients. The performances in the HPLC system of the 
different PNA probes with different lengths were studied in the present work. 
Hybrids with fullmatched and mismatched DNA oligonucleotides having the same length as 
the probe were tested and analyzed by anion exchange HPLC, using a TSK gel DNA-NPR 
column. The analyses were performed with a gradient from Tris 0.02M (pH= 9) to Tris 
0.02M, NaCl 1M (pH=9). The chromatograms were obtained by using a fluorescence detector 
(λex= 497nm; λem= 520nm), as reported in previous works25. For each probe, the duplexes 
were prepared in a 1:1 ratio with the fullmatch DNA, and the concentration was decreased 
until it was possible to observe a clear chromatographic peak, in order to find the lowest 
concentration detectable. At these concentrations, selectivity experiments were carried out in 
the optimized conditions; for this reason, fullmatch and mismatch hybrids were prepared and 
analyzed  as previously described. 
The chromatograms obtained with 11 mer and 13 mer probes showed a clear and sharp peak 
corresponding to the PNA-DNA hybrids (Figure 2-6), when hybrids are formed using 
fullmatch DNA. The 11 mer probe showed a good sensitivity, since the duplex could be 
clearly detected down to a concentration of 30 nM (Figure 2-6 A). A broad peak eluting 
before the duplex was also present: this signal can be attributed to the free probe and had not a 
constant intensity, probably due to small changes in the eluent. When the 13-mer probe was 
used, none of these broad signal could be detected (Figure 2-6 C), probably on account of the 
higher stability of the corresponding PNA-DNA duplex. The experiments performed using 
decreasing concentrations of probes and target sequences showed that the probe stabilities and 
the sensitivity offered by the fluorescence detector allow to use very small amounts of probes. 
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In particular, the 11mer probe could be efficiently set at the concentration of 30 nM (Figure 2-
6 B), while the higher stability offered by the 13mer probe allowed to work at a concentration 
of 10 nM (Figure 2-6 D), reaching limits which could not be afforded in previous similar 
works21, 25.  
 
Figure 2-6: AE-HPLC-FD chromatograms (λex= 497nm; λem= 520nm) obtained for PNA beacon-
DNA fullmatch hybrids at various concentrations with 11-mer (A) and 13-mer (C) probes. 
Chromatograms obtained with fullmatch DNA and single mismatch DNA at concentrations of 30 nM 
for 11-mer (B) and 10 nM for 13-mer (D) just above the limit of detection are shown. Conditions: 
TSK gel DNA-NPR column with a gradient from 100% A (Tris 0.02M, pH= 9) to 100% B (Tris 
0.02M, NaCl 1M pH=9). 
The lowest concentrations detectable were then used to perform selectivity tests, by using 
oligonucleotides containing one mismatch exactly corresponding to the SNP characteristic of 
other olive varieties. The chromatograms obtained (Figure 2-6) show that both probes did not 
give rise to any peak when mismatched oligonucleotides were used, allowing to recognize the 
mutation with an excellent selectivity at room temperature. 
The data obtained with the 15 mer PNA beacon, exactly mirroring the results in solution, 
were less clear than those with the shorter probes. The chromatograms always showed a 
double peak of unknown origin corresponding to the duplex signal, that could not be 
attributed to impurities or byproduct since either PNA and DNA were HPLC-purified and MS 
characterized. Moreover, the recognition experiments performed with this probe showed a 
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lower sensitivity, and significant peaks could be obtained only by using relatively higher 
concentrations (200nM, Figure 2-7). Finally, although some good chromatograms were 
obtained, a high variability in the peak intensity was noticed, making the probe not 
particularly suitable for this assay. To make bad things worse, a PNA-DNA hybrid could be 
clearly detected also when the beacon was hybridized with the mismatched oligonucleotides. 
 
Figure 2-7: Chromatogram obtained for fullmatched and mismatched hybrids using PNA Molecular 
Beacon 15 mer 200nM at different temperatures. The analytical conditions are the same, as described 
above 
Since the only difference between this PNA and the other previously reported is the length, 
these problems should be related to this parameter. The increased length may cause self-
aggregation in solution, due to the increased hydrophobicity, and a slower rate in the 
hybridization process also with complementary sequences. Moreover, the 15-mer beacon is 
less selective on account of the higher stability of the fullmatch and mismatch PNA-DNA 
hybrids at room temperature. In order to completely denaturate the mismatched duplex, the 
column temperature was increased. The chromatograms in figure 2-7 show that warming up 
to 35°C was necessary in order to get rid of the aspecific signal, but at this temperature the 
fullmatch hybrid was also highly destabilized, as demonstrated by its strongly decreased 
signal.  
Since all the results suggested that the optimal probe, in terms of selectivity and sensitivity, 
was a PNA beacon 13 bases long, this probe was used in the optimized conditions for the 
recognition of the DNA samples extracted from olive leaves and amplified by PCR. DNA 
extracted from leaves of two different cultivars of olive were used: one from “Ogliarola 
Leccese”, bearing the SNP at position 60 (thymine versus adenine) of the actine gene, for 
which the probe has been designed; the other from “Canino”, which was chosen as negative 
control, since it has an adenine at position 60 as other eleven cultivars. The extracted DNA 
was amplified by Polymerase Chain Reaction (PCR) and purified with an affinity column. 
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2.4 Experimental Part 
2.4.1 Materials and reagents 
PNA monomers were from Applera (Milan, Italy); MBHA Rink amide resin was from 
Novabiochem (Inalco spa, Milan, Italy); O-(benzotriazolyl)-N,N,N,N-tetramethyluronium 
hexafluorophosphate (HBTU) and N,N-diisopropylethylamine (DIEA) were fromAldrich 
(Milan, Italy) and N-methylpyrrolidone (NMP) was from Advanced Biotech Italia srl 
(Seveso, Italy). All solvents used for HPLC were of chromatographic grade. Doubly-distilled 
water was produced by Millipore Alpha-Q purification module. Oligonucleotides used for 
melting temperature measurement were purchased from Thermoelectron (Ulm, Germany), 
and their purity was checked by ion-exchange HPLC. DNA was extracted from certified olive 
leaves by Dr. Enzo Perri (CRA, Rende) and by Dr. Luciana Baldoni (CNR, Perugia). 
2.4.2 PNA Beacon Synthesis 
The synthesis was performed on an ABI 433A peptide synthesizer with software modified to 
run the PNA synthetic steps (scale: 5 micromol), using Fmoc chemistry and standard 
protocols with HBTU–DIEA coupling25. A MBHA-Rink amide resin (29 mg, 0.64 mmol 
active sites per g) was downloaded to 0.23 mmol g−1 with Fmoc-Dabcyl-Lys-OH. To this a 
second lysine unit (Fmoc(Boc)Lys) was coupled using a 5-fold excess and HBTU–DIEA. The 
PNA oligomer was subsequently synthesized, after Fmoc deprotection, according to the 
procedures previously described9,10 
After completion of the PNA part, a Fmoc(OtBu)Glu-OH residue was coupled at the N-
terminal PNA monomer and deprotected. A solution of 25 µmol of carboxyfluorescein in 
NMP was pre-mixed with a solution of 25 µmol of DHBtOH in NMP and 25 µmol of DIC 
and activated for 15 minutes. This solution was then added to the resin and stirred overnight25. 
After the coupling, the resin was washed with NMP and DCM and dried under vacuum. The 
PNAs were cleaved from resin by using a TFA/m-cresol (9: 1) mixture; the cleaving solution 
was filtered on sintered glass, the filtrate was concentrated under a nitrogen stream, and the 
crude products were precipitated by addition of Et2O. The mixture was cooled at −20°C for 2 
hours, followed by centrifugation (15min at 3500 rpm, twice) and removal of solvent by 
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pipetting to afford the crude PNA products as a red precipitate. Residual ether was removed 
under a stream of nitrogen. The crude PNAs were purified on RP-HPLC with UV detection at 
260 nm. A semi-preparative C18 (5 lm, 250 × 10 mm, Jupiter Phenomenex, 300 A) column 
was utilized, eluting with 0.1% TFA in water (eluent A) and 0.1% TFA in water–acetonitrile 
60 : 40 (eluent B); elution gradient: from 100% A to 100% B in 35 min, flow: 4 ml min−1. 
HPLC analysis for all PNAs was carried out by LC-MS by using an XTerra anlytical C18 
column (3x250 mm, 5 µm, flow 0.5 ml/min), gradient elution from 100% H2O (0.2% 
HCOOH, eluent A) to 60% H2O and 40% CH3CN (0.2%HCOOH, eluent B) in 30 min. MS 
detector set in the positive ion mode, capillary voltage 3kV, cone voltage 30V, full scan 
acquisition from 150 to 1500 m/z. 
PNA Beacon 11 mer. Yield (after purification): 9.2%. calculated MW: 3894.3; ESI-MS. m/z 
779.9 (MH5 5+), 650.1 (MH6 6+); 557.3 (MH7 7+); 487.8 (MH8 8+); 433.7 (MH9 9+) found: 
779.8, 650.0, 557.2, 487.7, 433.7 
PNA Beacon 13 mer. Yield (after purification): 14.3%. calculated MW: 4425.5; ESI-MS. 
m/z 886.1 (MH5 5+), 738.6 (MH6 6+); 633.2 (MH7 7+); 554.2 (MH8 8+);  found: 886.3, 738.8, 
633.4, 554.4 
PNA Beacon 15 mer. Yield (after purification): 1.3%. calculated MW: 5008.6; ESI-MS. m/z 
1002.7 (MH5 5+), 835.8 (MH6 6+); 716.5 (MH7 7+); 627.1 (MH8 8+); 557.5 (MH9 9+) found: 
1002.6, 835.7, 716.4, 627.1, 557.5 
2.4.3 UV melting analysis 
The PNA beacons were dissolved in water and their concentrations were determined by UV 
absorption at 260 nm on an UV/Vis Lambda Bio 20 spectrophotometer (Perkin Elmer) using 
the following molar absorptivities: Beacon 11 mer 149636 L mol−1 cm−1; Beacon 13 mer 
166836 L mol−1 cm−1; Beacon 15 mer 190236 L mol−1 cm−1, calculated using the following 
ε260 (M-1 cm-1) for the nucleobases: T 8600, C 6600, A 13700, G 11700 and molar 
absorptivity of the carboxyfluorescein and dabcyl units. 
For thermal melting measurements, solutions of 1: 1 DNA–PNA were prepared in pH= 7.0 
sodium phosphate buffer (100 mM NaCl, 10 mM phosphate, 0.1 mM EDTA). Concentrations 
were 5 µM for each component. Thermal denaturation profiles (Abs vs. T) of the hybrids 
were measured at 260 nm with an UV/Vis Lambda Bio 20 Spetrophotometer equipped with a 
Peltier Temperature Programmer PTP6 which is interfaced to a personal computer, using a 
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temperature ramp of 1°C min−1 from 25°C to 90°C. The melting temperature (Tm) was 
determined from the maximum of the first derivative of the melting curves. 
2.4.4 Fluorescence measurements 
Fluorescence measurements were performed on a Perkin Elmer Luminescence Spectrometer 
LS 55. All solutions were prepared in Tris buffer (0.25 mM MgCl2, 10 mM Tris, pH= 8.0). 
Concentrations were 1 µM for each component. All samples were excited at 497 nm and the 
emission was monitored at 520 nm. Triplicate measurements were performed for each 
composition. 
2.4.4 HPLC measurements 
All experiments were carried out using an Alliance 2690 Separation Module HPLC system 
(Waters), equipped with a temperature controller, dual k absorbance detector 2487 (Waters) 
and scanning fluorescent detector 474 (Waters). Anion-exchange chromatographic 
measurements were carried out using the column TSK-gel DNA-NPR 4.6 mm ID × 7.5 cm. 
Binary linear gradient was used: eluent A= Tris 0.02M pH 9; B= Tris 0.02M, NaCl 1M pH= 
9. flow: 0.5 mL min−1. Linear gradient: from 100% A to 100% B in 20 min; Fluorescence 
detector λex= 497 nm, λem = 520 nm. 
The chromatograms obtained by the fluorescence detector were corrected by subtraction of 
the baseline obtained with injection of water in order to compensate for the baseline drift. For 
each probe the concentration used varied from 200nM to 1nM with the fullmatched 
oligonucleotides. Selectivity experiments were performed using the lowest concentration 
possible (30nM for Beacon 11mer, 10nM for Beacon 13mer, 200nM for Beacon 15mer) 
2.4.5 PCR amplification 
PCR was performed in a PCRsprint Thermal Cycler (Thermo Hybaid, Basingstoke, UK) 
using the following conditions: 1 cycle of DNA denaturation and Blue Taq activation at 95°C 
for 5 min; 30 cycles consisting of DNA denaturation at 95°C for 50 s, primer annealing at 
58°C for 50 s and elongation at 72°C for 50 s; one step of final elongation at 72°C for 10 min.  
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The mastermix for the PCR was prepared using Buffer 1X, MgCl2 2mM, dNTPs 200 µM, 
Primer For and Rev 400 nM and Taq 0.05U/µl. The primer uses were:  
Forward 5’-TCTGTGGAGAAGAGCTACGAGTTG-3’, Reverse: 5’-
AGGCTGGTAAAGAACCTCAGGACA-3’ 
The PCR products were immediately analyzed by 2% agarose gel in 0.5× TBE or stored at 
−20°C until use. In the unbalanced PCR a first amplification was performed as described 
above, then a small amount (2–5 µL) of the reaction mixture was amplified in the second run 
using a fresh mastermix solution of the same composition except that a 10 fold excess of the 
primer on the target sequence was used. 
In order to prepare the samples for the HPLC analysis, two tubes containing 50 µl of PCR 
product each, were purified by Genuine PCR Clean-up Kit from Sigma-Aldrich and 
concentrated redissolved in 50 µl of water. 15 µl of this DNA solution was hybridized with 
PNA Beacon 13mer 100nM with a final volume of 30µl. Before the hybridization with the 
beacon, the sample was warmed up to 90°C for 3 minutes and cooled to 50°C for 3 minutes. 
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Chapter 3 
 
 
A new class of Chiral PNAs: Arginine PNAs 
 
This chapter presents a new class of modified PNAs: chiral arginine-based PNAs. The design 
and the synthesis of submonomers and monomers based on the structure of arginine are 
shown. The modified monomers have then used for the synthesis of a chiral PNA containing a 
2D,5L-Arg monomer, to be compared with homologous probes based on lysine, and of a PNA 
containing three modified monomers (2D; 2D,5L; 5L).The scope is to explore the effect that 
modifications based on chiral positively charged amino acids have on PNA hybridization 
properties. The properties of these PNAs have been tested by measuring the melting 
temperatures of the corresponding PNA-DNA duplexes and comparing them with the previous 
generations of chiral PNAs. 
  
Chapter 3 
56 
3.1 Introduction 
As discussed in chapter 1, the possibility to increase PNA recognition properties by 
introducing chemical modifications has always been intensely investigated. As previously 
shown, modifications of the 
PNA structure, either in the 
backbone1 or in nucleobases2, 
can deeply modify the 
recognition properties, obtaining 
better performances in some 
cases, but hampering the 
recognition of complementary 
sequences in other cases. 
Modifications of the PNA 
backbone based on the side 
chains of amino acids showed 
excellent properties1,3. As 
explained above, aminoacidic 
side chains can be introduced in position 2 or 5 of the backbone (Figure 3-1). In particular, 
modifications based on the structure of lysine showed increased affinity towards DNA mainly 
due to the positive charge present on its side chain4,5. The effect that different configurations 
of the stereogenic centers introduced in the PNA structures have on the hybridization 
properties towards complementary DNA were studied, allowing to define the correct 
configurations for improved DNA affinity. In particular it has been defined that modifications 
based on D-lysine in position 26 and on L-lysine in position 57 are improving the PNA affinity 
for complementary DNA sequences. This is due to the favored right-handedness that these 
configurations induce into the PNA strands: PNAs preferring right-handed helices show an 
improved DNA affinity8 being the DNA right-handed. The combination of the two favorable 
modifications in the same monomer led to the development of PNAs with a 2D,5L-Lysine 
monomer, obtaining a new class of modified PNAs that showed enhanced affinity for the 
complementary sequence, as well as a good selectivity in mismatch recognition9. 
The introduction of multiple modified monomers was investigated with PNAs bearing 2D-Lys 
modified units in different positions of the molecule. The introduction of three adjacent 2D-Lysine 
Figure 3-1: Chemical structure of chiral PNAs 
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monomers in the middle position of a PNA strand resulted in an excellent PNA probe (called the 
“chiral box” PNA), with good affinity and excellent selectivity10,11. “Chiral box” PNAs have been 
used in several applications for the discrimination of point mutations, obtaining excellent results in 
assays based on mass spectrometry and electrophoresis12,13. 
Unfortunately, it is difficult to apply of these molecules on surface devices, such as PNA microarrays, 
since the immobilization of the probes on the surface usually exploits the reaction between the 
terminal amino group of the PNAs and a reactive group on the surface14. The presence of the lysine 
primary amino groups, on its side chain, would thus interfere with this reaction. 
In this chapter a new class of chiral PNAs will be presented, mainly intended for surface 
applications, such as the development of chiral PNA microarrays. The general idea was to 
substitute the side chain of lysine with that of arginine, which also contains a positive charge 
but does not bear a primary amino group. A PNA with one 2D,5L-Arg modified monomer in 
the middle, to be compared with the analogous lysine-based PNAs, and a PNA with a series 
of chiral monomers resulting in four adjacent arginine side chains have been synthesized, and 
their binding properties towards complementary oligonucleotides have been studied. 
3.2 Results and Discussion 
3.2.1 Sequence Design 
The need to develop probes able to perform DNA recognition on surface determined the 
necessity to substitute the previously used lysine, in the development of chiral PNAs. In fact, 
the strategy usually employed to link the PNAs to glass surfaces is based on the reaction 
between a reactive group on the surface and the terminal amino group of the PNA14. The 
presence of the amino group of the lysine side-chains would thus compete with the terminal 
one in this reaction, making the PNA deposition less reproducible. For this reason, chiral 
modifications based on the structure of arginine were chosen, since the guanidium groups are 
much less nucleophilic than primary amines, but still bear a positive charge at physiological 
pH. 
Since it has been demonstrated that PNAs containing one residue with two lysine-derived side 
chains having configurations 2D and 5L had a highly improved affinity and selectivity in the 
recognition of complementary DNA sequences, a PNA was first designed bearing a 2D,5L-
arginine monomer in the middle (PNA 1, Figure 3-2), in order to compare its binding abilities 
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with those of the analogous PNA bearing in the middle a chiral monomer 2D,5L based on 
lysine. 
Moreover, since the introduction of several adjacent positively charged monomers in the 
sequence was demonstrated to improve the binding selectivity, another PNA was designed 
combining the features of the “chiral box” PNA and those of 2D,5L PNA. This new PNA was 
designed with a 2D,5L arginine-based monomer in the middle, which should determine an 
enhanced affinity for the complementary DNA sequence, flanked by 2D-modified and a 5L-
modified arginine-based monomers, which should improve the PNA selectivity in mismatch 
recognition (PNA 2, Figure 3-2). The sequence chosen for both probes was a standard 
decameric sequence used as model for the development of other modified PNAs, in order to  
compare the performances of the new probes with those given by other modifications10. 
3.2.2 PNA synthesis 
PNAs were synthesized by using the common SPPS protocol based on the Boc strategy for 
the standard monomers and for the monomer bearing the modification on the carbon atom in 
position 5, whereas the Boc submonomer strategy was used for the monomers bearing the 
substituents in position 2 or 2 and 5, in order to preserve the optical purity at the 2 position15.  
PNA 1 PNA 2
Figure 3-2: Chemical structure of PNA 1: 2D,5L-Arg PNA and of PNA 2: 2D-Arg_2D,5L-Arg_5L-
Arg PNA (right) 
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The synthesis of the PNAs required the preparation of three different modified units: a 2D-
Arg submonomer, a 2D,5L-Arg submonomer, and a 5L monomer. The 2D,5L-Arg 
submonomer and the 2D-Arg submonomer were prepared, as reported in Scheme 3-1, starting 
from the commercial D- and L-Boc-Arginine(Tos)-OH. Boc-L-Arg(Tos)-OH was 
transformed into the corresponding Weinreb amide and then reduced to the aldehyde. Boc-D-
Arg(Tos)-OH was transformed in the methyl ester and Boc deprotected. The PNA backbone 
was then synthesized by reductive amination of D-Arg(Tos)-OMe with the Boc-L-Arg(Tos) 
aldehyde (for 2D,5L subomonomer) or Boc aminoacethaldehyde (in the case of 2D 
submonomer). The methyl ester was hydrolyzed and the secondary amine was protected by 
the introduction of a Fmoc group (Scheme 3-1). 
The Arginine modified monomer was linked to a Cytosine, obtaining a 5L-Arg-Cytosine(Z) 
monomer. The molecule was prepared, as reported in scheme 3-2. The PNA backbone was 
then synthesized by reductive amination of Gly-OMe (hydrochloride) with the Boc-L-
Arg(Tos) aldehyde. The methyl ester was coupled with the carboxymethyl-(Z)-cytosine by 
i ii
iii iv
v
vi
+
Scheme 3-1: i) 0.97 eq. N-methyl-N-methoxyamine.HCl, HBTU, DIPEA, DMF η: 80%; ii) 4.6 eq.
LiAlH4 (1M in THF), THF, η: 94%; iii) SOCl2 1M in CH3OH, η: 98% iv) 1 eq. D-Arg(Tos)OMe, 1 
eq. NaBH3CN, 1.1 eq. CH3COOH, CH3OH, η: 51% (2D,5L), 48% (2D); v) 10eq. NaOH  THF: H2O 
= 1:1, η: 87% (2D,5L), 75% (2D) vi) 2eq. BSA, 1.5 eq. DIPEA, 2 eq. FmocCl, CH2Cl2 η: 30%
(2D,5L), 38% (2D). R= H for 2D submonomer; R=CH2CH2CH2NHC(NH-Tos)NH for 2D,5L 
submonomer 
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activating the carboxylic group with N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
(EDC)/ 3-Hydroxy-1,2,3-benzotriazin-4(3H)-one (DhbtOH). Finally the methyl ester was 
hydrolyzed, obtaining the desired monomer (Scheme 3-2). All the above compounds were 
characterized by 1H and 13C NMR and ESI mass spectrometry. 
According to previously reported procedures15, the chiral submonomers units were inserted by 
manual coupling with the HATU/DIEA protocol and, after Fmoc deprotection, the nucleobase 
residues were introduced by a double coupling with DIC/DhBTOH. All the PNA oligomers 
were purified by RP-HPLC and characterized by ESI-mass spectrometry (Figure 3-3). 
The analysis of HPLC-MS data in figure 3-3 shows that PNA 1 was obtained with good purity 
(>90%), whereas PNA 2, even after HPLC purification, showed ~28% of a byproduct 
identified by MS as the PNA2 without a carboxymethyladenine moiety. This byproduct was 
originated because of the low coupling efficiency between the carboxymethyladenine and the 
PNA in the last 2D chiral monomer, probably due to the steric hindrance exerted by the 
previous monomers. The iteration of the same coupling many times, as well as the use of 
other coupling agents or different reaction conditions, did not allow to obtain a quantitative 
i
ii
iii
+
Scheme 3-2: i) 1 eq. Gly-OMe·HCl, 1 eq. NaBH3CN, 1.1 eq. CH3COOH, CH3OH, η: 50%; ii)
2eq. carboxymethyl-(Z)-cytosine, 2 eq EDC·HCl, 2 eq DhBTOH, 3 eq DIPEA, DMF η: 83%.iii)
2eq. BaOH  THF: H2O = 1:1, η: 75% 
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yield in this reaction. Moreover, since the byproduct had a retention time very similar to that 
of the desired PNA molecule, the purification turned out to be very difficult, thus PNA 2 was 
obtained as a mixture with this byproduct. 
3.2.3 Selectivity of binding 
In order to verify the affinity of the synthesized probes for complementary and mismatched 
DNA sequences, melting temperatures were measured for the fullmatch hybrids and the 
mismatch ones, the latter using an oligonucleotide with a guanine replacing the adenine 
corresponding to the central modified PNA monomer. In the case of PNA 2, the presence of 
the byproduct was taken into consideration for the calculation of the real concentration of the 
molecule, assuming that the stability of the byproduct bound to DNA was too low to interfere 
with the melting temperature of the complete probe. Melting temperatures were evaluated as 
the first derivatives of the UV absorption curves at 260 nm in a temperature range from 20 to 
90°C. The values obtained are shown in Table 3-1, together with those of the corresponding 
achiral PNA and of the PNA containing a 2D,5L Lysine modified monomer in the middle, 
which are reported in order to compare the results obtained with the new PNA probes16. 
Figure 3-3: HPLC profiles and mass spectra of PNA1 and PNA 2 
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Table 3-1. PNA sequences and melting temperatures of the PNA:DNA antiparallel 
fullmatch/mismatch duplexes in phospate buffer (pH=7) at a 5µm concentration for each strand 
Sequence Tm (°C) 
PNA/DNA 
Fullmatch 
Tm (°C) 
PNA/DNA 
Mismatch 
ΔTm (°C) 
H-GTAGATCACT-NH2  50  40  10  
H-GTAGA(T2D,5L-Lys)CACT-NH2 60 43 17 
PNA 1: H-GTAGA(T2D,5L-Arg)CACT-NH2  60  41  19  
PNA2: H-GTAG(A2D-Arg)(T2D,5L-Arg)(C5L-Arg)ACT-NH2   60  40  20  
Oligonucleotide sequences: Fullmatch: 5’-AGTGATCTAC-3’ Mismatch: 5’-AGTGGTCTAC-3’ 
 
The melting temperatures in Table 3-1 confirm that the substitution of lysine side chains with 
arginine side chains did not impair the binding abilities of PNAs. The stability of the 
fullmatch PNA-DNA hybrids, indeed, was the same for both new PNAs, identical to those 
measured for the analogous Lys-based PNA11 and much better than that shown by the 
unmodified PNA. Even the selectivity was not affected: no selectivity decrease was observed 
for the Arg-PNAs, and even a small increase could be observed for these new probes, making 
it even more attractive for diagnostic applications. Thus, these new molecules are perfectly 
suitable for applications on surface, preserving all the good features of lysine-based PNAs 
without the presence of reactive amino groups. Quite unexpectedly, PNA 2, albeit the 
presence of an extended series of four arginine side chains flanking the nucleobase 
corresponding to the mismatch, showed for fullmatch and mismatch hybrids stabilities fully 
comparable to those obtained by using PNA 1, which only had two arginine side chains. 
Although PNA 2 presents two more positive charges,  the fullmatch hybrid stability did not 
change, and the increased sterical hindrance did not significantly decrease the stability of the 
mismatch hybrid. This can be explained according to previously published works16, by 
supposing that most of the contribution to the stability of the fullmatch duplex is given by the 
2D,5L monomer: both the positively charged arginine side chains and the correct 
configurations imparting a right-handedness to the PNA strand increase the DNA affinity. 
Increasing the number of arginine side chains probably does not further affect the preferred 
handedness, and the increased number of positive charges, which should enhance electrostatic 
attraction for the complementary DNA strand, is probably balanced by the increased 
hindrance introduced in the middle of the PNA strand. The same counteracting effects 
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(increased electrostatic attraction vs. increased sterical hindrance) probably contribute to the 
lack of improvements in mismatch recognition.  
3.3 Conclusions 
In this chapter we have demonstrated that it is possible to modify the structure of lysine-based 
PNAs, whose properties made them suitable for diagnostic application in solution, without 
any impairment in their binding properties, by using substituents based on the structure of 
arginine. We have designed and synthesized prototypical PNAs of a new class of modified 
PNAs: Arg-PNAs. These molecules are to be considered fully suitable for diagnostic 
applications on surfaces, thanks to the lack of primary amino groups, which would compete 
with the PNA amino terminus during surface derivatization, and for their binding properties, 
comparable or even slightly better than those of lysine-based PNAs. Finally, it has been 
demonstrated that increasing from two to four the number of arginine side chains in the 
middle of the PNA strand does not increase the PNA binding properties. 
3.4 Experimental Section 
3.4.1 Materials and Reagents 
PNA N-Boc protected standard monomers, N-[1H-1,2,3-(benzotriazol-1-yl)-
(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide 
(HBTU), N-[(dimethylamino)-1H-1,2,3-triazol[4,5-b]pyridine-1-ylmethylene]-N-
methylmethanaminium hexafluorophosphate N-oxide (HATU), dichloromethane, N–
methylpyrrolidone (NMP) and N,N-dimethylformamide (DMF) were purchased from Applied 
Biosystem (Foster City, CA, USA). Carboxymethyl-O-benzyl-guanine was purchased by 
ASM (Hannover, Germany). Boc-Arg(Tos)-OH, Boc-D-Arg(Tos)-OH and m-cresol were 
from Fluka (Buchs, Switzerland). (4-Methylbenhydryl)amine (MBHA) PS resin was from 
Novabiochem (Laufelfingen, Switzerland). Carboxymethylthymine, diisopropylethylamine 
(DIPEA), N,O-Bistrimethylsilyl acetamide (BSA), trifluoromethane sulfonic acid (TFMSA), 
trifluoroacetic acid (TFA), 3-hydroxy-1, 2,3-benzotriazin-4-(3h)-one (DhBtOH), N-(3-
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Dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) and diisopropylcarbodiimide (DIC) were 
from Sigma-Aldrich (St. Louis, MO, USA). Oligonucleotides (guaranteed oligos grade) were 
purchased from ThermoFisher Scientific (Ulm, Germany) and used without further 
purification. 
3.4.2 Chemical Synthesis 
D-Arg-Nω-Tosyl methyl ester hydrocloride. N-Boc-Nω-(Tosyl)-D-Arginine-OH (2g, 4.67 
mmol) was dissolved in methanol (80ml) with magnetic stirring. The mixture was cooled at 
0°C and thionyl chloride (5.8ml, 80mmol, 1M in methanol) was added dropwise. The solution 
was stirred for 6h at room temperature. The methanol was evaporated and the residue was 
washed few times with methanol to yield the product as a white foam. Yield: 98%. 1H-NMR 
(300MHz, [D6]-DMSO, 25°C): δ(ppm): 10.37 (sb, 3H, N-H amine), 8.64 (sb, 1H, Nη-H 
arginine side chain), 7.64 ( d, 2H, J= 6 Hz aromatic tosyl group), 7.38 ( sb, 1H, Nε-H arginine 
side chain), 7.29 ( d, 2H, J= 6 Hz aromatic tosyl group ), 6.79 (sb, 1H, Nη-H arginine side 
chain), 3.99-3.97 (m,1H, C-Hα), 3.71 (s, 3H, methyl ester), 3.1-3.05(m, 2H, CH2 arginine 
side chain), 2.34 (s, 3H, CH3 tosyl group), 1.77-1.72 (m, 2H, CH2 arginine side chain), 1.49-
1.44 (m, 2H, CH2 arginine side chain). 13C NMR (75 MHz, CDCl3):δ(ppm) 169.6,156.6, 
141.3, 141.0,129.0, 125.6, 52.6, 51.4, 48.4, 27.0, 24.4, 20.8. ESI-MS (CH3OH, positive ions): 
calculated m/z: 343.1 (MH+) found: 343.3. HRMS (ESI+): calcd m/z for C14H23N4O4S (MH+): 
343.1440, found: 343.1443 
Nα-Boc-L-Arg-Nω-Tosyl-N,O-dimethylhydroxyamide. N-Boc-Nω-(Tosyl)-L-Arg-OH (2g, 
4.67 mmol) was dissolved in DMF. The solution was cooled at 0°C and HBTU was added. 
After 15 minutes DIEA and N,O-dimethylhydroxyamine were introduced. The reaction was 
warmed at room temperature  and left stirring for two hours. DMF was evaporated under 
reduced pressure and the residue was recovered with ethyl acetate and washed with saturated 
potassium hydrogen sulphate (twice) and sodium hydrogen carbonate (twice). The combined 
organic phases were dried over magnesium sulphate and filtered, and solvent was evaporated 
under vacuum. The product was obtained as white foam. Yield: 80% 1H-NMR (300MHz , 
CDCl3): δ (ppm) 7.73 (d, 2H J(H,H)= 9 Hz, CH aromatic tosyl group), 7.22 ( d, 2H, J(H,H)= 
9 Hz, CH aromatic tosyl group), 6.47 (sb, 2H, NηH arginine side chain), 3.71 (s, 3H, N-
metoxy group), 3.35 (sb, 1H C-Hα), 3.17 (s, 3H, N-methyl group), 2.38 (s, 3H, CH3 tosyl 
group), 1.69-1.59 (m, 4H, CH2 arginine side chain), 1.45-1.43 (m, 11H, CH2 arginine side 
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chain + Boc methyl groups). 13C-NMR (75 MHz, CDCl3) δ (ppm): 172.5, 156.6, 156.3, 142.0, 
140.6, 129.2, 126.0, 80.2, 61.5, 49.2, 40.8, 32.1, 30.8, 28.3 , 24.7, 21.4. ESI-MS (CH3OH, 
positive ions): calculated m/z: 472.2 (MH+), 494.2 (MNa+), 510.2 (MK+), found: 472.5, 494.5, 
510.4. Elemental analysis: calculated C 50.83%, H 7.25%, N 14.82%, found: C 50.46%, H 
6.98%, N 14.71% 
Nα-Boc-L-Arg-Nω-Tosyl-aldehyde Nα-Boc-Arg-Nω-Tosyl-N,O-dimethylhydroxyamide 
(0.8g 1.7 mmol) was dissolved in dry THF (20 ml). A solution of LiAlH4 (1M in THF, 2ml, 2 
mmol) was added dropwise at 0°C. The mixture was then allowed to warm at room 
temperature and left stirring for one hour. The reaction was then diluted by adding ethyl 
acetate and evaporated. The residue was dissolved in DCM and washed with saturated 
potassium hydrogen sulphate (twice) and sodium hydrogen carbonate (twice). The combined 
organic phases were dried over magnesium sulphate and filtered, and solvent was evaporated 
under vacuum. The product was obtained as a colourless oil. Yield: 94%. 1H-NMR (300MHz, 
CDCl3): δ(ppm): 9.41 (s, 1H, CH aldehyde), 7.62 (d, 2H, J(H,H)= 7.6 Hz, CH aromatic tosyl 
group), 7.12 (d, 2H, J(H,H)= 7.6 Hz, CH aromatic tosyl group), 6.80 (bs, 1H, Nη-H arginine 
side chain), 5.58 (bs, 1H, Nε-H arginine side chain), 5.06 (bs, 1H, Nη-H arginine side chain), 
4.77 (bs, 1H, N-H carbamate), 3.65-3.42 (m, 2H, CH2 arginine side chain), 3.03-2.99 (m, 1H, 
C-Hα), 2.28 (s, 3H, CH3 tosyl group), 1.60-1.54 (m, 4H, CH2 arginine side chain), 1.32 (s, 
9H, CH3 Boc group). 13C-NMR (75 MHz, CDCl3): δ(ppm): 200.4, 156.2, 155.2, 142.1, 140.1, 
129.2, 125.8, 79.4, 50.3, 38.9, 28.3, 24.9, 24.4, 21.3. ESI-MS (CH3OH, positive ions): 
calculated m/z: 413.2 (MH+), 435.2 (MNa+), 451.2 (MK+), found: 413.4, 435.4, 451.3. HRMS 
(ESI+): calcd m/z for C18H29N4O5S (MH+): 413.1859, found: 413.1855. 
Nα-Boc-[L-Argψ-(Nω-Tosyl)-D-Arg-((Nω-Tosyl)] methyl ester. Arg-Nω-Tosyl methyl ester 
hydrochloride (0.57g, 1.52 mmol) and DIPEA (0.26ml) were dissolved in methanol (20 ml) at 
room temperature and the mixture was stirred for 20 minutes. Nα-Boc-Arg-Nω-Tosyl-
aldehyde (0.63g, 1.52mmol) was then added and the solution was stirred for 30 min. at room 
temperature, then cooled 0°C and NaBH3CN (0.1g, 1.52mmol) and CH3COOH (0.096ml, 
1.67mmol) were added. After 2h the methanol was evaporated. The residue was dissolved in 
DCM and washed with saturated potassium hydrogen sulphate (twice) and sodium hydrogen 
carbonate (twice). The combined organic phases were dried over magnesium sulphate and 
filtered, and solvent was evaporated under vacuum. The crude product was purified by flash 
chromatography (eluent ethyl acetate:methanol= 95:5) and obtained as colourless oil. Yield: 
51%. 1H-NMR (300MHz, CDCl3): δ(ppm) 7.70 (d, 4H, J(H,H) = 7.2 Hz, CH aromatic tosyl 
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group), 7.19 (d, 4H, J(H,H) = 7.2 Hz, CH aromatic tosyl group), 6.52 (bs, 2H, Nη-H arginine 
side chain), 3.67-3.60 (m, 4H, CH3 methyl ester + C(2)Hα), 3.18-3.00 (m, 3H, ψ CH2 + 
C(5)Hα), 2.74-2.64 (m, 4H, CH2 arginine side chain), 2.36 (s, 6H, CH3 tosyl group), 1.54-
1.45 (m, 8H, CH2 arginine side chain), 1.37 (s, 9H, CH3 Boc group). 13C-NMR (75 MHz, 
CDCl3, some signals are missing due to the pseudoequivalence of the arginine side chains): 
δ(ppm) 174.3, 156.9, 156.6, 142.0, 140.6, 129.2, 125.9, 79.7, 60.8, 52.3, 52.1, 50.4, 40.7, 
29.8, 28.3, 25.4, 21.4. ESI-MS (CH3OH, positive ions): calculated m/z: 739.3 (MH+), 761.3 
(MNa+), 777.3 (MK+), found: 739.7, 761.7, 777.7. HRMS (ESI+): calcd m/z for C32H51N8O8S2 
(MH+): 739.3271, found: 739.3272. 
Nα-Boc-[L-Argψ-(Nω-Tosyl)-D-Arg-((Nω-Tosyl)]-OH. Nα-Boc-[L-Argψ-(Nω-Tosyl)-D-
Arg-((Nω-Tosyl)] methyl ester (0.3g, 0.4 mmol) was dissolved in THF:H2O = 1:1 (10ml). 
NaOH (0.16g, 4mmol) was added and the mixture was stirred at room temperature for 1 hour 
and 30 min. THF was evaporated and the product was precipitated as a white solid at pH= 6.5, 
filtered and dried under vacuum. Yield: 87%. 1H-NMR (300MHz , CD3OD): δ(ppm) 7.72 (d, 
4H, J(H,H)= 6 Hz, CH aromatic tosyl group), 7.27 (d, 4H, J(H,H) = 8 Hz, CH aromatic tosyl 
group), 3.59-3.55 (m, 1H, C(2)-H α), 3.30-3.29 (m, 2H ψ CH2) 3.16-3.12 (m, 4H CH2 
ariginine side chain), 2.93-2.86 (m, 3H, C(5)Hα), 2.36 (s, 6H, CH3 tosyl group), 1.89-1.82 
(m, 4H, CH2 ariginine side chain), 1.64-1.51 (m, 4H CH2 side chain ariginine) 1.43 (s, 9H, 
CH3 Boc group). 13C-NMR ( 75 MHz, CDCl3, some signals are missing due to the 
pseudoequivalence of the arginine side chains): δ (ppm) 173.5, 159.2, 159.0, 143.9, 142.4, 
130.6, 127.4, 81.3, 63.8 , 53.4, 50.2, 41.5, 31.2, 28.8, 26.9, 21.8. ESI-MS (CH3OH, positive 
ions): calculated m/z: 747.3 (MNa+), 763.3 (MK+), found: 747.5, 763.2. HRMS (ESI+): calcd 
m/z for C31H49N8O8S2 (MH+): 725.3115, found: 725.3117. 
Nα-Boc-[L-Argψ-(Nω-Tosyl)-D-Arg-(Nα-Fmoc)-(Nω-Tosyl)]-OH. 
Bis(trimethylsilyl)acetamide (BTSA) (0.21ml, 0.86 mmol) and DIPEA ( 0.05ml, 0.29 mmol) 
were added to Nα-Boc-[L-Argψ-(Nω-Tosyl)-D-Arg-(Nω-Tosyl)]-OH (0.21g, 0.29 mmol) 
suspended in DCM (15 ml), with exclusion of humidity by a CaCl2 drying tube. When the 
solution was nearly clear (10-15 min were usually required), Fmoc-Cl (0.1g, 0.58 mmol) was 
added and the mixture was stirred for 2 hours at room temperature. Methanol (1 ml ) was 
carefully added and the mixture was stirred for an additional 15 min, diluted with 15 ml of 
DCM, washed with 1M potassium hydrogen sulphate (3 times) and brine (times), dried over 
magnesium sulfate and evaporated to dryness. The residue was purified by flash 
chromatography (dichlomethane:methanol = 9:1) and the product was obtained as a white 
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foam. Yield: 30%. 1H NMR (600MHz, CD3OD): δ (ppm) 7.79-7.74 (m, 2H, CH aromatic 
Fmoc group), 7.72-7.70 (m, 4H CH aromatic tosyl group), 7.59-7.57 (m, 2H CH aromatic 
Fmoc group), 7.36-7.33 (m, 2H, CH aromatic Fmoc group), 7.27-7.22 (m, 6H CH aromatic 
Fmoc group + CH aromatic tosyl group), 4.55-44.36 (m, 2H CH2 Fmoc), 4.25-4.15 (m, 1H 
CH Fmoc), 3.36 (bs, 1H C(2)-H α), 3.30-3.29 (bs, 1H, C(5)Hα), 3.14-3.07 (m, 2H, ψ CH2), 
2.33-2.30 (m, 10H, CH2 arginine side chain + CH3 tosyl group), 1.34-1.24 (m, 17H, CH2 
arginine side chain + CH3 Boc group). 13C-NMR (150 MHz, CD3OD, the CH3  signals of the 
tosyl groups have identical chemical shifts due the pseudoequivalence of the arginine side 
chains): δ(ppm) 178.1, 159.4, 158.8, 158.5, 158.4, 145.7, 145.5, 143.8, 143.0, 142.9, 142.5, 
130.6, 129.2, 128.7, 127.8, 127.4, 126.4, 126.2, 121.3, 80.4, 68.8, 68.5, 64.2, 53.1, 51.2, 48.8, 
42.2, 31.9, 29.2, 28.8, 28.4, 27.3, 21.8. ESI-MS (CH3OH, positive ions): calculated m/z: 
969.4 (MNa+), found: 969.3. HRMS (ESI+): calcd m/z for C46H58N8O10NaS2 (MNa+): 
969.3615, found: 969.3624. 
Nα-Boc-Glyψ-[D-Arg(Nω-Tosyl)] methyl ester. D-Arg-Nω-Tosyl methyl ester hydrochloride 
(0.57g, 1.52 mmol) and DIPEA (0.26ml) were dissolved in methanol (20 ml) at room 
temperature and the mixture was stirred for 20 minutes. Boc-Gly-aldehyde (0.24g, 1.52mmol) 
was then added and the solution was stirred for 30 min. at room temperature, then cooled 0°C 
and NaBH3CN (0.1g, 1.52mmol) and CH3COOH (0.096ml, 1.67mmol) were added. After 2h 
the methanol was evaporated. The residue was dissolved in DCM and washed with saturated 
potassium hydrogen sulphate (twice) and sodium hydrogen carbonate (twice). The combined 
organic phases were dried over magnesium sulphate and filtered, and solvent was evaporated 
under vacuum. The crude product was purified by flash chromatography (eluent 
dicloromethane :methanol= 95:5) and obtained as white foam. Yield: 48%. 1H-NMR 
(300MHz, DMSO-d6): δ(ppm) 7.64 (d, 2H, J(H,H) = 8.1 Hz, CH aromatic tosyl group), 7.29 
(d, 2H, J(H,H) = 8.0 Hz, CH aromatic tosyl group), 7.03 (bs, 1H, Nη-H arginine side chain), 
6.72 (bs, 1H, NH-Boc), 6.56 (bs, 1H, Nη-H arginine side chain), 3.61 (s, 3H, CH3 methyl 
ester), 3.34 (s, 1H, C(2)H α), 3.23-2.86 (m, 6H, CH2 arginine side chain + Glyψ CH2CH2), 
2.35 (s, 3H, CH3 tosyl group), 1.61-1.43 (m, 4H, CH2 arginine side chain), 1.37 (s, 9H, CH3 
Boc group). 13C-NMR (75 MHz, DMSO-d6): δ(ppm) 174.9, 156.4, 156.2, 141.2, 140.9, 128.9, 
125.4, 77.3, 60.1, 51.2, 46.9, 40.6, 29.6, 29.2, 28.3, 25.5, 21.4. ESI-MS (CH3OH, positive 
ions): calculated m/z: 486.6 (MH+), 508.6 (MNa+), 524.7 (MK+), found: 486.5, 508.5, 524.4. 
Nα-Boc-Glyψ-[D-Arg-(Nω-Tosyl)]-OH. Nα-Boc-Glyψ-[D-Arg-((Nω-Tosyl)] methyl ester 
(0.66g, 1.37 mmol) was dissolved in THF:H2O = 1:1 (25ml). NaOH (0.42g, 10.5mmol) was 
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added and the mixture was stirred at room temperature for 3 hour. THF was evaporated and 
the product was precipitated as a white solid at pH= 7.5, filtered and dried under vacuum. 
Yield: 75%. 1H-NMR (300MHz , DMSO-d6): δ (ppm) 7.97 (bs, 1H, N-Hη arginine side 
chain), 7.64 (d, 2H, J(H,H)= 8 Hz, CH aromatic tosyl group), 7.29 (d, 2H, J(H,H) = 8 Hz, CH 
aromatic tosyl group), 7.18 (bs, 1H, Nη-H arginine side chain), 6.99 (bs, 1H, NH-Boc), 3.29-
3.05 (m, 5H, C(2)Hα + Glyψ CH2CH2), 2.79-2.69 (m, 2H, CH2 arginine side chain), 2.34 (s, 
3H, CH3 tosyl group), 1.73-1.40 (m, 4H, CH2 arginine side chain), 1.38 (s, 9H, CH3 Boc 
group). 13C-NMR ( 75 MHz, DMSO-d6): δ (ppm) 170.8, 156.8, 155.5, 141.6, 140.8, 128.9, 
125.4, 77.9, 61.0, 45.9, 37.1, 28.0, 27.2, 25.0, 20.7. ESI-MS (CH3OH, positive ions): 
calculated m/z: 472.6 (MH+), 494.6 (MNa+), 510.7 (MK+), found: 472.4, 494.4, 510.4  
Nα-Boc-Glyψ-[D-Arg-(Nα-Fmoc)-(Nω-Tosyl)]-OH. Bis(trimethylsilyl)acetamide (BTSA) 
(0.21ml, 0.86 mmol) and DIPEA ( 0.05ml, 0.29 mmol) were added to Nα-Boc-Glyψ-[D-Arg-
(Nω-Tosyl)]-OH (0.14g, 0.29 mmol) suspended in DCM (15 ml), with exclusion of humidity 
by a CaCl2 drying tube. When the solution was nearly clear (10-15 min were usually 
required), FmocCl (0.1g, 0.58 mmol) was added and the mixture was stirred for 2 hours at 
room temperature. Methanol (1 ml ) was carefully added and the mixture was stirred for an 
additional 15 min, diluted with 15 ml of DCM, washed with 1M potassium hydrogen sulphate 
(3 times) and brine (3 times), dried over magnesium sulfate and evaporated to dryness. The 
residue was purified by flash chromatography (dichlomethane:methanol = 9:1) and the 
product was obtained as a white foam. Yield: 38%. 1H NMR (300MHz, DMSO-d6):(some 
signals are splitted due to presence of rotamers) δ (ppm) 7.92-7.82 (m, 2H, CH aromatic 
Fmoc group), 7.70-7.59 (m, 4H CH aromatic tosyl group + CH aromatic Fmoc group), 7.45-
7.18 (m, 6H CH aromatic Fmoc group + CH aromatic tosyl group), 4.33-4.00 (m, 3H CH2CH 
Fmoc), 3.31 (bs, 1H, C(2)-Hα), 3.14-2.87 (m, 6H, CH2 arginine side chain + Glyψ CH2CH2), 
2.30 (s, 3H, CH3 tosyl group), 1.66-1.38 (m, 13H, CH2 arginine side chain + CH3 Boc group). 
13C-NMR (75 MHz, DMSO-d6,): δ(ppm) 175.0, 156.7, 155.9, 155.5, 143.8, 141.7, 140.8, 
140.5, 128.8, 127.5, 127.1, 126.9, 125.4, 125.0, 119.9, 77.3, 66.4, 60.8, 48.3, 46.6, 45.2, 29.9, 
28.1, 26.6, 20.7. ESI-MS (CH3OH, positive ions): calculated m/z: 694.81 (MH+), 716.81 
(MNa+), 732.9 (MK+)found: 694.5, 716.4, 732.4.  
Nα-Boc-[L-Argψ-(Nω-Tosyl)]-Gly methyl ester. Nα-Boc-L-Arg-Nω-Tosyl-aldehyde (686.7 
mg, 1.66 mmol) and Gly-OMe•HCl (250.8 mg, 2.00 mmol) were dissolved in MeOH (20 ml). 
The reaction mixture was cooled to 0° C with an ice bath and NaBH3CN (132.1 mg, 2.00 
mmol), and acetic acid (144 µl, 2.00 mmol) were added to the stirred solution. The reaction 
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was allowed to stir for 30 minutes at 0°C, then at room temperature for 4 hours. The solvent 
was evaporated and the residue was redissolved in EtOAc, and washed with saturated 
NaHCO3 (3 times) and KHSO4 (3 times). The organic layer was dried over Na2SO4, filtered 
and evaporated to afford an oil. The oil was purified via column flash chromatography (from 
EtOAc to AcOEt/MeOH 9:1) to afford a colorless foam. Yeld: 50%. 1H NMR (300 MHz, 
CDCl3): δ(ppm) 7.75 (d, 2H, J = 8.2 Hz, CH aromatic tosyl group), 7.22 (d, 2H, J = 8.2 Hz, 
CH aromatic tosyl group), 6.45 (bs, 3H, N–H), 5.00 (d, 1H, J = 8,4 Hz, NH-Boc), 3.72 (s, 3H, 
CH3 methyl ester), 3.70-3.55 (m, 1H, C(5)Hα), 3.44 (d, 1H, J = 17,5 Hz, Gly CH2), 3.35 (d, 
1H, J = 17,5 Hz, C(2)H2), 3.18 (bs, 2H, CH2NH side chain), 2.70-2.50 (m, 2H, Argψ CH2 
pseudopeptide moiety), 2.38 (s, 3H, CH3 tosyl group), 1.78 (bs, 1H, NH amine), 1.61-1.43 (m, 
4H, CH2CH2 side chain),1.41 (s, 9H, CH3 Boc group). 13C NMR (75.4 MHz, CDCl3): δ(ppm) 
= 172.8, 156.8, 156.2, 141.8, 140.6, 129.1, 125.7, 79.0, 53.5, 52.9, 51.6, 50.3, 40.7, 30.1, 
28.2, 25.6, 21.2. ESI-MS(CH3OH, positive ions): calculated m/z 486.6 (MH+), found 486.4.  
Nα-Boc-[L-Argψ-(Nω-Tosyl)]-Gly[Nα-(Z)carboxymethylcytosine] methyl ester. N4-
benzoxycarbonyl-N1-carboxymethylcytosine (CMC(Z)) (502.9 mg, 1.65 mmol) was 
dissolved in DMF (10 ml) at 0° C, together with DHBtOH (268.8 mg, 1.65 mmol) and DIPEA 
(423 µl, 2.56 mmol). EDC•HCl (314.4 mg, 1.64 mmol) was then added, and the solution was 
stirred for 10 minutes at 0° C, then for 20 minutes at room temperature; Nα-Boc-[L-Argψ-
(Nω-Tosyl)]-Glymethyl ester (408.2 mg, 0.84 mmol) was then added to the mixture, and the 
solution was stirred overnight. After completion of the reaction the DMF was evaporated 
under vacuum. The residue was redissolved in AcOEt and washed with saturated KHSO4 (3 
times), and saturated NaHCO3 (3 times). The organic layer was dried over Na2SO4 and 
filtered; the solvent was removed and the residue was purified via flash chromatography 
(AcOEt/MeOH = 95 : 5) to afford the product as a pale yellow foam. Yeld 95%. 1H NMR 
(300 MHz, CDCl3 ): major rotamer δ(ppm) 10.81 (bs, 1H, NH Cytosine), 7.69 (d, 2H, J = 8.1 
Hz, CH aromatic tosyl group), 7.55 (bs, 1H, C(6)H Cytosine), 7.35-7.10 (m, 8H, C(5)H 
Cytosine, CH aromatic tosyl and benzyl group), 6.55 (bs, 2H, NH), 5.56 (bs, 1H, NH-Boc), 
5.16 (s, 2H, CH2 benzyl group), 4.90-4.45 (m, 2H, CO-CH2-Cytosine), 4.40-3.85 (m, 2H, 
C(2)H2), 4.00-3.70 (m, 2H, Argψ CH2), 3.59 (s, 3H, CH3 methyl ester), 3.41 (bs, 1H, C(5)H), 
3.17 (bs, 2H, CH2NH Arg side chain), 2.32 (s, 3H, CH3 tosyl group), 1.80-1.30 (m, 13H, CH3 
Boc group and CH2 side chain). 13C NMR (75.4 MHz, CDCl3): major rotamer δ(ppm) 169.5, 
167.4, 163.3, 156.9, 156.2, 156.0, 152.5, 150.2, 141.8, 140.9, 135.0, 129.1, 128.6, 128.3, 
128.2, 125.9, 95.6, 79.7, 77.2, 67.7, 52.8, 52.2, 50.9, 49.2, 48.9, 40.2, 28.8, 28.3, 25.6, 21.4. 
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ESI-MS(CH3OH, positive ions): calculated 771.9 (MH+), 793.9 (MNa+), 810.0 (MK+); found 
771.8, 793.8, 809.9. 
Nα-Boc-[L-Argψ-(Nω-Tosyl)]-Gly[Nα-(Z)carboxymethylcytosine]-OH. To a stirred 
solution of Nα-Boc-[L-Arg-(Nω-Tosyl)]ψ-Gly[Nα-(Z)carboxymethylcytosine] methyl ester 
(594.3 g, 0.77 mmol) in THF (40 ml) , a solution of Ba(OH)2•H2O (363.9 mg, 1.15 mmol) in 
water (40 ml) was added. The reaction mixture was stirred for 30 minutes. The THF was then 
evaporated and the pH of the solution was lowered to 5 with a solution of HCl to induce the 
precipitation of the product. The solution was cooled at 4°C for 2 hours, then filtered and 
dried under vacuum to afford the desired product as a whithe solid. Yeld 72%. 1H NMR (300 
MHz, DMSO-d6 ): major rotamer δ(ppm) 10.81 (bs, 1H, NH Cytosine), 7.81 (d, 1H, J = 7.2 
Hz, Cytosine C(6)H), 7.64 (d, 2H, J = 8.1 Hz, CH aromatic tosyl group), 7.45-7.25 (m, 7H, 
CH aromatic tosyl and benzyl group), 7.02 (d, 1H, J = 7.2 Hz, Cytosine C(5)H), 6.90-6.60 (br 
m, 3H, NH side chain), 5.19 (s, 2H, CH2 benzyl group), 4.90 (d, 1H, J = 15.9 Hz, CO-CH2-
Cytosine), 4.77 (d, 1H, J = 16.2 Hz, CO-CH2-Cytosine), 4.03 (d, 1H, J = 17.1 Hz, Gly CH2), 
3.87 (d, 1H, J = 17.4 Hz, Gly CH2), 3.70-2.90 (m, 5H, C(5)H, Argψ CH2 and CH2NH side 
chain), 2.34 (s, 3H, CH3 tosyl group), 1.60-1.30 (m, 13H, CH3 Boc group and CH2 side 
chain). 13C NMR (75.4 MHz, DMSO-d6): major rotamer δ(ppm) 170.3, 167.1, 163.0, 156.5, 
155.5, 154.9, 153.1, 150.5, 141.6, 141.0, 135.9, 129.0, 128.4, 128.1, 127.9, 125.5, 93.8, 77.9, 
66.4, 51.4, 49.4, 48.5, 47.8, 40.2, 28.6, 28.1, 25.4, 20.8. HR-MS: calculated m/z for 
C34H45O10N8S (MH+): 757.2974, found: 757.3019; calculated for m/z for C34H44O8N10NaS 
(MNa+): 779.2793, found: 779.2831; calculated m/z for C34H43O10N8S (M-H-): 755.2817, 
found: 755.2819. 
3.4.3 PNA synthesis 
The synthesis of chiral PNAs was performed as described previously for similar molecules17 
by using manual synthesis for the chiral residues and automated Boc-SPPS protocols on a 
ABI 433A synthesizer, following the procedures provided from the company, for the achiral 
residues. The chiral submonomers were introduced by using HATU/DIEA coupling protocol, 
Fmoc group was deprotected by piperidine/NMP (20%) and carboxymethyl-Z-adenine, 
carboxymethyl-thymine 18 were linked to the submonomers on resin by using DIC/DhBtOH 
coupling protocol. Free PNAs were cleaved from the resin by using a 1:3 TFMSA/TFA 
mixture (10% thioanisole + 10% m-cresol) and precipitated by Et2O. HPLC analysis for all 
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PNAs was carried out by LC-MS by using an XTerra anlytical C18 column (3x250mm, 5µm, 
flow 0.5ml/min), gradient elution from 100% H2O (0.2% HCOOH, eluent A) to 60% H2O and 
40% CH3CN (0.2%HCOOH, eluent B) in 30 min. MS detector set in the positive ion mode, 
capillary voltage 3kV, cone voltage 30V, full scan acquisition from 150 to 1500 m/z. HPLC 
purification for all PNAs was carried out on a semipreparative Jupiter (Phenomenex) C18 
column (10x300mm, 5µm, flow 4ml/min); eluent A: 100% H2O (0.1% TFA), eluent B: 60% 
H2O and 40% CH3CN (0.1%TFA). Specific preparative elution conditions for every PNA are 
given below.  
PNA 1:H-GTAGAT(2D,5LArg)CACT-NH2. The synthesis was performed on 25mg of a 
preloaded Boc-T-MBHA-PS resin (loading 0.2mmol/g). Crude yield: 75%. The crude 
products were purified by semipreparative RP-HPLC, in gradient elution: from 100% A to 
100% B in 30 min ESI-MS: calcd m/z: 976.0 (MH33+), 732.2 (MH44+), 586.0 (MH55+), 488.5 
(MH66+) found m/z 976.2, 732.3, 586.2, 488.6. PNA 2 H-GTAGA(2D-Arg)T(2D,5L-Arg)C(5L-
Arg)ACT-NH2. Crude yield: 80%. The crude product was purified by RP-HPLC in gradient 
elution: from 100% A to 100%B in 30 minutes. ESI-MS calcd m/z: 1042.1 (MH33+), 781.8 
(MH44+), 625.6 (MH55+), 521.5 (MH66+) found m/z 1042.0, 781.6, 625.4, 521.1. 
3.4.4 Melting temperature measurements 
Stock solutions of PNA 1, 2, and of oligonucleotides were prepared in doubly distilled water 
and their actual concentration calculated by UV absorbance using the following ε260 (M-1 cm-
1) for the nucleobases: T 8600, C 6600, A 13700, G 11700. By using these concentrations, 
hybrid solutions containing 5µM PNA-DNA duplexes were prepared. All the hybridisation 
experiments were carried out in 10mM phosphate buffer, 100mM NaCl, 0.1mM EDTA, pH= 
7. All the hybrid samples reported were first incubated at 90°C for 5 minutes, then slowly 
cooled to room temperature. The samples were heated (1°C/min) and the UV signal variation 
at 260nm was recorded. Melting temperatures were measured as the maximum of the first 
derivatives of the melting curves. 
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Chiral PNA application on surface: Arginine-based PNA 
microarrays for ApoE genotyping 
 
In this chapter PNAs containing a 2D-5L arginine monomer are utilized in diagnostic 
applications on surface. The design and synthesis of the modified PNAs  by submonomeric 
strategy are described. The probes have been designed targeting sequences contained in the 
human gene coding for ApoE (a protein related to the cholesterol metabolism), in order to 
recognize six different genotypes corresponding to SNPs present in two different positions 
and related to the risk of the Alzheimer disease onset. After the synthesis, an innovative 
application is described, consisting in the fabrication of microarrays bearing chiral PNAs for 
a fast and precise genotype characterization. 
 
  
Chapter 4 
74 
4.1 Introduction 
Single nucleotide polymorphisms (SNPs) are one of major sources of genetic variation in the 
human genome1. Many SNPs have been linked to several diseases or pathological conditions, 
such as the Alzheimer disease (AD), which was found to be related to SNPs located in the 
ApoE gene. This gene encodes for the apolipoprotein E, a protein involved in cholesterol 
metabolism. This protein has been found to exist in three main isoforms (ε2, ε3, ε4)2 that 
differ for the substitution of amino acids at position 112 and 158: Cys112/Cys158 (ε2), 
Cys112/Arg158 (ε3) and Arg112/Arg158 (ε4). The combination of the variants on the two 
alleles generates six different genotypes3. An increased frequency of the ApoE ε4 allele in 
late-onset AD patients, both familiar and sporadic, has been demonstrated, and a gene dose 
effect for the ε4 allele was found in AD families, implicating that this allele is a major risk 
factor for AD4.  
Selective SNP recognition is useful both in diagnostic and therapeutic applications. For 
example, in the case of AD, having this disease origin in early-life5 and given that no cures 
are at the moment available, accurate and early diagnosis of a genetic predisposition could be 
very important, since early therapeutic intervention, before severe cellular damages, would 
improve the prognosis and life quality of AD patients. Moreover, since AD diagnosis can be 
confirmed only by autoptic post-mortem analysis, a reliable genetic testing to be performed 
on all subjects suffering for dementia might help to distinguish between AD and non-AD 
subjects6. 
Recently, great efforts have been devoted to develop selective and specific methods for SNP 
analysis, yielding a large number of distinct approaches7. Usually, a PCR amplification of the 
desired SNP-containing region is initially performed in order to specifically increase the 
number of DNA molecules for detection. After PCR, allelic discrimination is done by 
different strategies: primer extension (nucleotide incorporation), ligation, enzymatic cleavage 
and hybridization7. Hybridization approaches exploit differences in thermal stability of 
double-stranded DNA to distinguish between matched and mismatched target-probe pairs. 
Thus, it is critical to perform assays under conditions where hybridization occurs only if the 
probe and the target are perfectly complementary. 
Selective hybridization methods have been implemented not only in solution but also on 
surface-based methods, such as microarrays8,9. Such methods usually rely on the recognition 
of a DNA target by hybridization with a single strand oligonucleotide probe immobilized onto 
Arg-PNA Microarrays 
75 
a surface. Although methods performed in solution are usually more affordable and robust, 
surface systems display several features not achievable with other techniques. The 
concentration effect obtained on the surface where the probe is deposited usually results in a 
sensitivity increase of the method. Surface devices are fabricated with microsystems that 
allow to work with only very small amounts of probes, and small volumes of analyte solution 
for the hybridization process. The possibility to use multiple probes at the same time enables 
this technique to simultaneously give a large number of information and so to reduce the 
number of the necessary analyses. Finally, when the system has been used, it can be recycled 
by denaturating the duplex formed on the surface and thus leaving the probes linked to the 
surface ready to be further rehybridized. 
The possibility to freely modify the surfaces allows to exploit different physical properties for 
revealing the duplex formation. The improvement of these techniques led to development of 
optical, electrochemical, or mass sensitive devices. Detection methods by fluorescence are 
mostly used being fast and very sensitive. In order to achieve optimal results, the probes 
should be highly selective10. Oligonucleotide probes suffer from two drawbacks: the strong 
dependence of the duplex stability upon the ionic strength11 and the inability of the 
oligonucleotide probes to invade DNA secondary structures, which disfavours the target 
hybridization on the surface12. Therefore, these systems may be improved by substituting 
oligonucleotide molecules with other similar compounds with improved specificity and 
selectivity. Typical example of such compounds are Peptide Nucleic Acids (PNAs)13. 
PNA microarrays can be made by directly linking the probes to a surface (glass or polymeric) 
through a covalent linkage with suitably active functional groups. PNA microarrays can be 
built by deposition of pre-synthesized and purified probes14, or by in-situ synthesis of PNAs15. 
PNA probes have particularly suitable features which allow them to be applied extensively for 
the analysis of particular DNA sequences14,16, or for the detection of SNPs15,17,18, obtaining 
good performances. First experiments in this field were carried out hybridizing amplified and 
labeled DNA samples12 on surface and reading the fluorescence by laser scanners studied for 
these systems. This method is still the most used because it is robust and reproducible. 
Commercial PNA arrays exploit this detection method, albeit fluorescent labeling is not 
introduced directly, but in two steps; amplified DNA is labeled with a biotin and, after 
hybridization and washing are performed, a streptavidin-fluorophore is coupled and bound to 
the DNA19. Although fluorescent detection is still the most used, many efforts have been done 
for improving the detection performances, either by changing the detection method, or by 
improving the probe performances, introducing ad hoc modifications. Early works were 
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obtained by coupling array technology with mass spectrometry, exploiting the lack of 
phosphates in PNA backbone. The detection of phosphate group by TOF-SIMS mass 
spectrometry was, thus, used to determine whether the probe was hybridized with 
complementary DNA or not20,21. Conjugation of PNA-microarrays with fluorescent positively 
charged polymers was exploited to visualize hybridization with non-labeled DNA by 
fluorescence signals, exploiting the fact that positively charged polymers could interact with 
the duplex thanks to the negative charges from the DNA backbone, but not with PNA that has 
a neutral backbone22,23. The introduction of groups able to recognize selectively the PNA-
DNA duplex has been done using gold nanoparticles bearing DNA sequences able to 
recognize the same strand hybridized by the PNA, enhancing the detection using silver and 
measuring the scattering of the light by the nanoparticle labeled spots24. 
Although many improvements in the readout signals led to very powerful methods, selectivity 
needs to be increased in order to achieve a better recognition of SNPs. For this reason it is 
important to have systems able to perfectly bind to matched targets and not to mismatched 
targets. PNAs have been modified to improve performances in the recognition of single point 
mutations. It has been demonstrated that this can be achieved by introducing suitable 
modifications in the PNA backbone25. Among modified PNAs, chiral amino acid-based 
analogues substituted at position 2 and 5 (Figure 4-1) have recently gained increasing 
attention, due to their 
peculiar DNA binding 
abilities easily tuneable 
according to the 
different 
configurations26, as 
described in the 
previous chapter. 
Four modified PNA 
probes carrying one chiral monomer, derived from two arginine units, with two stereogenic 
centres in positions 2 and 5 having suitable configurations were synthesized in order to 
improve the specificity and the strength of DNA binding. The synthesized PNAs have then 
been used to build PNA microarrays for the genotypization of two different SNPs in the ApoE 
gene. The performances of these microarrays have been studied by using oligonucleotide 
mixtures simulating the different genetic profiles corresponding to the different SNPs in the 
ApoE gene. 
Figure 4-1: Chemical structure of chiral PNAs 
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4.2 Results and Discussion 
4.2.1 Design and synthesis of modified chiral PNA probes 
The properties of modified chiral PNAs containing lysine based monomers in the middle of 
the sequence have been showed in chapter 3, demonstrating that PNAs containing one residue 
with two lysine-derived side chains (2D,5L) had a highly improved affinity and selectivity in 
the recognition of complementary DNA sequences. An homologous PNA having the same 
modification but based on the structure of arginine maintained the same properties.  
As explained in chapter 3, arginine has been used instead of lysine because the PNAs will be 
linked to surface for building PNA-microarrays. The presence of the guanidium group on the 
side chain of arginine allows to avoid any interference in the reaction between the terminal 
amino group of the probe and the reactive groups on the surface (which was possible if using 
lysine-based PNAs). 
The PNA sequences to be synthesized had to be complementary to the two gene tracts bearing 
the SNPs, codifying for the three ApoE protein isoforms. Four undecameric PNAs (for two 
different SNPs in two different gene tracts) were designed (PNA 1-4, Table 4-1), with the 
chiral (2D,5L-Arg) unit located in the middle of the sequence, corresponding to the SNP 
positions. In both regions containing the codons for amino acid 112 and 158 in the ApoE 
protein, a T/C SNP was present, thus in both cases the PNA nucleobase corresponding to the 
SNP was an A or a G. It was also decided to place two spacer groups 
(aminoethoxyethoxyacetyl, AEEA) at the amino terminus in agreement with previous 
studies27 which established the right distance between the probes and the surface of 
microarray for obtaining a good surface hybridization.  
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Table 4-1. PNA sequences and melting temperatures of the PNA:DNA antiparallel 
fullmatch/mismatch duplexes in phospate buffer (pH=7) at a 5µm concentration for each 
strand 
PNA Sequence[a] Tm (°C) 
 PNA/DNA 
Fullmatch[b] 
Tm (°C) 
PNA/DNA 
Mismatch[b] 
ΔTm 
(°C) 
1 H(AEEA)2GCCGCA(2D,5LArg)CACGT-NH2 78 (with 1’) 61 (with 3’) 17 
2 H-(AEEA)2CAGGCA(2D,5L-Arg)CTTCT-NH2 69 (with 2’) 50 (with 4’) 19 
3 H(AEEA)2GCCGCG(2D,5LArg)CACGT- NH2 85 (with 3’) 69 (with 1’) 16 
4 H-(AEEA)2CAGGCG(2D,5L-Arg)CTTCT-NH2 75 (with 4’) 60 (with 2’) 15 
[a] The chiral monomer corresponding to the SNP position is underlined in bold  
[b] Oligonucleotide sequences (SNP base is underlined in bold): 1’: 5’-ACGTGTGCGGC-3’, 2’: 5’-
AGAAGTGCCTG-3’,3’: 5’-ACGTGCGCGGC-3’, 4’: 5’-AGAAGCGCCTG-3’ 
 
PNAs were synthesized by using common SPPS protocol based on the Boc strategy for the 
standard monomers, combined to the Boc submonomeric strategy for the chiral monomer 
only, since better suited to preserve the optical purity at the 2 position28 and also because one 
single submonomer can be used for the synthesis of PNAs bearing different nucleobases on 
the chiral residue. The submonomer was prepared, as reported in Chapter 3, starting from the 
commercial D- and L-Boc-Arginine(Tos)-OH. Boc-L-Arg(Tos)-OH was transformed in the 
corresponding Weinreb amide and then reduced to the aldehyde. Boc-D-Arg(Tos)-OH was 
transformed in the methyl ester and Boc deprotected. The PNA backbone was then 
synthesized by reductive amination of D-Arg(Tos)-OMe with the Boc-L-Arg(Tos) aldehyde. 
The methyl ester was hydrolyzed and the secondary amine was protected by the introduction 
of a Fmoc group. 
According to previously reported procedures15, the chiral submonomers units were inserted by 
manual coupling with the HATU/DIEA protocol and, after Fmoc deprotection, the nucleobase 
residues were introduced by a double coupling with DIC/DhBTOH. All the PNA oligomers 
were purified by RP-HPLC and characterized by ESI-mass spectrometry (Figure 4-2). 
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Figure 4-2: HPLC profiles and mass spectra of PNAs 1-4 
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4.2.2 DNA recognition by PNA probes in solution 
Probe performances were initially tested in solution by measuring the melting temperatures of 
both fullmatch and mismatch PNA-DNA duplexes, by using oligonucleotides homologous to 
the ApoE sequences (Table 4-1). Melting temperatures were evaluated as the first derivatives 
of the UV absorption curves at 260 nm in a temperature range from 20 to 90°C.  
The chiral PNA probes were found to bind with very high stability to complementary DNA 
sequences (Tm from 69 to 85°C) and also exerted very high sequence recognition, with 
differences between full match and mismatch melting temperatures ranging from 15°C to 
19°C. The high stability of the full match complexes, together with the increased specificity, 
make feasible to find conditions, after PNA deposition on a microarray, in which it is possible 
to have good signals for full match duplexes and no signals for the mismatched ones. 
4.2.3 PNA spotting on the array platform 
 
Figure 4-3: Optimization of washing procedure (effect of solution composition) 
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PNA-microarray platforms were built by using glass slides derivatised with N-
hydroxysuccinimide active groups, which were allowed to react with the PNA terminal amino 
groups. The solutions for PNA spotting were prepared by dissolving the PNA probes (50 µM) 
in carbonate buffer (0.1 M, pH=9) containing SDS (0.001%). The deposition of the probes on 
the surface was done by using a pin system spotter.  
Since PNAs are known to be strongly absorbed on many types of surfaces, three so called 
“washing-spotting” cycles had to be introduced after each PNA deposition, in order to avoid 
false positive signals due to the contamination of the pin. The optimization of the washing 
step was done by spotting a PNA, followed by two or three spotting of washing solutions, and 
finally spotting the same buffer used to spot the probe, in order to check if any residue 
contamination was present in the pin. The essays allowed to evaluate the “washing power” of 
different mixtures, looking for the one able to completely remove the undeposited PNA from 
the pin. Washing solutions were prepared using organic solvents (such as acetonitrile and 
dimethylformamide) and different mixtures of SDS (Figure 4-3). The effect of pH on the 
ability to solubilize the adsorbed probe on the pin was also tested using different buffer 
mixtures (Figure 4-4). 
The results showed in 
figures 4-3 and 4-4 
indicate that the best 
results in terms of lack of 
cross contamination is 
obtained with the same 
buffer used for depositing 
the PNAs, composed by 
0.1 M sodium carbonate 
buffer at pH= 9 with SDS 
present at various 
concentration (0.2%, 1% 
and 0.001%); after these 
cycles no traces of PNAs 
were detected upon 
spotting (as confirmed by 
the lack of hybridization 
with the complementary Cy5-oligonucleotide). Deposition efficiency was checked in every 
Acetate Buffer pH=4
PNA Wash WashWash Buffer
Carbonate Buffer pH=9
PNA Wash WashWash Buffer
Tris Buffer pH=9
PNA Wash WashWash Buffer
Borate Buffer pH=9
PNA Wash WashWash Buffer
Formiate Buffer pH=4
PNA Wash WashWash Buffer
Figure 4-4: Optimization of washing procedure (effect of pH and
buffer) 
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slide by spotting a fluorescent oligonucleotide derivatised with the Cy3 fluorophore. Thus the 
definitive protocol used for spotting the PNAs was the following: PNA deposition at the 
concentration of 50μM in SDS 0.001%, Carbonate 0.1M pH= 9, followed by three washing 
with Carbonate 0.1M and SDS 0.2%, SDS 1%, and SDS 0.002%  
The spotting process was followed by an incubation step in a dark room with controlled 
humidity overnight, and by a capping process with, a 50 mM ethanolamine solution, in 0.1M 
TRIS buffer (pH=9) at 50°C for 1h, in order to block any unreacted active group on the slide, 
followed by washing of the slides with buffer and water. 
4.2.4 Oligonucleotide hybridization 
Several microarray slides, each bearing all four different PNAs, were then hybridised with 
100 nM solutions of oligonucleotides derivatised with the Cy5 fluorophore.  
In order to increase the hybridization efficiency and to refine shapes of the spots, an 
incubation-hydration step in SDS 0.1%, SSC buffer (0.3M NaCl, 0.03M sodium citrate, pH= 
7), at 40°C for 30 minutes was added before the hybridization with oligonucleotide 
solutions29. This step was particularly required when using the slides several days after PNA 
spotting, allowing to maintain the efficiency of the devices, which could be used months after 
the preparation without significative differences. 
The hybridation-incubation was carefully optimised in order to eliminate any signal due to 
mismatched PNA-DNA duplexes without depleting the signals due to full match duplexes: 
optimal results were obtained by incubation at 55°C for 2 hours. Every slide-bound PNA was 
singularly tested with the different oligonucleotides: in all cases, under the above reported 
conditions, a clear signal was detected for full match PNA-DNA duplexes, whereas no signal 
or only a very weak signal was detected for the mismatched complexes. 
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In order to simulate the different genotype combinations, further experiments were then 
performed by using oligonucleotide mixtures. The SNPs in the ApoE gene tracts coding for 
the 4 different isoforms are: a thymine in ε2 and ε3 and a cytosine in ε4 for the codon 
corresponding to the amino acid 112; a thymine in ε2 and a cytosine in ε3 and ε4 for the 
codon corresponding to the amino acid 158. By considering all the allelic combinations, the 6 
different genotypes were simulated by mixing the corresponding oligonucleotides, as reported 
in Table 4-2.  
The oligonucleotide mixtures were then incubated in six independent experiments with the 
arginine-PNA microarrays, in the same conditions reported before. The results are reported in 
figure 4-4. 
Table 4-2. Genotypes related to ApoE mutations 
Genotype Oligonucleotide simulation[a]
ε2/ε2 1’ + 2’ 
ε2/ε4 1’ + 2’ + 3’ + 4’ 
ε3/ε4 1’ + 3’ + 4’ 
ε4/ε4 3’ + 4’ 
ε2/ε3 1’ + 2’ + 4’ 
ε3/ε3 1’ + 4’ 
 [a] Oligonucleotide sequences (SNP base is underlined in bold): 1’: 5’-
ACGTGTGCGGC-3’, 2’: 5’-AGAAGTGCCTG-3’,  
3’: 5’-ACGTGCGCGGC-3’, 4’: 5’-AGAAGCGCCTG-3’.  
All the oligonucleotides were derivatized with Cy5 
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complex mixtures simulating the real genotype profiles. Six different hybridization patterns 
related to six different genotypes in the ApoE gene were clearly obtained in microarray 
experiments, potentially allowing for an easy genetic assessment. Work is now in progress in 
order to apply this diagnostic system to human DNA samples amplified by PCR. 
4.4 Experimental Section 
4.4.1 Materials and reagents 
PNA N-Boc protected standard monomers, N-[1H-1,2,3-(benzotriazol-1-yl)-
(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide 
(HBTU), N-[(dimethylamino)-1H-1,2,3-triazol[4,5-b]pyridine-1-ylmethylene]-N-
methylmethanaminium hexafluorophosphate N-oxide (HATU), dichloromethane, N–
methylpyrrolidone (NMP) and N,N-dimethylformamide (DMF) were purchased from Applied 
Biosystem (Foster City, CA, USA). Carboxymethyl-O-benzyl-guanine was purchased by 
ASM (Hannover, Germany). Boc-Arg(Tos)-OH, Boc-D-Arg(Tos)-OH and m-cresol were 
from Fluka (Buchs, Switzerland). (4-Methylbenhydryl)amine (MBHA) PS resin was from 
Novabiochem (Laufelfingen, Switzerland). Diisopropylethylamine (DIPEA), N,O-
Bistrimethylsilyl acetamide (BSA), trifluoromethane sulfonic acid (TFMSA), trifluoroacetic 
acid (TFA), 3-hydroxy-1, 2,3-benzotriazin-4-(3h)-one (DhBtOH) and 
diisopropylcarbodiimide (DIC) were from Sigma-Aldrich (St. Louis, MO, USA). 
Oligonucleotides (guaranteed oligos grade) were purchased from ThermoFisher Scientific 
(Ulm, Germany) and used without further purification. 
4.4.2 PNA synthesis 
The synthesis of  chiral (2D,5L)-Arg-based PNAs was performed as described previously for 
similar PNAs30 by using manual synthesis for the chiral residues and automated Boc-SPPS 
protocols on a ABI 433A synthesizer, following the procedures provided from the company, 
for the achiral residues. The chiral submonomers were introduced by using HATU/DIEA 
coupling protocol, Fmoc group was deprotected by piperidine/NMP (20%) and 
carboxymethyl-Z-adenine31 or carboxymethyl-O-benzyl-guanine (commercialy available) 
Chapter 4 
86 
were linked to the submonomers on resin by using DIC/DhBtOH coupling protocol. Free 
PNAs were cleaved from the resin by using a 1:3 TFMSA/TFA mixture (10% thioanisole + 
10% m-cresol) and precipitated by Et2O. HPLC analysis for all PNAs was carried out by LC-
MS by using an XTerra anlytical C18 column (3x250mm, 5µm, flow 0.5ml/min), gradient 
elution from 100% H2O (0.2% HCOOH, eluent A) to 60% H2O and 40% CH3CN 
(0.2%HCOOH, eluent B) in 30 min. MS detector set in the positive ion mode, capillary 
voltage 3kV, cone voltage 30V, full scan acquisition from 150 to 1500 m/z. HPLC 
purification for all PNAs was carried out on a semipreparative Jupiter (Phenomenex) C18 
column (10x300mm, 5µm, flow 4ml/min); eluent A: 100% H2O (0.1% TFA), eluent B: 60% 
H2O and 40% CH3CN (0.1%TFA). Specific preparative elution conditions for every PNA are 
given below.  
PNA 1:H-(AEEA)2GCCGCA(2D,5L-Arg)CACGT-NH2. The synthesis was performed on 25mg 
of a preloaded Boc-T-MBHA-PS resin (loading 0.2mmol/g). Crude yield: 82%. The crude 
products were purified by semipreparative RP-HPLC, in gradient elution: from 100% A to 
100% B in 25 min ESI-MS: calcd m/z: 691.5 (MH55+), 576.4 (MH66+), 494.2 (MH77+) found 
m/z 691.8, 576.5, 494.4. PNA 2 H-(AEEA)2CAGGCA(2D,5L-Arg)CTTCT-NH2. Crude yield: 
80%. The crude product was purified by RP-HPLC in gradient elution: from 100% A to 
100%B in 30 minutes. ESI-MS calcd m/z: 689.5 (MH55+), 574.7 (MH66+), 492.8 (MH77+) 
found m/z: 689.7, 574.7, 492.6.  PNA 3. H-(AEEA)2GCCGCG(2D,5L-Arg)CACGT-NH2. The 
manual synthesis was performed on 25mg of a preloaded Boc-T-MBHA-PS resin (loading 
0.2mmol/g). Crude yield: 80%. The crude product was purified by RP-HPLC in gradient 
elution : from 100% A to 100% B in 25 min. ESI calcd m/z: 694.7, 579.1, 496.5 found m/z: : 
694.7, 579.0, 496.5. PNA 4 H-(AEEA)2CAGGCG(2D,5L-Arg)CTTCT-NH2 Crude yield: 85%. 
The crude product was purified by RP-HPLC in gradient elution: from 100% A to 100%B in 
30 minutes. ESI-MS calcd m/z: 1153.8 (MH33+) 865.6 (MH44+), 692.7 (MH55+), 577.4 
(MH66+) found m/z: 1154.0, 865.8, 692.8, 577.5. 
4.4.3 Melting temperature measurements 
Stock solutions of PNA 1, 2, 3, 4 and of oligonucleotides were prepared in doubly distilled 
water and their actual concentration calculated by UV absorbance using the following ε260 
(M-1 cm-1) for the nucleobases: T 8600, C 6600, A 13700, G 11700. By using these 
concentrations, hybrid solutions containing 5µM PNA-DNA duplexes were prepared. All the 
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hybridisation experiments were carried out in 10mM phosphate buffer, 100mM NaCl, 0.1mM 
EDTA, pH= 7. All the hybrid samples reported were first incubated at 90°C for 5 minutes, 
then slowly cooled to room temperature. The samples were heated (1°C/min) and the UV 
signal variation at 260nm was recorded. Melting temperatures were measured as the 
maximum of the first derivatives of the melting curves. 
4.4.4 PNA spotting on microarray slides 
Each PNA was dissolved in a solution containing carbonate buffer (0.1M, pH= 9), SDS 
0.001% at a concentration of 50 µM and spotted by using a pin system spotter SpoArray 24 
(Perkin-Elmer, Waltham, USA) onto commercial slides (CodeLink, Amersham Bioscences, 
New Jersey, USA). Then the following washing steps were performed: washing solution 1: 
carbonate 0.1M and SDS 0.2%; washing solution 2: carbonate 0.1M and SDS 1%; washing 
solution 3: carbonate 0.1M and SDS 0.001%. Fixing was performed overnight at a controlled 
moisture ( ∼ 75%). Capping of the unreacted sites was done by using a solution of Tris 0.1M, 
ethanolamine 50mM, pH=9, at 50°C for 1h. Conditioning of the slides was performed at 50°C 
with SSC buffer (0.6M NaCl, 0.06M sodium citrate, pH= 7) and SDS 1% solution for 1h. 
Final washings were carried out with doubly distilled water for 5 minutes. 
4.4.5 Oligonucleotide hybridization on microarray slides 
Each Cy5 labeled oligonucletide was dissolved in a solution containing SSC buffer (0.3M 
NaCl, 0.03M sodium citrate, pH= 7), SDS 0.1% at a concentration of 100nM. Before 
hybridization the slides were hydrated with a solution of SSC buffer (0.3M NaCl, 0.03M 
sodium citrate, pH= 7), SDS 0.1% at 40°C for 30 minutes. Then, oligonucleotide solutions 
were deposited on the slides by using a hybridization chamber and left at 50°c for 2 hours. 
After hybridization, washing steps were performed at 50°C for 5 minutes with a solution of 
SSC buffer (0.3M NaCl, 0.03M sodium citrate, pH= 7), SDS 0.1%. Final washing was carried 
out for 1 minute at room temperature with a two different SSC buffer solutions: 0.03M NaCl, 
0.003M sodium citrate, pH= 7 and 0.01M NaCl, 0.001M sodium citrate, pH= 7. 
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4.4.6 Microarrays analysis 
Pictures of the PNA microarrays were recorded by using a scanner ScanArray Express 20 
(Perkin Elmer, Waltham, USA). Laser was set  at excitation wavelenght of 646nm and 
emission at 664nm, for Cy5. Pictures were acquired with  laser power at 100% and 
photomultiplier at 40%. 
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Chapter 5 
 
 
Peptide Nucleic Acid microcontact printing for the 
fabrication of microarrays 
 
In this chapter an advanced technique for surface derivatization is reported. Microcontact 
Printing is a widely used technique to pattern surfaces with micrometer features, allowing to 
obtain well-defined and homogeneous patterns in a shorter time than standard methods. 
Surface patterning with PNAs and characterization of the surface is shown in the first part. 
Hybridization studies with complementary and mismatch TAMRA labeled  oligonucleotides is 
shown in the second part. Finally the system is combined with a commercial arrayer in order 
to create a PNA-microarray by microcontact printing, for the fabrication of arrays that are 
able to recognize DNA on surface with high selectivity. The work reported in this section has 
been carried out  at the University of Twente, The Netherlands, in the group of Molecular 
Nanofabrication (MNF).  
  
Chapter 5 
92 
5.1 Introduction 
The increasing requirements for methods able to selectively recognize nucleic acid sequences 
in a short time and for routine analysis has strongly pushed science and technology towards 
the development of a wide range of devices. The systems used for this purpose should ideally 
have a high selectivity towards complementary sequences, good sensitivity, and the 
possibility to perform high throughput analysis in a short time1. The fabrication of such 
devices should also be easy, less time consuming and reproducible. As previously described, 
the analysis by microarray-based techniques fulfills most of these requirements2,3. These 
platforms are obtained by linking the probes through covalent or non covalent interactions to 
a great variety of solid supports such as glass, silicon, gold, carbon etc4. Array techniques can 
exploit different properties in order to have a hybridization readout signal, and among these, 
glass surfaces can be used in fluorescence assays and are the most common. Although a lot of 
improvements have been introduced lately, it is clear that some features can still be further 
improved, especially in the fabrication, where the coupling with advanced printing techniques 
can show good performances5. 
The use of modified DNA analogues having improved performance in DNA or RNA 
recognition is one of the strategies used to develop better performing techniques. Among all 
the modification inserted in DNA structure6, PNAs present some of the best performances7 in 
terms of affinity, selectivity and chemical and enzymatic resistance, as described in previous 
chapters. 
PNAs have been extensively applied in many devices for DNA analysis either in solution or 
on surface. The use of PNAs for surface-based recognition has been carried out on a wide 
range of materials (glass, gold, silicon), obtaining devices based on the read out of many 
chemical or physical signals. Among the various systems developed, some examples are quite 
interesting, such as sensors based on Electrochemical or electrical signal on surface or 
nanowires 8,9,10,11, Surface Plasmon Resonance12,13, IR absorbance14, Mass Spectrometry15, 
Surface Enhanced Raman Scattering16 or Fluorescence. The chemistry usually adopted for the 
immobilization depends on the material to which the probe should be linked. When the probe 
has to be linked to gold, a cysteine is usually linked at the N-terminus of the PNA in order to 
exploit its SH group17,18. Thiol groups have been used also to link probes to silicon through 
bifunctional molecules bearing a maleimido group able to react with the thiol and an N-
hydroxysuccinimidyl group that should react with an amino or hydroxyl group linked to the 
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surface19. The immobilization on glass or silicon can be done by activating the surface 
through reactive monolayers such as isothiocyanate20, N-hydroxysuccinimidyl21,22 or 
aldehydic23 groups used to link the amino-end; click chemistry has been exploited, as well, in 
a reaction between an acetylene-modified surface and an azido-coumarin modified-PNA24. 
Moreover coupling of PNAs to nanoparticles has been studied as well; these systems have 
been developed by coupling the PNA directly through its amino group to the nanoparticle by 
EDC mediated coupling25, or by click chemistry26 and their aggregation has been studied with 
complementary DNA sequences. 
Although the combination of PNA probes with the microarray technology can show good 
performances, the fabrication methods are still time consuming and good performances can 
usually be achieved only under strictly controlled moisture and temperature conditions which 
are not always reproducible24. One way to improve the fabrication of these devices on surface, 
is to derivatize the surface by microcontact printing (µCP).  
 
 
Microcontact printing is a well-known powerful tool to functionalize substrates with spatially 
patterned molecular monolayers27. The technique is based on the use of a stamp made of a 
cross-linked elastomer bearing the desired features on the surface exploited for the printing. 
The stamps are obtained using a silicon master containing the pattern to be printed and 
silanized to make it hydrophobic. The elastomer (usually polydimethtylsiloxane, PDMS) is 
poured on the master and the crosslinking reaction is carried out at 60°C for at least 4 hours. 
The solid stamp is then removed from the master and inked with a solution of the molecule to 
Figure 5-1: Schematic representation of microcontact printing (A. Bernard, J. P.
Renault et al., Adv. Mater., 2000, 12, 14, 1069) 
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be printed, in order to make this molecule adsorbed on the surface. The inked stamp is 
afterwards printed on the surface, resulting in the transfer of the molecules to the surface in a 
pattern exactly reproducing that of the stamp (Figure 5-1).  
µCP was first used to print monolayers of alkylthiols on gold surfaces28. It has been shown 
that also silanes, lipids, proteins, DNA, synthetic polymers, nanoparticles, and even metal 
nanofilms can be printed by µCP upon modification of the stamps29. A striking feature of µCP 
is the short contact time necessary to form a dense monolayer of ink on the substrate. Contact 
times are typically around one minute, but µCP has also been performed with millisecond 
contact of stamp and substrate29. Another feature of this technique, when used to pattern 
surfaces, is the possibility to perform reactions that usually would not take place in standard 
conditions, such as formation of amide bonds by printing of amino acids over an amino 
monolayer30 or the Huisgen cycloaddition of alkynes on azides monolayer (“click chemistry”) 
without using Cu(I) as catalyst31. Although the general mechanism of microcontact chemistry 
remains uncertain, it is reasonable to assume that any reaction would benefit from a 
concentration effect due the micrometer confinement of the reagents. In addition, 
preorganisation effects on the substrate, due to alignment caused by the self assembled 
monolayer formation, are also probably present. Moreover, also the pressure used for 
stamping the surface probably can help the reaction29.  
In this work we show that the printing of chiral Arginine-PNAs (Figure 5-2)21 on glass, quartz 
and silicon surfaces can be achieved by µCP. Afterwards, the surfaces and the hybridization 
properties of the linked PNAs are studied, demonstrating the good probe performances in 
terms of selectivity. Finally, we show that this strategy can be coupled with a commercial 
arrayer for the fabrication of PNA-microarrays, which demonstrate improved features as 
compared to standard arrays in terms of the time required for the reaction and the quality of 
the surfaces obtained. The work has been carried out in the laboratories of the group of 
Molecular Nanofabrication (MNF) at the University of Twente (The Netherlands), under the 
supervision of Dr. Pascal Jonkheijm and Prof. Jurriaan Huskens, 
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5.2 Results and Discussion 
5.2.1 PNA Design and synthesis 
The probes used for the fabrication of PNA these devices were chiral Arginine-PNAs 
containing an arginine side chain in position two or two and five21 as shown in Figure 5-2. 
Chiral PNA synthesis was performed by using the submonomeric strategy as described in 
chapter 3: a submonomer was synthesized with a Boc group on the primary amino group and 
a Fmoc on the secondary amine, then it was coupled to the growing PNA chain, Fmoc group 
was removed, and the carboxymethyl base was linked on the resin. 2D-Arg submonomer and 
PNA 2 have been synthesized in a previous work32. The synthesis of PNAs 3, 4, 5 and 6 was 
reported in chapter 4. The PNA sequences used in this work are shown in Table 5-1.  
 
 
 
 
 
 
 
 
Figure 5-2: Structure of achiral (A), 2D-Arginine (B), and 2D,5L Arginine PNA
monomers inserted in the probes used in this work 
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PNA 1 was first used in order to study the patterning on the surface by a fluorescent label. For 
this reason, a lysine unit protected on the side chain with a Dde group was introduced at the 
C-end of the PNA, and, when the synthesis was complete, it was removed by hydrazine and a 
carboxyfluorescein molecule was coupled to the primary amino group of the lysine side chain, 
with the PNA still on resin. This was necessary because the N-terminal primary amino group 
was to be used for linking the probe to the surface. Then, the PNA was cleaved from the resin; 
characterization of PNA 1 is shown in figure 5-3.  
 
Figure 5-3: HPLC profile and mass spectrum of PNA 1 
Table 5-1. PNA sequences and melting temperatures of the PNA:DNA antiparallel 
fullmatch/mismatch duplexes in phospate buffer (pH=7) at a 5µm concentration for each strand 
PNA  Sequence[a] Tm (°C) 
PNA/DNA 
Fullmatch[b] 
Tm (°C) 
PNA/DNA 
Mismatch[b] 
ΔTm 
(°C) 
1 H-(AEEA)2TTACTCT(2D-Arg)TTCACC-
Lys(Fluorescein)-NH2 
48 (with c1) 37 (with c2) 11 
2 H-(AEEA)2TTACTCA(2D-Arg)TTCACC-NH2 55 (with c2) 35 (with c1) 20 
3 H(AEEA)2GCCGCA(2D,5L-Arg)CACGT-NH2 78 (with c3) 61 (with c5) 17 
4 H-(AEEA)2CAGGCA(2D,5L-Arg)CTTCT-NH2 69 (with c4) 50 (with c6) 19 
5 H(AEEA)2GCCGCG(2D,5L-Arg)CACGT- NH2 85 (with c5) 69 (with c3) 16 
6 H-(AEEA)2CAGGCG(2D,5L-Arg)CTTCT-NH2 75 (with c6) 60 (with c4) 15 
[a] The chiral monomer corresponding to the SNP position is underlined in bold  
[b] [b] Oligonucleotide sequences: c1: 5’-GGTGAAAGAGTAA-3’, c2: 5’-GGTGAATGAGTAA-3’ 
c3: 5’-ACGTGTGCGGC-3’, c4: 5’-AGAAGTGCCTG-3’, c5: 5’-ACGTGCGCGGC-3’,  
c6: 5’-AGAAGCGCCTG-3’ 
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5.2.2 PNA microcontact printing 
The chemical strategy adopted for the fabrication of PNA monolayers was based on the 
reaction between the PNA primary amino group and an aldehyde monolayer on the surface, 
obtaining a Schiff base that could be reduced to secondary amine by NaBH415. The 
microcontact printing strategy was used to print PNA full layers or to pattern them in well 
defined structures. Since the material used to make the stamp, polydimethylsyloxane (PDMS), 
is hydrophobic, it had, first to be modified by oxygen plasma oxidization, in order to be 
compatible with more polar molecules such as PNA. Then, the oxidized PDMS stamps were 
inked with a 10µM solution of PNA 1 (Table 5-1) in CH3CN for 5 minutes, then dried and 
printed over an aldehyde-derivatized substrate for 15 min applying a pressure of 15g. The 
samples thus obtained were reduced with a solution of NaBH4, sonicated for two minutes in a 
solution of sodium carbonate 0.1M and SDS 2% (pH=9) in order to remove non reacted 
molecules, and finally washed with a 1mM solution of sodium carbonate. The samples were 
imaged using a fluorescence microscope.  
In figure 5-4 (first row) a printing test performed using different concentration of PNA is 
reported. The figure shows the quality of the patterning process, which allowed to obtain well 
defined structures with high fluorescence intensity. In order to verify the specificity of the 
bond between PNA and the aldehyde group of the surface, a blank experiment was performed 
Figure 5-4: Pattern obtained printing increasing concentration of PNA 1 and hybridizing with DNA c1
labeled with TAMRA. Samples were imaged using a green filter (fluorescein) and a red one
(TAMRA) 
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printing the PNA on a glass slide not derivatized with the aldehyde monolayer (Figure 5-5). 
The lack of any significant pattern confirmed that the patterning took place through chemical 
reaction and not by physisorption. 
The same samples were hybridized with the 
complementary DNA oligonucleotides labeled with 
TAMRA, in order to demonstrate that the probes attached 
to surface presented the possibility to recognize 
complementary DNA sequences via Watson-Crick 
hydrogen bonds. The hybridization was done by using a 1 
µM solution of DNA in a buffer saline sodium citrate 300 
mM of NaCl and 34 mM of citrate (SSC 2x), containing 
sodium dodecyl sulfate (SDS) 0.1%; this solution was 
incubated on the PNA-slide for 2h at room temperature and briefly washed with a solution of 
SSC 2x and SSC 0.2x at room temperature. Figure 5-4 shows the hybridization experiment 
with the same concentration of DNA on different concentrations of PNA used for deposition 
(second row). Looking at the first row, it is clear that the optimal concentration for the 
printing was 10 to 20 µM, because the fluorescence reached its maximum, whereas the second 
row, where fluorescence is read at the emission wavelength of TAMRA, demonstrates that 
oligonucleotides could be recognized and complexed by the PNAs on the surface. Comparing 
the upper row (PNA only) with last one (PNA + complementary DNA at the emission 
wavelength of fluorescein), it can be seen that no PNA loss occurred during the hybridization 
process, because the green fluorescence did not change before and after the hybridization. The 
increase in red fluorescence of TAMRA labeled oligonucleotide with the increase of PNA 
concentration suggests that higher probe density did not disturb the hybridization process. 
In order to further confirm that PNA monolayers can be printed on solid surfaces, a full layer 
of the molecule was printed on quartz slides using flat stamps (no pattern), and UV-Vis 
absorption spectra were registered (Figure 5-6). The spectra of the printed slides show the 
typical peak at 260 nm deriving from the nucleobases absorbance, absent in non printed 
slides. 
Figure 5-5: Blank sample obtained
printing PNA1 on a non derivatized
glass slide 
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Figure 5-6: UV-vis absorption spectra of aldehyde (red) and PNA (blue)monolayers obtained 
derivatizing quartz slides 
5.2.3 PNA-DNA binding properties on surface 
The recognition properties of the PNAs linked to the surface were then throughly studied, in 
order to determine their affinity for the complementary DNA sequences and the specificity of 
the recognition. The possibility to obtain well defined patterns in the range of micrometers 
and to image them with microscopy was applied to study the hybridization properties of the 
PNA onto the surface, studying the affinity and the selectivity of the binding by evaluating the 
melting curve of the duplex formed with fluorescent DNA oligonucleotides on surface. 
Patterns of non labelled PNAs were prepared by printing PNA 2 (containing a 2D-Arginine 
modified monomer) on glass slides, and hybridizing it with the complementary and 
mismatched oligonucleotides labeled with TAMRA (DNA c2 and c1) at room temperature for 
90 min, followed by a short wash with SSC 2x solution. In order to simulate the conditions in 
which hybridization usually takes place in solution, the slides were immersed in 1 ml solution 
of DNA 10 nM in SSC 2x SDS 0.1% pH=7 buffer and imaged using a laser scanner confocal 
microscope during a temperature increase from 20°C to 40°C. The reason for using a confocal 
microscope lies in the necessity to have a high resolution, which is necessary in order to 
separate the fluorescence contribution of the solution from that of the pattern. The pictures 
obtained showed a very intense and well defined fluorescent pattern at room temperature, 
whose intensity and definition decreased by increasing the temperature of the solution. At the 
end of the experiment the pattern was hardly detectable (Figure 5-7). 
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Figure 5-7: Images of fullmatch TAMRA-labeled PNA-DNA duplex at different temperatures. 
Images were taken using a laser scanning confocal microscope 
The fluorescence intensity was measured in three different areas of the picture, and then 
averaged; at the same time, the same was done for the background, which was subtracted 
from the fluorescence intensity. These averaged and normalized values were plot against the 
temperature, resulting in a sigmoid curve typical of the cooperative behavior shown by PNA-
DNA duplexes during their melting (Figure 5-8). The possibility to fit the points with a 
sigmoidal curve allowed to calculate the flex point, obtaining the melting temperatures for 
these hybrids directly on surface. In table 5-2 the values obtained on surface are compared 
with the melting temperatures in solution, either measured in PBS or in SSC 2x SDS 0.1%, 
order to have the same buffer used for the hybridization on surface. It is possible to notice that 
a significative destabilization both of the fullmatch and of the mismatch PNA-DNA duplexes 
in solution was caused by the presence of SDS; indeed this surfactant, being negatively 
charged, apparently interferes with the positively charged PNAs in DNA binding, decreasing 
the stability of the duplexes of about 10°C (Tm from 55°C to 45°C for the fullmatch duplex 
and from 35° to about 25°C for the mismatch duplex). The data obtained on the surface show 
that, for fullmatch PNA-DNA duplexes, a further destabilization was introduced when the 
binding took place between molecules in different phases, with the Tm decreasing from 45°C 
22.4°C 24.0°C 25.5°C 27.2°C
29.0°C 30.8°C 32.7°C 35.3°C
36.8°C 38.2°C 39.6°C 41.7°C
42.2°C
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Table 2: melting temperatures of the PNA:DNA 
antiparallel fullmatch/mismatch duplexes of PNA 2 in 
phospate buffer (pH=7)  or in SSC 2x SDS o.1% at a 
5µM concentration for each strand
Hybrid Solution
(PBS)
Solution
(SSC 2X 
SDS 0.1%)
Surface
(SSC 2X 
SDS 0.1%)
Fullmatch 55°C 45°C 35°C
Mismatch 35°C ~25°C 30°C 
to 35°C going from solution to surface recognition. The fullmatch destabilization can be 
explained by the interaction of the probe with the surface that may disturb the hybridization in 
terms of steric hindrance, since it reduces the access of the DNA in solution to the unbound 
PNA. The value obtained for the mismatch complex (which appear to be less destabilized) 
can be rationalized in terms of aspecific interaction of the labeled DNA with the surface, 
which cannot be detected when more stable and specific duplexes are formed, but becomes 
relevant when specific duplex formation is not possible. It is, anyway, clear that a temperature 
range exists where mismatch discrimination is possible also on the surface, as in solution. 
In order to test the performance of the PNA molecules in a SNP recognition experiment, a set 
of chiral 2D,5L-Arg PNA (PNA 3-6) was used. These PNAs were the same previously 
designed and synthesized for obtaining a microarray system for the recognition of two single 
nucleotide polimorphysms (SNPs) related to the mutation of ApoE lipoprotein (see chapter 
4)21. Three of these probes (PNA 3, 5, 6) were printed on the same glass slide by µCP using 
the same method optimized with the fluorescent probe. The slides were hybridized with 
different combinations of TAMRA labeled DNA oligonucleotides, both fullmatched and 
mismatched (DNA c3 and c5). The hybridization was done using DNA solutions 1 µM in a 
SSC buffer and SDS 1% at 50°C for 4h. The slides were then washed with a solution of SSC 
2X, SDS 0.1% for 5 minutes at 50°C and then shortly rinsed with a solution of SSC 0.2X at 
room temperature. 
Figure 5-8: Melting curves obtained by plotting the fluorescence of the images taken in the melting
experiment. Blue line corresponds to the fullmatch hybrid, while red line is obtained for the mismatch
hybrid 
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Figure 5-9: Fluorescence images of PNA slides hybridized with full-matched and mismatched 
fluorescent oligonucleotides 
The fluorescence pictures (Figure 5-9) shows that these devices fabricated as previously 
reported have excellent selectivity. PNA 6 has a sequence totally unrelated to DNA c3 and c5, 
and never binds to any of these oligonucleotides (figure 5-9, last picture of every row): this 
PNA is used to demonstrate the selectivity towards different sequences. PNAs 3 and 5 
recognize their complementary sequence (Figure 5-9, first row, first and second pictures; 
second row, first picture; third row, second picture). Moreover, the figure demonstrates that 
point mutations can be discriminated with a good selectivity (no signal was visible when 
mismatched DNA was used, Figure 5-9, second row, second picture; third row, first picture). 
The last row of figure 5-9 shows the images obtained upon hybridization with a long synthetic 
oligonucleotides (60mer) including the c1 sequence, in order to simulate a real PCR product. 
As it can be seen, the system recognized quite efficiently also this molecule. A signal, in fact, 
is produced only where the fullmatch hybrid is formed, while no recognition takes place in the 
case of PNA 5 which only differs for one nucleobase, demonstrating that point mutation 
discrimination is totally feasible with this system. However, it should be noted that in this 
Slide 1
DNA c3 + DNA c5
Slide 2
DNA c3
Slide 3
DNA c5
PNA 3 PNA 5 PNA 6
Slide 3 DNA c3
60 bases
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case the signals are weaker, and this may be due to the steric hindrance of the surface, which 
might be an important factor for long DNA sequences and could be more relevant if even 
longer sequences are used. 
5.2.4 PNA Microarrays fabrication by microcontact printing 
The good results obtained by derivatizing surfaces using this technique, the short time 
necessary to fabricate the devices, and the quality of the recognition process when PNAs were 
linked to surface, led us to explore the possibility to couple µCP with an existing technology 
in order to fabricate microarrays.  
 
As previously reported5, in fact, the application of microcontact printing in the fabrication of 
microarray devices can make the process cheaper, more reproducible and less time 
consuming. The system used to fabricate these devices is a commercial piezoelectric arrayer; 
the fabrication of the device took place producing PDMS stamps having the same size of a 
microarray slide without any pattern on the surface and gluing the oxidized stamp onto glass 
slides in order to fit in the arrayer system. The stamps so modified were used as substrate for 
PNA spotting. The stamp was inked with a PNA solution, dried for 15 minutes and printed 
over glass slides derivatized with the aldehyde monolayer using 3 weights of 15gr each. The 
slides were printed for 15 minutes and the same stamp was used to repeat the printing on 
other slides without any further modification of the PDMS. The printing was repeated eight 
Figure 5-10: Fluorescence image (fluorescein dye) of PNA microarray fabricated via printing with a
flat PDMS stamp onto which a PNA array was spotted; aside the fluorescence intensity after 8
printing is reported. 
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times. The substrates were, then, treated using the same procedure shown before and imaged 
using a fluorescence microscope. The array was done printing water solution having different 
concentrations of PNA 1 (10, 20, 50, 100 µM) and PNA 3-4-5 (1, 5, 10, 20, 50, 100 µM) to 
test the selectivity performance of the fabricated platform. PNA  1 was visualized using a 
fluorescence microscope; since the array was too big to fit in one picture, the overall image 
was obtained pasting together many pictures (Figure 5-10). The results show that µCP 
technique can improve standard microarray fabrication, since a good homogeneity between 
the spots and within each spot was obtained. The fluorescence intensity of the first three 
replicates was almost the same, while after the fourth a decrease was observed, demonstrating 
the good reproducibility of the process. 
The possibility to apply the slides fabricated for DNA recognition assays was tested using two 
of them in hybridization experiments with fullmatch and mismatch oligonucleotides. TAMRA 
labeled DNA oligomer c3 and c5 100nM in SSC2x SDS 0.1% were used to incubate the 
slides at 55°C for 3 hours. The slides were then imaged using a laser scanner (Figure 5-11); 
the results showed the good performance of the platform in terms of selective recognition, 
since signals were seen only where expected. 
 
Figure 5-11: Hybridization of the devices fabricated as previously described with complementary and 
mismatched oligonucleotides. Image is taken using a laser scanner fluorescence system 
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5.3 Conclusions 
In this work the possibility to use microcontact printing techniques to derivatize different kind 
of surfaces with PNAs is demonstrated. In particular, chiral Arg-PNAs have been tested in 
patterning of surfaces and imaged by a fluorescein dye inserted in the molecule. The 
molecules linked on surfaces have been studied in order to evaluate their recognition 
properties, measuring for the first time a melting temperature of a PNA-DNA duplex directly 
on surface. All the techniques developed in the first part of the work have been exploited for 
preparing PNA microarrays by microcontact printing, demonstrating several improvements in 
comparison with standard microarrays. Further optimization of the method may allow to 
develop a commercial method for preparing PNA microarrays based on microcontact printing, 
reducing fabrication cost, time, and improving the quality. 
5.4 Experimental Section 
5.4.1 Materials and reagents 
PNA N-Boc protected standard monomers, N-[1H-1,2,3-(benzotriazol-1-yl)-
(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide 
(HBTU), N-[(dimethylamino)-1H-1,2,3-triazol[4,5-b]pyridine-1-ylmethylene]-N-
methylmethanaminium hexafluorophosphate N-oxide (HATU), dichloromethane, N–
methylpyrrolidone (NMP) and N,N-dimethylformamide (DMF) were purchased from Applied 
Biosystem (Foster City, CA, USA). Carboxymethyl-O-benzyl-guanine was purchased by 
ASM (Hannover, Germany). Boc-Arg(Tos)-OH, Boc-D-Arg(Tos)-OH and m-cresol were 
from Fluka (Buchs, Switzerland). (4-Methylbenhydryl)amine (MBHA) PS resin was from 
Novabiochem (Laufelfingen, Switzerland). Diisopropylethylamine (DIPEA), N,O-
Bistrimethylsilyl acetamide (BSA), trifluoromethane sulfonic acid (TFMSA), trifluoroacetic 
acid (TFA), 3-hydroxy-1, 2,3-benzotriazin-4-(3h)-one (DhBtOH) and 
diisopropylcarbodiimide (DIC) were from Sigma-Aldrich (St. Louis, MO, USA). 
Oligonucleotides were purchased from Sigma or MWG eurofins. All nucleotides were 
purified by HPLC and modified by the manufacturer. All buffers and immobilization 
solutions were prepared with 18 MΩ·cm distilled water (MilliQ). The following materials and 
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chemicals were used as received: poly(dimethylsiloxane) (PDMS) (Dow Corning), NaBH4 
(Aldrich), trimethoxysilylalkylaldehyde (Fluorochem). All solvents were HPLC grade, and all 
other reagents were analytical grade. Other solvents or reagents were purchased from either 
Aldrich or Sigma.  
5.4.2 PNA synthesis 
The synthesis of chiral 2D-Arg-based PNAs was performed as described previously for 
similar PNAs33 by using manual synthesis for the chiral residues and automated Boc-SPPS 
protocols on a ABI 433A synthesizer, following the procedures provided from the company, 
for the achiral residues. The chiral submonomers were introduced by using HBTU/DIEA 
coupling protocol, Fmoc group was deprotected by piperidine/NMP (20%) and 
carboxymethyl-Z-adenine34 or carboxymethyl-O-benzyl-guanine (commercialy available) 
were linked to the submonomers on resin by using DIC/DhBtOH coupling protocol, for PNA 
1 Dde group was deprotected by hydrazine/DMF 2% and carboxyfluorescein was linked by 
DIC/DhBtOH coupling protocol. Free PNAs were cleaved from the resin by using a 1:3 
TFMSA/TFA mixture (10% thioanisole + 10% m-cresol) and precipitated by Et2O. HPLC 
analysis for all PNAs was carried out by LC-MS by using an XTerra anlytical C18 column 
(3x250mm, 5µm, flow 0.5ml/min), gradient elution from 100% H2O (0.2% HCOOH, eluent 
A) to 60% H2O and 40% CH3CN (0.2%HCOOH, eluent B) in 30 min. MS detector set in the 
positive ion mode, capillary voltage 3kV, cone voltage 30V, full scan acquisition from 150 to 
1500 m/z. HPLC purification for all PNAs was carried out on a semipreparative Jupiter 
(Phenomenex) C18 column (10x300mm, 5µm, flow 4ml/min); eluent A: 100% H2O (0.1% 
TFA), eluent B: 60% H2O and 40% CH3CN (0.1%TFA). Specific preparative elution 
conditions for every PNA are given below.  
PNA 1: H-(AEEA)2TTACTCT(2D-Arg)TTCACC-Lys(Fluorescein)-NH2. The synthesis was 
performed on 25mg of a preloaded Fmoc-Lys(Dde)-MBHA-PS resin (loading 0.2mmol/g). 
Crude yield: 70%. The crude products were purified by semipreparative RP-HPLC, in 
gradient elution: from 100% A(H2O + TFA 0.1%) to 100% B(CH3CN + TFA 0.1%) in 30 min 
ESI-MS: calcd m/z: 1075.1 (MH44+), 860.6 (MH55+), 717.3 (MH66+), 615.0 (MH77+) found 
m/z 1074.2, 859.9, 716.7, 614.5. PNA 2 H-(AEEA)2TTACTCA(2D-Arg)TTCACC-NH2. Crude 
yield: 88%. The crude product was purified by RP-HPLC in gradient elution: from 100% A to 
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100%B in 30 minutes. ESI-MS calcd m/z: 956.0 (MH44+), 764.9 (MH55+), 637.6 (MH66+), 
546.7 (MH77+) found m/z: 955.8, 764.8, 637.8, 546.7. 
The synthesis and characterization of chiral (2D,5L)-Arg submonomer chiral (2D,5L)-Arg-
based PNAs (PNA 3 to 6) were described in chapter 4. 
5.4.3 Melting temperature measurements 
Stock solutions of PNA 1, 2, 3, 4 and of oligonucleotides were prepared in doubly distilled 
water and their actual concentration calculated by UV absorbance using the following ε260 
(M-1 cm-1) for the nucleobases: T 8600, C 6600, A 13700, G 11700. By using these 
concentrations, hybrid solutions containing 5µM PNA-DNA duplexes were prepared. All the 
hybridisation experiments were carried out in 10mM phosphate buffer, 100mM NaCl, 0.1mM 
EDTA, pH= 7. All the hybrid samples reported were first incubated at 90°C for 5 minutes, 
then slowly cooled to room temperature. The samples were heated (1°C/min) and the UV 
signal variation at 260nm was recorded. Melting temperatures were measured as the 
maximum of the first derivatives of the melting curves. 
5.4.4 Modification of substrate.  
Clean microscope cover glass (Paul Marienfeld Gmbh & Co. KG, Germany), quartz slides 
were activated with piranha solution for 30 min (concentrated H2SO4 and 33% aqueous H2O2 
in a 3:1 ratio) (Warning! Piranha solution should be handled with caution: it has been reported 
to detonate unexpectedly!), rinsed with water (MilliQ), and put under vacuum with 0.1 ml of 
trimethoxysilylalkylaldehyde overnight; the substrates were rinsed with toluene to remove 
any excess of silanes and subsequently dried in N2. 
5.4.5 Fabrication of Stamps.  
Silicon wafer-based masters with etched structures were prepared by UV photolithography. 
The master surface was fluorinated using fluorosilanes. PDMS stamps were fabricated by 
curing Sylgard 184 on the surface of the master at 60°C overnight.  
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5.4.6 Microcontact Printing of PNA.  
PDMS stamps were first oxidized in UV/plasma reactor (Ultra-Violet Products, modelPR-
100) for 30 min at a distance of about 2 cm from the plasma source. This reactor contains a 
low-pressure mercury UV light operating with UV emissions at 185 nm (1.5 mW cm-2) and 
254 nm (15 mW cm-2). The stamps thus obtained were stored in MilliQ water. Subsequently 
the hydrophilic stamps were dried with nitrogen and incubated with a drop of 10 µM PNA 
solution in acetonitrile for 5 minutes at room temperature. The stamp was dried with nitrogen 
and brought into conformal contact with the aldehyde-terminated glass slide for 15 min using 
a 15 gr weight. After printing the glass slides were immersed in a solution containing 100 mg 
NaBH4 in 40 mL PBS with 10 mL EtOH for 5 min. After reaction time the substrate was 
rinsed in MilliQ water, sonicated in a carbonate buffer 0.1 M pH=9 with SDS 2% for 2 
minutes, rinsed in a 1 mM carbonate buffer and dried with nitrogen. 
5.4.7 Hybridization on the Substrate Surface.  
For hybridization oligonucleotides were diluted to 1 µM in 4X SSC containing 0.1% SDS and 
applied to the surface of the modified glass using disposable hybridization chamber (Gene 
Frame, Thermo Scientific, UK). The temperature was tuned depending on the affinity of the 
probe for the complementary sequence, and the time was 4 hours. Non hybridized molecules 
were removed washing with SSC 2X, SDS 0.1% at hybridization temperature for 5 min. and 
with SSC 0.2X at room temperature for 1 min. After washing, the glass slides were dried with 
nitrogen  
5.4.8 Fluorescence Microscopy 
Fluorescence microscope images were taken using an Olympus inverted research microscope 
IX71equipped with a mercury burner U-RFL-T as light source and a digital Olympus DR70 
camera. For image acquisition blue excitation (450nm ≤ λex ≤ 480 nm), green emission 
(λem≥ 515nm), green excitation (510nm ≤ λex ≤550nm) and red emission light (λem≥ 
590nm) were filtered using a U-MWB Olympus filter cube. All fluorescence microscopy 
images were acquired in air and analyzed on a fluorescence microscope (Olympus inverted 
research microscope IX71). 
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5.4.9 Surface Melting experiments.  
The samples for the melting experiments were prepared printing the PNA, hybridizing it with 
a 1 µM solution of TAMRA labeled oligonucleotide and washing with SSC 2X at room 
temperature. The samples, thus prepared were immersed in a 10 nM solution of the same 
oligonucleotide in SSC 2X SDS 0.1% buffer and imaged using a laser scanning confocal 
microscope during temperature increase the temperature.  
5.4.10 Laser scanning confocal microscopy 
Confocal microscopy images of the microcontact-printed substrates were taken on a Carl 
Zeiss LSM 510 microscope. The light was focused on the substrate using a 40X LD Acroplan 
objective. TAMRA derivatised features were excited at 543 nm, using a Helium-Neon laser. 
The emitted fluorescence was collected on. The images were acquired in a 10nM solution of 
TAMRA labeled oligonucleotides in a SSC (2x) SDS (0.1 %) buffer pH= 7. Temperature was 
regulated using a Temperature Controller TC202A Harvard Apparatus with a heating stage. 
Real temperature was checked using a thermocouple dipped in the solution. Fluorescence 
intensity was calculated in three different areas of the image and averaged; the value was 
normalized subtracting the background intensity calculated in the same way. 
5.4.11 Contact Printing by Robotic Systems.  
The spots of oligonucleotides were fabricated using Scienion S3 spotter (Scienion AG, Berlin, 
GER). Spots of 350 pL were dispensed using the piezo non-contact printing system in a 16x8 
array. Flat, 2-3 mm thick stamps were glued to a glass microscope glass, oxidized and used as 
substrates for PNAs spotting. The PNAs used for this fabrication were prepared in water at 
concentration from 1 to 50 µM. After 15 minutes from the spotting, the stamps were used for 
multiple microcontact printing. Samples were hybridized as described before and scanned 
using a fluorescence scanner. 
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Chapter 6 
 
 
The double nature of Peptide Nucleic Acids: design and 
synthesis of a PNA embedding a Nuclear Localization 
Signal pseudopeptide sequence in the backbone able to 
behave as a peptide mimic 
 
In this chapter it is shown how the introduction of amino acid-derived functional groups 
within the backbone of a PNA can introduce new properties, affecting not only the 
recognition and discrimination of complementary nucleic acid sequences, but also giving the 
PNA peptide-like properties, enabling them to behave as nucleic acids and peptides at the 
same time. The design and synthesis of a short PNA model embedding in the backbone the 
amino acid side chains which mimics a Nuclear Localization Signal peptide will be described. 
Its ability to interact with proteins  involved in the cell nuclear uptake, exactly like the natural 
peptide,  will be demonstrated by nuclear internalization experiments. 
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6.1 Introduction 
The use of PNAs in diagnostic applications has been presented in the previous chapters. 
Although PNAs are useful tools in diagnostics, this is not the only field in which these 
molecules can be usefully applied. As reported in the first chapter, application of PNAs in 
gene therapy is a very hot topic, since they have features suited to most requirements for 
selectively targeting and blocking a DNA or RNA sequence1. Enzymatic and chemical 
resistance, in fact, make these molecules suitable for in-vivo applications, since these features 
increase their life in a biological system2, whereas selectivity and affinity for the 
complementary sequences allow specific and strong binding of the sequences of interest. 
Nevertheless, some drawbacks still limits their extensive application; the low solubility due to 
the apolar structure is a problem, since it limits the concentrations to be used in therapy, and 
also cellular and nuclear uptake3 might be a limiting factor, since, in order to have a 
significant effect, these molecules have to selectively concentrate in the cell region where the 
targeting is required (the cytoplasm if the target is RNA, the nucleus when the target is DNA). 
Although it has been demonstrated that, in some cases, unmodified PNAs are able to enter 
some types of cell without any modification or transfection approach4, usually there is the 
necessity to develop a strategy aimed at increasing cellular and/or nuclear uptake of these 
molecules. Some approaches involved the techniques developed for DNA uptake4, such as 
electroporation5 or co-transfection with lyposomes6. Nevertheless, the necessity to develop 
more general and efficient delivery methods led to the design of modified PNAs for enhanced 
uptake. The most exploited strategy has been the conjugation of PNAs with molecules able to 
cross cellular or nuclear membrane, thus carrying the linked probe; a great variety of moieties 
have been linked to PNAs for this purpose. The conjugation of PNAs to terpyridine units 
promoted the cellular and nuclear delivery of such molecules. The possibility for terpyridine 
to chelate the zinc ion, turned out in a preferential uptake by zinc-rich tissues7. The synthesis 
of a PNA linked to a neamine unit allowed to obtain a molecule able to cross the cellular 
membrane and hydrolyze RNA within the cytoplasm8. Lipophilic units such as adamantane or 
triphenylphosphonium cation have been bound as well to PNAs in order to improve the 
uptake, but this approach showed always good results in terms of uptake and targeting 
efficience only in some cases4,9. Other groups linked to PNAs aimed at interacting with 
specific cell membrane receptors. For example, PNAs linked to a lactose unit were selectively 
internalized into hepatic cells that possessed a receptor for this sugar10. In another experiment, 
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the coupling of PNAs with dihydrotestosterone caused the selective uptake of such molecules 
by the cells having the corresponding receptor11.  
The most explored strategy, both receptor-based and non receptor-based, to modify PNAs for 
cell delivery is the conjugation with a peptide able to cross the cellular membrane and/or to 
selectively carry the molecules inside the nucleus. The main reason for selecting this 
modification as the strategy of choice, beside its efficiency, is undoubtedly the easiness of 
obtaining peptide-PNA conjugates, given the identical chemistry used for their synthesis. An 
example is the linking of PNAs to trojan peptides, a class of  amphiphilic 
cationic/hydrophobic peptides, able to transport several classes of molecules 
(oligonucleotides, peptides, etc.) across biological membranes in a receptor independent way4. 
The conjugation of PNAs to positively charged peptides such as spermine was studied in 
order to improve the solubility of the molecule and the stability of the duplex with the 
complementary DNA12, obtaining an enhanced cellular uptake. The development of PNAs 
conjugated to cell penetrating peptides was carried out using peptides rich in positively 
charged amino acids, able to promote uptake through receptor-mediated active processes. One 
of firstly developed PNA-peptide conjugate was obtained by using penetratin, a 16-residue 
peptide derived from the Drosophila homeodomain transcription factor13. Also arginine-rich 
peptides derived from the Tat sequence were coupled to PNAs, allowing a good cellular and 
nuclear uptake14,15. Many other classes of peptides have been studied in order to promote 
PNA uptake and to trigger enhanced endosomal release in the cytoplasm, where further 
nuclear uptake may take place15. The active uptake of PNAs conjugated to cell penetrating 
peptides was also furtherly enhanced by linking a fatty acid16 or a phospholipid17 unit to a 
PNA-peptide conjugate, thus improving the uptake due to the possibility to form micelles. 
Similar cooperative effects have been exploited by using PNA-peptide conjugates able to 
form dendrimers, upon supramolecular interactions, that enhanced their cellular uptake18. 
PNA-peptide conjugates  have also been labeled in order to study the uptake mechanism, 
usually by linking a fluorophore, in order to exploit fluorescence microscopy, but also , 
introducing a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) group, able 
to coordinate a Gadolinium atom, in order to study the interaction with the cell by Magnetic 
Resonance Imaging (MRI)19.  
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Among all the peptides used as cytoplasmatic and/or nuclear carriers, one of the most 
exploited is the so-called Nuclear Localization Signal peptide (NLS), that showed a high 
efficiency in the transport of macromolecules inside the nucleus. This peptide consists of 
seven amino acids (PKKKRKV), a hydrophylic sequence derived from the simian virus 40 
large T-antigen, able to carry macromolecules such as proteins, plasmidic DNA and PNA 
within the nucleus of a cell20. Its conjugation with PNAs and the application for gene 
regulation has been deeply investigated and exploited 20. Deeper studies into this field allowed 
to define at least five classes of NLS, differing in sequences and lengths, but having in 
common the presence of one or two basic amino acid core within the sequence21. These 
molecules are able to penetrate the nucleus, together with the linked macromolecules, through 
binding to specific receptors, known as importins (karyopherins). Nuclear uptake is, in fact, 
mediated by specific gates (nuclear pores) on the nuclear membrane, where specific receptors 
selectively recognize  peptide-importin complexes and allow the passage through the pore. 
The best understood pathway of nucleocytoplasmic transport is the nuclear import pathway 
represented in Figure 6-1. Importin α recognizes and binds the NLS peptide in the cytoplasm, 
linking it to the importin β. Importin β then mediates the interaction of the trimeric complex 
(NLS-Importin α- Importin β) with the 
nuclear pore, which translocates it into the 
nucleus. Once the complex has reached the 
inner part of the nucleus, it is dissociated 
by Ran GTPase-activating protein 
(RanGTP). Binding of RanGTP to 
importin causes a conformational change 
that results in the release of the importin α-
NLS complex22. A subsequent interaction 
with other factors determines the final 
release of the NLS peptide, with the 
eventual cargo molecule linked to it. An 
asymmetric distribution of Ran-GTP and 
Ran-GDP between the nucleus and the 
cytoplasm controls the import and export, 
and this gradient is maintained by various 
Ran associated regulatory factors23. Antigene strategies often made use of NLS-labeled 
molecules, like PNAs, allowing their nuclear uptake and improving the system efficiency20,24.  
Figure 6-1: The NLS-based nuclear import cycle.
(A. Lange et al., Journal of Biological Chemistry,
2007,282, 8, 5101) 
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6.2 Results and discussion 
6.2.1 PNA design and synthesis 
Recently, it has been demonstrated that PNAs bearing ad hoc modifications within the 
backbone have enhanced nuclear uptake properties, comparable to those linked to carrier 
peptides. In particular, chiral PNAs having arginine-modified monomers were demonstrated 
to concentrate in the nucleus upon uptake experiments (like poly arginine peptides)25,26 due to 
the positive charges of the arginine side chains.  
These crude preliminary experiments demonstrate that backbone derivatization of PNAs can 
be exploited in order to create more complex systems, characterized by new properties typical 
of aminoacidic sequences. In fact, a particularly fascinating, but seldom explored, aspect of 
PNAs,  is their “double nature”: PNAs are not only able to recognize through the nucleobases 
a complementary DNA sequence (a property typical of nucleic acids), but they also possess a 
pseudopeptidic backbone and therefore might potentially display properties similar to those 
performed by proteins. The backbone can be, indeed, considered as a long sequence of 
pseudoglycylglycine dipeptides, therefore a mimic of a polyGly protein. In order to express 
all the “proteic potential” of PNAs, the backbone should be modified in order to become a 
real peptide mimic, by inserting amino acid-derived side chains in positions 2 and 5 (Figure 6-
2). In this way, a real “peptide” and “nucleic acid” could be obtained, fully exploiting the 
intrinsinc double nature of the molecule.  
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Although the introduction of substituents in the PNA backbone have been used in order to 
introduce functional groups and charges (thus modulating the properties of PNA)27,28,29, the 
use of side chains mimicking an entire complex peptide consensus sequence with a specific 
biological function has never been reported, and represents a challenging task both 
conceptually and synthetically. The possibility to develop a PNA able to act as a mimic of 
NLS peptide, would allow the PNA to enter a cell, recognize importin α protein, enter the 
nucleus, and perform its antigene activity without the need to couple the molecule to any cell 
penetrating peptide. In this chapter the design and the synthesis of a modified model PNA 
embedding in its backbone a mimic of a Nuclear Localization Signal (NLS) is reported, 
together with preliminary studies on its ability to penetrate cell nuclei.  
As reported in the introduction (chapter 1), the correct configurations for having right-handed 
PNAs, thus able to efficiently bind complmentary DNA, in 2,5 substituted PNAs have been 
found to be 2D,5L and 2L,5L. Thus, a backbone including L-amino acid-derived side chains 
at positions 2 and 5 (Figure 6-2) has the potential to be a good mimic of natural peptides, 
formed by all L-amino acids, at the same time preserving the correct handedness for DNA 
binding. 
Figure 6-2: A standard PNA compared with a 2S,5S-modified PNA: both
are able to perform DNA recognition, but the backbone of the latter has
also the potential to mimic a peptide sequence 
PNAs embedding NLS peptide 
117 
NH3
+
NH3
+
N
H
N
H
O
N
H
O
N
H
N
H
O
O
N
H
O
O
N
H
O
NH3
+
NH3
+
NH
NH2 NH2
+
N
Rho-AEEA
Gly-NH2
NH3
+
NH
NH2 NH2
+
NH3
+
NH3
+
NH3
+
O
N
H
N
H
N
O
O
G
N
H
N
O
O
T
N
H
N
O
O
A
N Gly-NH2
Rho-AEEA
N
H
N
H
N
O
O
G
N
H
N
O
O
T
N
H
N
O
O
A
Gly-NH2Rho-AEEA
NH
Rho-AEEA
NH3
+
NH
NH2 NH2
+
NH3
+
NH3
+
NH3
+
N
H
N
O
O
G
N
H
N
O
O
T
N
H
N
O
O
A
Gly-NH2
1
3
2
4
The sequence chosen to be embedded in the PNA backbone was the NLS peptide 
PKKKRKV. The structure of 
the NLS peptide (1) chosen 
to be embedded in the PNA 
backbone is represented in 
Figure 6-3. A model PNA 
consisting in only three 
residues was chosen for 
embedding the peptidic 
structure (2, Figure 6-3). The 
fusion of the two structures 
led us to design the modified 
PNA 3 (Figure 6-3), 
embedding side chains 
derived from natural L-
amino acids. The proline 
residue was linked as 
aminoacidic residue at the N-
terminus, since, bearing a 
secondary amine, could not 
be included in a PNA 
structure in that particular 
position. The modified PNA 
4, lacking the terminal 
proline, was also synthesized 
to be used as control. All 
compounds were synthesized 
with a rhodamine linked at 
the N-terminus, with an 
aminoethoxyethoxyacetyl (AEEA) spacer in between, in order to be visualized in the cell 
penetration studies, and with a glycine residue at the C-terminus, on account of synthesis on 
solid phase. 
The syntheses of the NLS peptide 1 and of the standard PNA trimer 2 were performed on 
solid phase by following standard Fmoc protocols. After cleavage from the resins, the NLS 
Figure 6-3: The NLS peptide PKKKRKV (1), a standard PNA
trimer ATG (2), the modified PNA trimer ATG embedding the
NLS sequence (3), the modified PNA trimer ATG embedding the
NLS sequence without proline (4). A = adenine, T = thymine, G =
guanine, Gly = glycine, Rho = Rhodamine, AEEA = 2-
aminoethoxyethoxyacetyl spacer. 
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peptide 1 and the PNA trimer 2 were purified by RP-HPLC and characterized by ESI-mass 
spectrometry.  
A Boc submonomer strategy was used for the modified PNA 3, in order to better preserve the 
optical purity at the 2 position30. The submonomers were prepared from the corresponding 
commercial Boc-L-amino acids suitably protected on the side chains. The Boc-L-Lysine-(2-
Cl-Z)-OH, to be used as synthon for inserting the lysine side chains in positions 5, was 
transformed in the corresponding Weinreb amide and then reduced to the aldehyde. Boc-L-
Lys-(2-Cl-Z)-OH, Boc-L-Arg-(Tos)-OH and Boc-L-Val were transformed in the 
corrsponding methyl esters and Boc deprotected by using HCl/MeOH. The PNA backbones 
were then synthesized by reductive amination on L-amino acid methyl esters with the Boc-L-
Lys-(2-Cl-Z) aldehyde. The methyl esters were hydrolyzed and the secondary amines were 
protected by the introduction of a Fmoc group. All the compounds were characterized by 1H 
and 13C NMR and ESI mass spectrometry. 
According to the previously reported procedures30, the chiral submonomers units were 
inserted by manual coupling with the HATU/DIEA protocol on a MBHA-PS resin and, after 
Fmoc deprotection, the nucleobase residues were introduced by a double coupling with 
DIC/DhBTOH. After the cleavage from the resin, the PNA trimer 3 was purified by RP-
HPLC and characterized by ESI-mass spectrometry (Figure 6-4).  
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Figure 6-4: HPLC profiles and mass spectra of the synthesized PNAs 
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6.2.2 Uptake experiments 
The ability of the different compounds to be internalized in the cell nuclei was then assessed 
in vivo: RH30 cells (a rabdomiosarcoma line) were incubated with 10 µmol/L of peptide 1, 
standard PNA 2 or modified PNAs 3 and 4 and analyzed after 3 hours. Fluorescence 
microscopy images showed that after 3 hours in the RH30 cell line, high intracellular levels 
with main nuclear localization could be observed for the NLS peptide 1 (Figure 6-5), as 
expected. The unmodified PNA 2, on the other hand, does not show any nuclear 
internalization, and a very low cellular uptake, confirming the lack of recognition from cargo 
proteins, as reported in previous data24. Incubation of cells with PNA 3, instead, showed a 
very intense red fluorescence signal in the nucleus, with a behavior comparable to that 
displayed by the NLS peptide. 
 
Figure 6-5: Fluorescence microscopy analysis (left) of uptake of RH30 cells treated for 3 hours with  
NLS peptide 1, unmodified PNA 2, modified PNA 3, and modified PNA 4 without proline. Optical 
images are also reported (right) 
The uptake in the nuclear region and the homogeneous diffusion is consistent with a receptor-
mediated internalization process, showing no difference in behavior between the NLS peptide 
1, for which the importin-mediated nuclear transport mechanism has been demonstrated, and 
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the modified PNA 3 (Figure 6-5). RH30 cells were then incubated with the modified PNA 4 
(10 µmol/L) and analyzed after 3 hours, in order to confirm the specificity of the uptake 
mechanism for PNA 3. The results obtained showed a very scarce and punctuated 
internalization (Figure 6-5). Although the number of positively charged side chains was the 
same for the PNA 3 and 4, a different uptake is clear from the images in figure 6-5. This 
suggests that, while PNA 4 probably undergoes an unspecific uptake process and for this 
reason only a small amount is internalized, PNA 3 is selectively recognized by the cargo 
protein complex and carried in the nucleus through a specific uptake with the same 
mechanism of the NLS peptide 1, indicating that such PNA can behave as peptide mimic.  
6.3 Conclusions 
We have demonstrated the chemical feasibility of synthesizing Peptide Nucleic Acids 
embedding in the structure amino acid side chains mimicking a complex peptide sequence. 
The preliminary data here reported on an NLS-mimicking PNA demonstrate that the 
pseudopeptide sequence encripted in the backbone of such modified PNA can behave as a 
fully functional peptide mimic, shedding light on a new dimension concerning the PNA 
properties, which may find numerous applications in bioorganic chemistry and molecular 
biology. For example, a PNA embedding the NLS sequence could be used for efficiently 
traslocate the PNA in the cell nuclei after injection in the blood stream avoiding the 
degradation from serum proteases, as it may happen when the NLS sequence is simply linked 
as normal peptide at the C-terminus. In general terms, a peptide nucleic acid embedding the 
functionalities of the proteins might be potentially used in order to develop PNAs endowed of 
catalytic functions, fully exploiting their intrinsic double nature of nucleic acid and peptide.  
6.4 Experimental section 
6.4.1 Materials and reagents 
PNA N-Boc protected standard monomers, N-[1H-1,2,3-(benzotriazol-1-yl)-
(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide 
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(HBTU), N-[(dimethylamino)-1H-1,2,3-triazol[4,5-b]pyridine-1-ylmethylene]-N-
methylmethanaminium hexafluorophosphate N-oxide (HATU), dichloromethane, N–
methylpyrrolidone (NMP) and N,N-dimethylformamide (DMF) were purchased from Applied 
Biosystem (Foster City, CA, USA). Carboxymethyl-O-benzyl-guanine was purchased by 
ASM (Hannover, Germany). Boc-Arg(Tos)-OH, Boc-Lys(2-Cl-Z)-OH, Val-OH, Boc-Pro-OH 
and m-cresol were from Fluka (Buchs, Switzerland). (4-Methylbenhydryl)amine (MBHA) PS 
resin was from Novabiochem (Laufelfingen, Switzerland). Carboxymethyl-thymine, 
diisopropylethylamine (DIPEA), N,O-Bistrimethylsilyl acetamide (BSA), trifluoromethane 
sulfonic acid (TFMSA), trifluoroacetic acid (TFA), 3-hydroxy-1, 2,3-benzotriazin-4-(3h)-one 
(DhBtOH) and diisopropylcarbodiimide (DIC) were from Sigma-Aldrich (St. Louis, MO, 
USA), Rhodamine. Oligonucleotides (guaranteed oligos grade) were purchased from 
ThermoFisher Scientific (Ulm, Germany) and used without further purification. 
6.4.2 Submonomer syntheses 
General procedure for submonomer synthesis 
L-amino acid methyl esters (Val, Lys, Arg) were prepared by dissolving the N-Boc and side 
chain protected (Lys as 2-Cl-Z and Arg as Tosyl) amino acid derivatives, commercially 
available, in methanol with magnetic stirring. The mixtures were cooled at 0 °C and added of 
thionyl chloride dropwise up to a final concentration of 1M. The solutions were stirred 
overnight at room temperature. Methanol was evaporated and the residues were added of 
methanol and evaporated again (few times) to yield Boc-deprotected, side chain protected 
chloridrated methyl esters as white foams in quantitative yields. In order to synthesize the 
different substituted N-(2-aminoethyl)amino acid (PNA backbones), the corresponding 
methyl esters were dissolved in the minimum amount of methanol at room temperature 
together with diisopropylethylamine (DIPEA, 1 eq.) and the mixtures were stirred for 20 
minutes. Boc-L-Lys(2-Cl-Z)-H aldehyde (1 eq.), synthesized as previously reported31, was 
then added and the solutions were stirred for 30 min at room temperature, then cooled to 0°C 
and NaBH3CN (3 eq) and CH3COOH (1.1 eq) were added. After 2h the methanol was 
evaporated. The residues were dissolved in CH2Cl2 and washed with saturated KHSO4 (twice) 
and NaHCO3 (twice). The combined organic phases were dried over MgSO4 and filtered, and 
the solvent was evaporated under vacuum. The crude products were purified by flash 
chromatography (eluent ethyl acetate : methanol = 95:5) and obtained as colourless foams. 
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Yields 30-35%. Methyl ester deprotections were performed by dissolving the backbones in 
CH3OH:H2O = 1:1 (10 ml) and by adding NaOH up to a final concentration of 0.25 M. The 
mixtures were refluxed for 2.5 hour, then CH3OH was evaporated and the products were 
precipitated as white solids at pH 5.5, filtered and dried under vacuum. Yields: 87-90%. Fmoc 
protections of the secondary amines were achieved by mixing the zwitterionic backbones in 
CH2Cl2, in flasks equipped with CaCl2 drying valves. Bis(trimethylsilyl)acetamide (BTSA, 2 
eq) and DIPEA (1.5 eq) were then added and when the solutions were nearly clear (10-15 min 
were usually required), Fmoc chloride (2 eq) was added and the mixtures were stirred for 2 
hours at room temperature. CH3OH (1 ml ) was then carefully added and the mixtures were 
stirred for additional 15 min, diluted with CH2Cl2, washed with 1M KHSO4 (3 times) and 
saturated NaCl (1 time), dried over MgSO4 and evaporated to dryness. The residues were 
purified by flash chromatography (dichloromethane : methanol = 9:1) and the products were 
obtained as white foams (Yields 30-35%). 
 
Compounds 2 (a- L-Val methyl ester hydrochloride, b- L-Arg-Nω-Tosyl methyl ester 
hydrochloride)..Compound 2 a: Yield: Quantitative. 1H NMR (300MHz ,CDCl3, 25°C): 
δ(ppm): 8.82 (sb, 1H, NH3+), 3.90-4.03 (m, 1H, CHα), 3.8 (s, 3H, methyl ester), 2.41-2.53 (m, 
1H, CH side chain), 1.20 (dd, 6, J=3 Hz, 7Hz, CH3 side chain). 13C NMR (75 MHz, CDCl3): 
δ(ppm) 169.1, 57.1, 54.4, 29.1, 18.3, 17.4. ESI-MS (CH3OH, positive ions): calculated m/z: 
131.1 (MH+), 154.1 (MNa+); found: 132.0, 154.0. Compound 2 b: 1H NMR (300MHz ,[D6]-
DMSO, 25°C): δ(ppm) : 10.37 (sb, 3H, N-H amine), 8.64 (sb, 1H, N-Hη arginine side chain), 
7.64 ( d, 2H, J= 6 Hz aromatic tosyl group), 7.38 (sb, 1H, N-Hε arginine side chain), 7.29 ( d, 
2H, J= 6 Hz aromatic tosyl group ), 6.79 (sb, 1H, N-Hη arginine side chain), 3.99-3.97 
(m,1H, C-H α), 3.71 (s, 3H, methyl ester), 3.1-3.05(m, 2H, CH2 arginine side chain), 2.34 (s, 
3H, tosyl methyl group), 1.77-1.72 (m, 2H, CH2 arginine side chain), 1.49-1.44 (m, 2H, CH2 
arginine side chain). 13C NMR (75 MHz, CDCl3):δ(ppm) 169.6,156.6, 141.3, 141.0,129.0, 
125.6, 52.6, 51.4, 48.4, 27.0, 24.4, 20.8. ESI-MS (CH3OH, positive ions): calculated m/z: 
343.1 (MH+) found: 343.3. HRMS (ESI+): calcd m/z for C14H23N4O4S (MH+): 343.1440, 
found: 343.1443 
Compound 3 (Nα-Boc-L-Lys-Nω-2-Cl-Z-N,O-dimethylhydroxyamide). Yeld: 92%. 1H 
NMR (300MHz , CDCl3): δ (ppm) 7.43-7.20 (m, 4H, CH aromatic 2-Cl-Z group), 5.19 (sb, 
2H, CH2 2-Cl-Z group), 4.99 (bs, 1H, N-Hω lysine side chain), 4.65 (sb, 1H N-Hα), 3.75 (s, 
4H, N-metoxy group + CHα), 3.23-3.11 (m, 5H, N-methyl group + CH2 lysine side chain), 
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1.41 (s, 9H, Boc methyl groups), 1.78-1.35 (m, 6H, CH2  lysine side chain). 13C NMR (75 
MHz, CDCl3) δ (ppm): 172.9, 156.1, 155.6, 134.3, 133.4, 129.6, 129.4, 129.2, 126.7, 79.6, 
63.7, 61.5, 49.9, 40.7, 32.5, 32.0, 29.1, 28.3, 22.3. ESI-MS (CH3OH, positive ions): calculated 
m/z: 480.5 (MNa+), found: 480.1 
Compound 4 (Nα-Boc-L-Lys-Nω-2-Cl-Z-aldehyde).Yield: 78%. 1H NMR (300MHz , 
CDCl3): δ (ppm) 9.54 (s, 1H, CH aldehyde), 7.43-7.20 (m, 4H, CH aromatic 2-Cl-Z group), 
5.18 (s, 2H, CH2 2-Cl-Z group), 5.09 (bs, 1H, Nω-H lysine side chain), 4.20 (sb, 1H Nα-H), 
3.74 (s, 1H, CHα), 3.26-3.09 (m, 2H, CH2 lysine side chain), 1.65-1.47 (m, 2H, CH2 lysine 
side chain), 1.47-1.30 (m, 4H, CH2  lysine side chain) 1.42 (s, 9H, Boc methyl groups). 13 C 
NMR ( 75 MHz, CDCl3): δ (ppm) 199.9, 156.3, 155.7, 134.2, 133.5, 129.7, 129.3, 128.5, 
126.9, 80.1, 63.8, 59.5, 40.4, 32.5, 29.4, 28.3, 22.1. ESI-MS (CH3OH, positive ions): 
calculated m/z: 453.89, found: 453.3 
Compound 5 (a- Nα-Boc-L-Lysψ-(Nω-2-Cl-Z)-L-Val methyl ester, b- Nα-Boc-L-Lysψ-
(Nω-2-Cl-Z)-L-Arg-(Nω-Tosyl) methyl ester). Compound 5 a: Yield: 31%. 1H NMR 
(300MHz, CDCl3): δ (ppm) 7.46-7.19 (m, 4H, CH aromatic 2-Cl-Z group), 5.20 (s, 2H, CH2 
2-Cl-Z group), 4.93 (bs, 1H, Nω-H lysine side chain), 4.58 (sb, 1H, Nα-H), 3.70 (s, 3H, CH3 
methyl ester), 3.54 (bs, 1H, C(2)Hα), 3.24-3.10 (m, 2H, CH2 lysine side chain), 2.98-2.87 (m, 
1H, C(5)Hα), 2.72-2.28 (m, 2H, Lysψ CH2), 1.60-1.21 (7H, m, CH2 lysine side chain, CH 
valine side chain), 1.42 ( s, 9H, CH3 Boc group), 0.91 (d, 6H, J(H,H) = 6.6 Hz, CH3 valine 
side chain) 13C NMR (75 MHz, CDCl3): δ (ppm) 175.3, 156.3, 156.2, 138.3, 129.6, 129.2, 
128.6, 126.9, 125.7, 79.5, 64.2, 62.5, 52.3, 51.5, 50.6, 40.7, 32.5, 31.4, 29.8, 28.3, 22.8, 19.1, 
18.6; ESI-MS (CH3OH, positive ions): calculated m/z: 515.0 (MH+), 537.0 (MNa+), 553.0 
(MK+), found: 514.4, 536.4, 552.4. Compound 5 b: Yield: 30%. 1H NMR (300MHz, CDCl3): 
δ (ppm) 7.74 (d, 2H, J(H,H) = 8.1 Hz, CH aromatic tosyl group), 7.42-7.20 (m, 4H, CH 
aromatic 2-Cl-Z group), 7.20 (d, 2H, J(H,H) = 8.1 Hz, CH aromatic tosyl group), 6.46 (bs, 
2H, N-Hη arginine side chain), 5.11 (bs, 2H, CH2 2-Cl-Z group), 3.68 (s, 3H, CH3 methyl 
ester), 3.51 (bs, 1H, C(2)Hα), 3.25-3.10 (m, 5H, CH2 arginine side chain + lysine side chain + 
C(5)H α), 2.77-2.31 (m, 2H, Lysψ CH2), 2.36 (s, 3H, CH3 tosyl group), 1.89-1.21 (m, 10H, 
CH2 arginine side chain, CH2 lysine side chain), 1.38 ( s, 9H, CH3 Boc group.13 C NMR (75 
MHz, CDCl3): δ (ppm) 175.1, 156.7, 156.4, 156.2, 141.7, 140.9, 134.2, 133.1, 129.4, 129.3, 
129.1, 129.0, 126.7, 125.8, 79.2, 63.7, 60.8, 51.8, 51.6, 50.8, 40.7, 40.5, 32.2, 29.6, 29.4, 28.3, 
25.5, 22.6, 21.3. ESI-MS (CH3OH, positive ions): calculated m/z: 725.3 (MH+), 747.3 
(MNa+); found: 725.4, 747.4 
PNAs embedding NLS peptide 
125 
Compound 6 (a- Nα-Boc-L-Lysψ-(Nω-2-Cl-Zl)-L-Val-OH, b- Nα-Boc-L-Lysψ-(Nω-2-Cl-
Z)-L-Arg-(Nω-Tosyl)-OH). Compound 5 a Yield: 87% 1H NMR (300MHz, DMSO): δ 
(ppm) 7.50-7.32 (m, 4H, CH aromatic 2-Cl-Z group), 5.07 (s, 2H, CH2 2-Cl-Z group), 3.45 
(bs, 1H, C(2)Hα), 3.02-2.91 (m, 2H, CH2 lysine side chain), 2.91-2.80 (m, 1H, C(5)Hα), 
2.65-2.38 (m, 2H, Lysψ CH2), 1.50-1.15 (7H, m, CH2 lysine side chain, CH2 valine side 
chain), 1.37 ( s, 9H, CH3 Boc group), 0.88 (d, 6H, J(H,H) = 6.6 Hz, CH3 valine side chain). 
13C NMR (75 MHz, DMSO): δ (ppm) 173.3, 155.6, 155.4,134.5, 132.1, 129.5, 129.1, 127.1, 
79.3, 67.0, 62.3, 51.7, 49.5, 40.1, 31.5, 30.0, 29.1, 28.1, 22.6, 18.9, 18.4. ESI-MS (CH3OH, 
positive ions): calculated m/z: 500.0 (MH+), 522.0 (MNa+), 552.0 (MK+), found: 500.4, 522.3, 
552.3. Compound 6 b Yield: Quantitative. 1H NMR (300MHz , DMSO): δ (ppm) 7.62 (d, 
4H, J(H,H)= 8.0 Hz, CH aromatic tosyl group), 7.51-7.32 (m, 4H, m, 4H, CH aromatic 2-Cl-Z 
group), 7.27 (d, 4H, J(H,H) = 8.0 Hz, CH aromatic tosyl group), 6.72 (d, 1H, J(H,H) = 8.31 
Hz, N-Hη arginine side chain), 5.07 (s, 2H, CH2 2-Cl-Z group), 3.52 (bs, 1H, C(2)Hα), 3.11-
2.90 (m, 5H, CH2 arginine side chain + CH2 lysine side chain + C(5)Hα), 2.78-2.55 (m, 2H, 
Lysψ CH2), 2.33 (s, 3H, CH3 tosyl group), 1.63-1.12 (m, 10H, CH2 arginine side chain, CH2 
lysine side chain), 1.36 ( s, 9H, CH3 Boc group). 13C NMR (75 MHz, DMSO): δ (ppm) 172.8, 
156.7, 155.6, 155.3, 141.6, 140.8, 134.5, 132.1, 129.5, 129.1, 128.9, 127.1, 125.4, 79.2, 62.4, 
61.6, 50.4, 48.7, 40.1, 38.3 31.7, 29.1, 28.3, 28.1, 25.4, 22.5, 20.7. ESI-MS (CH3OH, negative 
ions): calculated m/z: 709.3 ([M-H]-), 745.6. ([MCl]-); found: 709.3, 709.3 
Nα-Boc-L-Lysψ-(Nω-2-Cl-Zl)-L-Val-(Nα-Fmoc)-OH (L-Lys-L-Val submonomer). 1H-NMR 
(300MHz, d6-DMSO): δ(ppm) 0.84 (d, J=6 Hz, 6H, CH3 Val), 1.32 (s, 9H, CH3 Boc), 1.0-1.6 
(m, 6H, -CH2-CH2-CH2- Lys), 2.4-2.5 (1H, m, CH Val)  2.8-3.6 (m, 6H, CH2-N Lys + CH2-N 
backbone + CHα Val + CHα Lys), 4.1-4.7 (m, 3H, CH-CH2 Fmoc), 5.07 (s, 2H, CH2 Z 
group), 7.2-7.5 (m, 8H, aromatic CH Fmoc + CH Z group), 7.64 (d, J=7Hz, 2H, CH aromatic 
Fmoc group), 7.86 (d, J=7Hz, 2H, CH aromatic Fmoc group). 13C-NMR (75 MHz, d6-
DMSO): δ(ppm) 19.1, 22.5, 27.6, 28.4, 29.2, 31.9, 40.6, 46.6, 50.0, 51.0, 52.0, 62.4, 66.3, 
77.3, 119.9, 124.7, 126.9, 127.1, 127.4, 129.1, 129.5, 132.1, 134.5, 140.7, 143.6, 143.7, 155.1, 
155.6, 156.5, 172.0. HRMS (ESI-MS, positive ions): calcd m/z for C39H48ClN3O8Na (MNa+): 
744.30277; found m/z: 744.30066. 
Nα-Boc-L-Lysψ-(Nω-2-Cl-Z)-L-Arg-(Nα-Fmoc)-(Nω-Tosyl)-OH (L-Lys-L-Arg 
submonomer).Yield: 18% 1H-NMR (300MHz, CDCl3): δ(ppm) 1.33 (s, 9H, CH3 Boc), 1.1-
1.8 (m, 10H, -CH2-CH2-CH2- Lys + -CH2-CH2- Arg side chains), 2.31 (s, 3H, CH3 tosyl 
group), 2.8-3.5 (m, 6H, CH2-N Arg + CH2-N Lys + CH2-N backbone), 3.5-3.8 (m, 2H, CHα 
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Arg + CHα Lys), 4.0-4.6 (m, 3H, CH-CH2 Fmoc), 5.16 (s, 2H, CH2 Z group), 6.40 (sb, 2H, 
NH), 7.2-7.4 (m, 9H, aromatic CH tosyl + CH Fmoc + CH Z group), 7.4-7.6 (m, 2H, CH 
aromatic Fmoc group), 7.7-7.8 (m, 5H, aromatic CH tosyl + CH Fmoc + CH Z group). 13C 
NMR (75 MHz, CDCl3): δ(ppm) 21.3, 22.6, 22.9, 26.6, 28.4, 29.4, 32.4, 40.3, 40.7, 47.1, 
50.3, 51.5, 63.7, 67.0, 77.1, 79.7, 119.2, 124.6, 126.0, 126.8, 127.1, 127.3, 127.5, 127.7, 
129.1, 129.3, 133.3, 134.3, 140.8, 141.2, 141.9, 143.7, 156.4, 156.6, 156.7, 156.8, 172.0. 
HRMS (ESI-MS, positive ions): calcd m/z for C47H58ClN6O10S (MH+): 933.36237; found 
m/z: 933.36298. 
Nα-Boc-L-Lysψ-(Nω-2-Cl-Z)-L-Lys-(Nα-Fmoc)-(Nω-2-Cl-Z)-OH (L-Lys-L-Lys 
submonomer). The synthesis and characterization of the submonomer of has already been 
already reported31. HRMS (ESI-MS, positive ions): calcd m/z for C48H56Cl2N4O10Na (MNa+): 
941.32712; found m/z: 941.32703.  
6.4.3 PNA and peptide synthesis 
The NLS peptide 1 and the achiral PNA 2 were synthesized by standard Boc-SPPS protocols 
on a ABI 433A synthesizer, following the procedures provided from the company, whereas 
modified PNA 3 (with or without the N-terminal proline) was synthesized by submonomeric 
strategy31. The syntheses were performed  on 25 mg of a preloaded Boc-Gly-MBHA-PS resin 
(loading 0.2 mmol/g). The synthetic cycle for the synthesis of modified PNA 3 were the 
following: Boc deprotection by neat TFA (added of 5% m-cresol), coupling of the desired 
chiral submonomer by using HATU/DIEA, Fmoc removal by piperidine/NMP (20%) and 
carboxymethyl-Z-adenine, carboxymethyl-O-benzyl-guanine or carboxymethyl-thymine 
coupling by using DIC/DhBtOH. In all cases an aminoethoxyethoxyacetyl  (AEEA) spacer 
and rhodamine B were coupled to the growing chains before the cleavage. The peptide and 
the PNAs were cleaved from the resin by using a 1:3 TFMSA/TFA mixture (10% thioanisole 
+ 10% m-cresol) and precipitated by Et2O. HPLC analyses of the crude products were carried 
out by LC/MS by using an analytical C18 column (3x250 mm, 5 µm, flow 0.5 ml/min), 
gradient elution from 100% H2O (0.2% HCOOH, eluent A) to 100% CH3CN (0.2%HCOOH, 
eluent B) in 30 min. MS acquisition in the positive ion mode, capillary voltage 3kV, cone 
voltage 30V, full scan acquisition from 150 to 1500 m/z. HPLC purifications of the crude 
products were carried out on a semipreparative Jupiter (Phenomenex) C18 column 
(10x300mm, 5 µm, flow 4 ml/min), gradient elution from 100% H2O (0.1% TFA, eluent A) to 
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100% CH3CN (0.1% TFA, eluent B) in 30 min. Final purity was checked by analytical HPLC 
and was always higher than 95%. 
NLS peptide 1: Rhodamine-(AEEA)-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-NH2 Crude yield: 
85%. ESI-MS, positive ions: calcd m/z 755.5 (MH22+), 504.0 (MH33+), 378.2 (MH44+), 302.8 
(MH55+), 252.5 (MH66+); found m/z 755.6, 503.8, 378.2, 302.8, 252.4. 
Standard PNA 2: Rhodamine-(AEEA)-ATG-Gly-NH2. Crude yield: 82%. ESI-MS, positive 
ions: calcd m/z 739.3(MH22+), 493.2 (MH33+), 370.2 (MH44+); found m/z 739.1, 493.1, 370.1. 
Modified PNA 3: Rhodamine-(AEEA)-Pro-A(2L,5L-Lys)T(2L-Arg,5L-Lys)G(2L-Val,5L-Lys)-Gly-NH2. 
Crude yield: 80%. ESI-MS, positive ions calcd m/z: 667.4 (MH33+), 500.8 (MH44+), 400.8 
(MH55+), 334.2 (MH66+); found m/z: 667.5, 500.8, 400.8, 334.2. 
Modified PNA 4 without N-terminal proline: Rhodamine-(AEEA)-A(5L, 2L-Lys)T(5L-Lys, 2L-
Arg)G(5L-Lys, 2L-Val)-Gly-NH2. Crude yield: 85%. ESI-MS, positive ions calcd m/z: 635.0 
(MH33+), 476.5 (MH44+), 381.4 (MH55+), 318.0 (MH66+); found m/z: 634.9, 476.5, 381.4, 
318.0. 
6.4.4 Fluorescence microscopy 
Fluorescence microscopy analysis to evaluate the intracellular localization of NLS peptide 1, 
standard PNA 2, modified PNA 3 and modifed PNA 4  in RH30 cells was done by the method 
previously described24. 
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